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ABSTRACT 
This thesis investigates the distribution and function of neuronal nitric oxide 
synthase (nNOS) in the inferior colliculus (IC) the principal midbrain nucleus in the 
auditory pathway. 
Firstly, experiments using immunocytochemistry and fluorescent microscopy in the 
rat IC showed two, previously unreported, different subcellular distributions of nNOS 
in the IC. Secondly, the presence of nNOS positive post-synaptic puncta in the 
central nucleus suggests that nNOS, contrary to previous reports, is not limited to 
the IC cortices. Expression of nNOS was observed in both glutamatergic and 
GABAergic cells. Cells expressing nNOS were shown to often contain calbindin or 
parvalbumin but rarely calretinin.  
In vivo electrophysiological experiments were conducted in the anaesthetised 
guinea pig. Recording of multiunit neuronal activity was combined with local reverse 
microdialysis of drugs in the IC.  
Dialysis of NMDA increased both spontaneous and sound driven activity in the IC 
in a dose dependent manner. These effects were blocked when NMDA was paired 
with L-MeArg, a NOS inhibitor, or ODQ, a soluble guanylate cyclase (sGC) inhibitor. 
These results suggest that NMDA receptor-mediated effects in the IC involve NO 
and its action on sGC. 
Systemic administration of sodium salicylate, a drug known to induce tinnitus, 
resulted in a doubling of spontaneous activity in the IC. In contrast, local delivery of 
salicylate in the IC reduced spontaneous activity in a time/concentration-dependent 
manner. Both locally and systemically administered salicylate influenced sound 
driven activity, suggesting these effects are, in part, mediated directly within the IC. 
No effect of L-MeArg was observed on the salicylate mediated effects, but this could 
be due to methodological issues.  
These results demonstrate that NO play plays a role in sound processing in the IC 
and further work is required to establish its functional significance. 
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Chapter  1. Introduction 
1.1 Opening statement 
This thesis will address the role of nitric oxide (NO) signalling in auditory processing in the 
inferior colliculus (IC), the principal midbrain nucleus of the auditory pathway.  
NO, a gaseous diatomic molecule, highly reactive, non-respiratory and lethal in high 
quantities, seems an odd choice for nature to use as a ubiquitous signalling molecule. NO 
is believed to be one of the earliest signalling molecules employed by organisms since the 
origins of life (Garthwaite, 2008). Today NO signalling is observed both in eukaryotes and 
prokaryotes and given the fact that it has been part of life right from the outset, it is perhaps 
less surprising to find that NO is so widely produced in the human body. NO relaxes 
vascular smooth muscle leading to vasodilation in the cardiovascular system but has also 
been shown to function as a neurotransmitter in the central nervous system. In the 
mammalian brain, NO is catalysed by neuronal nitric oxide synthase (nNOS) a protein that 
catalyses the conversion of L-Arginine to L-Citrulline and NO. nNOS is abundant throughout 
the brain, but expression is especially pronounced in the brainstem nuclei and cerebellum. 
Of all brainstem nuclei the inferior colliculus (IC) expresses the most nNOS, in fact, it 
expresses more nNOS than all other nuclei combined (Coote, 2008). Although nNOS has 
been identified in the IC, the functional properties of NO signalling in the IC are unknown. 
In this thesis, I will discuss the results of experiments that have started to address this 
question as well as investigate whether there is a link between NO and tinnitus.  
1.2 Organisation of the Thesis 
In order to get a better understanding about the cells that express nNOS in the IC. I will 
start this thesis with a broad introduction into the relevant topics that are required for the 
experiments that follow. Key topics that will be addressed are the IC, and its position within 
the auditory pathway, glutamate signalling, NMDA receptors, nNOS, NO, sGC, and tinnitus. 
Throughout the Introduction I will highlight the unknowns and identify gaps in our current 
knowledge and understanding, these gaps will be summarised at the end of the introduction 
and form the aims and hypothesis tested. Before presenting the experimental data, the 
methods used throughout this project are discussed in Chapter 2.  
In Chapter 3, the first data chapter, I will discuss studies investigating the distribution of 
NOS through the different subdivisions of the IC, and the neurotransmitter phenotypes of, 
and glutamatergic inputs to the neurons expressing NOS. Findings from the structural 
studies in Chapter 3 will feed forward into Chapter 4 in which I will present 
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electrophysiological recordings from experiments that aim to learn more about the 
functional role NO has on auditory processing in the IC. NOS activity has traditionally 
always been described as being closely associated with the NMDA receptors for reasons I 
will discuss below, therefore the studies presented in the second results chapter (Chapter 
4) first investigate the functional role of the NMDA receptor in the responses to auditory 
stimuli and then the interaction of NMDA receptor signalling with NO. Animal models of 
tinnitus have shown upregulation of NOS expressing neurons in auditory brainstem nuclei, 
suggesting that NO signalling might be related to tinnitus, and in Chapter 5 I present 
electrophysiological data recorded in a salicylate based animal model of tinnitus. The 
literature discussion from the Introduction and the data discussed in the Chapters 3, 4 and 
5 will be summarised and synthesized in Chapter 6 in a final discussion. 
The three data chapters aim to further our understanding of NOS and NO signalling in the 
IC, but before this data is discussed, I will first introduce a number of topics which at first 
may seem unrelated but are all of vital importance to understanding the full picture.  
I will start this Introduction with a discussion of the IC and its place in the auditory brainstem 
pathway, with a particular focus on the structures and connections that are important to 
understanding the role of the IC in auditory processing. I will discuss the main cell types 
and neurotransmission occurring in the IC along with some markers of specific 
neurotransmitter phenotypes. The neurotransmitter phenotypes will bring me to focus on 
glutamatergic neurotransmission and in particular on the NMDA receptor. NMDA receptor 
activity has been linked to the production of NO and is therefore of special interest. Once 
this link is clear I will explain the NOS protein followed by a discussion of the NO signalling 
cascade. Because there is a potential link between NO, NMDA and tinnitus I will give a 
short background on tinnitus and highlight some key elements from the tinnitus research, I 
will focus on the studies using salicylate to induce tinnitus because in Chapter 5 data 
extending previous work on salicylate models of tinnitus will be presented. Therefore in the 
Introduction some discussion of how salicylate affects the brain and the auditory pathway 
is required.  
1.3 The IC and the Auditory Brainstem Pathway 
The auditory system is capable of transducing and perceiving an astonishingly large 
spectrum of frequencies and levels, which in the form of complex sounds, such as 
conspecific vocalisations and in human speech and music, can be perceived and localised 
in space and time with remarkable accuracy. Unlike vision where objects imaged on the 
retina are spatially organised, the location of a sound source is not extracted at the sense 
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organ (cochlea), it requires the auditory brainstem pathway to compare the inputs from the 
two ears. Furthermore, because sounds are rapidly changing waveforms the encoding of 
precise timing is critical in auditory processing. Highly specialised mechanisms are required 
to extract these features. Neurons in the auditory pathway display some of fastest spike 
rates observed in the central nervous system (Altschuler and Shore, 2010). Therefore, the 
organisation of the auditory brainstem pathway leading to the cortex is more complex 
compared to the visual, olfactory and gustatory systems which have shorter, more direct 
pathways to the cortex. All features extracted in the auditory brainstem pathway are 
projected to the IC, the principal midbrain nucleus in the auditory pathway that processes 
virtually all ascending information before projecting it to the medial geniculate body (MGB) 
the auditory thalamus.  
The inferior colliculus (IC), meaning lower (posterior) hill in Latin, is located in the posterior 
half of the midbrain, one colliculus in each hemisphere, connected to one another through 
the commissure. The IC colliculi lay caudal to the superior colliculus together with which it 
forms the tectum. The IC is traditionally described as comprised of three principal 
subdivisions, the central nucleus, the dorsal cortex, and the lateral or external cortex as 
depicted in Figure 1-1. Although within these subdivisions distinct nuclei that differ in 
neuronal structure (Morest and Oliver, 1984; Malmierca et al., 2005) and cytoarchitectual 
makeup (Chernock et al., 2004) have been recognised.  
The central nucleus is easily recognised in Golgi labelled preparations by the laminated 
neuropil showing disc shaped dendritic fields (Figure 1-1 Left ), whereas the cortices show 
a more loosely defined neuropil labelling, with layers running orthogonal to those in the 
central nucleus (Jhaveri and Morest, 1982). The subdivisions based on Golgi labelling were 
suggested to have strict boundaries, however, although labelling protocols employing 
NADPH diaphorase and immunohistochemistry targeting NOS and other markers (e.g. 
calcium binding proteins) largely follow that architecture, the boundaries appear to be more 
gradual than previously believed (Druga and Syka, 1993; Coote and Rees, 2008) (Oliver, 
2005a).  
1.3.1 The IC Structure
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Figure 1-1 Left: a Golgi-impregnated IC coronal section in cat showing the neuronal organisation in the three regions 
of the IC; the dorsal cortex, the lateral cortex and the central nucleus. Adapted from Morest and Oliver 1984. Right: 
a schematic drawing of the IC, the arrows indicate its main sources of input. Blue indicates ascending stream of 
information, while red represent the corticofugal innervation. 
The lateral and dorsal cortex receive relatively little ascending auditory input from lower 
level brain stem nuclei and are believed to get their auditory information from intracollicular 
connections arising from the central nucleus (Malmierca et al., 1995) and corticofugal 
connections from the cortex (Winer et al., 1998). The nuclei in the lateral cortex have been 
described as being multisensory and receive input from and send projections to both 
auditory and non-auditory structures. Somatosensory information has been shown to 
influence auditory processing in the inferior colliculus (Aitkin et al., 1978; Aitkin et al., 1981; 
Szczepaniak and Møller, 1993). Although the auditory cortex has been shown to project 
most intensely to the dorsal and lateral cortex, a gradient of corticofugal projections that 
extends well into the central nucleus has been demonstrated (Feliciano and Potashner, 
1995), indicating that the auditory cortex directly influences auditory processing in the IC.  
The central nucleus is exclusively involved in auditory processing and is an absolute 
requirement for normal auditory processing (Tokunaga et al., 1984; Jenkins and Masterton, 
1982; Kelly and Kavanagh, 1994). The central nucleus is a highly laminated structure which 
receives the bulk of its information from ascending glutamatergic projections (Winer and 
Schreiner, 2005b; Ito et al., 2009). Like many other auditory structures, the central nucleus 
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has a tonotopic organisation that preserves the tonotopic map from the basilar membrane. 
(Rose et al., 1966; Merzenich and Reid, 1974). The innervating fibres tuned to low 
frequencies terminating in the dorsal areas of the central nucleus whereas the fibres tuned 
to high frequencies terminate in ventral areas of the central nucleus.  
The IC is strategically placed at the top of the brain stem and is a central hub for auditory 
information. The IC receives and processes virtually all ascending auditory information from 
the lower level auditory brainstem nuclei before projecting it onwards to the auditory 
thalamus (MGB). In addition to these ascending projections, the IC receives direct 
projections from its contralateral counterpart as well as corticofugal projections from the 
auditory cortex (Malmierca, 2004). The most important projections the IC receives are 
summarised in Figure 1-2. 
Auditory brainstem pathway 
The changes in air pressure which constitute sound waves are mechanically transmitted 
through the outer and middle ear to be transduced by the hair cells on the basilar membrane 
in the organ of Corti in the cochlea. The sound pressure fluctuations in the acoustic 
environment are conducted by the middle ear to evoke pressure waves in the cochlear fluid. 
The one row of inner hair cells forming part of the organ of Corti sitting on the basilar 
membrane detect these pressure waves and transduces them into action potentials which 
leave the cochlea via the auditory nerve (AN) (Dallos, 1992; Fettiplace and Hackney, 2006). 
The mammalian cochlea also contains three rows of outer hair cells, which are involved in 
amplifying the travelling wave on the basilar membrane evoked by the incoming stimuli 
(Dallos, 1992). The transduced signals from the cochlea enter the brainstem via the auditory 
nerve (AN), which is the first site in the auditory pathway where action potentials relaying 
auditory information are observed.  
1.3.2 Input to the IC 
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Figure 1-2 Auditory pathway highlighting the projections to the IC. Solid lines: Glutamatergic projections, Dashed 
lines: GABAergic projections. Terminals are indicated by triangles. The major pathways (DAS, IAS and 
VAS/Trapezoid body arising from distinct cell types in the CNC (blue rectangle). Abbreviations: OHC(outer hair cells), 
IHC(inner hair cells), AN (Auditory nerve),CNC (cochlear nuclear complex) GBC (globular bushy cells), SBC 
(spherical bushy cells), T-M (T-stellate cells), D-M (D-stellate cells), O (octopus cells), PY (pyramidal cells), Gi (giant 
cells), DAS, IAS and VAS (dorsal, intermediate and ventral acoustic striae), LnTB (lateral nucleus of the trapezoid 
body), MnTB (medial nucleus of the trapezoid body), MSO (medial superior olive), LSO (lateral superior olive), SPN 
(superior paraolivary nucleus), nLL (nucleus of the lateral lemniscus), IC (inferior colliculus),COM (commissure of 
the IC), AC (auditory cortex), MGB (medial geniculate body).Figure adapted with permission from (original by) Prof. 
E.D. Young.  
The auditory nerve bifurcates in the cochlear nuclear complex (CNC) with one branch 
innervating the anterior ventral cochlear nucleus (AVCN) and the other innervating both the 
dorsal cochlear nucleus (DCN) and the posterior ventral cochlear nucleus (PVCN) which in 
turn also innervates the DCN. The tonotopic organisation from the basilar membrane is 
preserved in all three sub nuclei (Ryugo and Parks, 2003). The AN fibres terminate on 
distinct highly specialised cell types that in turn give rise to three principal parallel auditory 
processing pathways the dorsal, intermediate and ventral acoustic striae (DAS, IAS and 
VAS/trapezoid body). The specialised cells in the CNC and the pathways they give rise to 
are illustrated in Figure 1-2. The five major cell types have distinct morphologies and 
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electrophysiological profiles and are associated with specific auditory information and 
unique projections to other auditory structures.  
Pyramidal and giant cells project directly from the DCN through the DAS to the contralateral 
IC. Octopus cells project via the IAS to the contralateral superior paraolivary nucleus (SPN) 
and to the ventral nuclei of the lateral lemniscus (VnLL), which in turn projects to the IC 
(Cant and Benson, 2003). Octopus cells are the only cells in the CNC that do not receive 
any form of inhibitory input (Osen et al., 1991) and are believed to signal pitch. The 
multipolar cells are signalling for the spectral properties of the sound. The D-stellate cells 
project from the CNC directly to the contralateral CNC (Doucet and Ryugo, 1997) and have 
been shown to be the only glycinergic projections to arise from the CNC (Kolston et al., 
1992). The T-stellate cells project through the VAS to both the central nucleus of the IC and 
to the (nLL) which in turn also projects to the central nucleus of the IC (Adams, 1979; 
Malmierca et al., 2005). The spherical bushy cells in the VCN project to the medial superior 
olive (MSO) and the lateral superior olive (LSO). The projections to the MSO are bilateral 
with symmetrical connections on both sides (Cant and Benson, 2003). The globular bushy 
cells form large synapses on the contralateral medial nucleus of the trapezoid body (MnTB) 
which in turn projects an inhibitory glycinergic input to the MSO and LSO (Cant and Hyson, 
1992). The globular bushy cells also synapse on the lateral nucleus of the trapezoid body 
(LnTB) which sends glycinergic projections to the MSO and back to the CNC (not shown in 
Figure 1-2). The MSO and LSO receive their excitatory input from the spherical bushy cells 
and their inhibitory, largely glycinergic input indirectly from the globular bushy cells via the 
MnTB (Cant and Hyson, 1992). Owing to the fact that both the LSO and the MSO receive 
symmetrical input from both ears allows these centres to perform calculations necessary 
for sound localisation in the horizontal plane (Shepherd, 2003). The projections of the CNC 
via the MSO to the nLL and the IC are largely concerned with processing of interaural time 
difference, and those from the CNC via the LSO and nLL to the IC are principally concerned 
with interaural level differences. The direct connections from the DCN to the IC carry pinna 
cues that allow for the location of sounds in the vertical plane.  
On top of this large number of ascending neuronal connections, the IC receives a vast 
number of corticofugal projections from the AC and MGB, which constitute top down inputs. 
Although, the AC and MGB also project to some of the lower level auditory brainstem nuclei 
independent from the IC (Schofield, 2010).  
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The main target of axonal efferent IC projections is the MGB of the thalamus, the 
connections are bilateral (Andersen et al., 1980) and the projections from the central 
nucleus of the IC to the ventral MGB retain their tonotopic organisation but are unusual in 
the sense that these projections are both glutamatergic and GABAergic (Winer et al., 1996; 
Gelfand, 2016). The IC also has extensive intrinsic connections and forms dense 
commissural connections with its counterpart in the other hemisphere (Malmierca et al., 
1995).  
Retrograde and anterograde tracer studies showed that the central nucleus of the IC has 
direct descending projections to the dorsal nLL, the SPN, MSO, lateral regions of the LSO, 
the ventral nucleus of the trapezoid body and the CNC (Malmierca and Rees, 1996; Oliver 
et al., 1999). The external cortex of the IC has been shown to send projections to nucleus 
sagulum, the rostral periolivary nucleus, the ventral nucleus of the trapezoid body and again 
the CNC (Caicedo and Herbert, 1993).  
The IC also projects to the amygdala via the MGB, and these connection are likely to 
mediate aversive responses (LeDoux et al., 1984). Although the central nucleus is generally 
described as being auditory some studies have shown that manipulating neuronal activity 
in the ventral central nucleus of the IC can impact motor behaviour (De Araújo Moreira et 
al., 2003) suggesting that the central nucleus does project to non-auditory brain regions. 
The IC also receives some projections from and sends some projections to non-auditory 
structures (e.g. the tegmentum, the substantia nigra, the superior colliculus as well as the 
spinal trigeminal and posterior column nuclei) (Tokunaga et al., 1984) suggesting direct 
involvement in multisensory integration as well as direct links to orienting behaviour 
(Casseday et al., 2002; Malmierca, 2004).  
Thus the main target of the IC is the MGB, but the IC also projects to many of the auditory 
structures it receives input from and also has direct inputs to the striatum and sensorimotor 
areas which are presumed to be related to orienting behaviours necessary for survival (De 
Araújo Moreira et al., 2003).  
 
 
 
1.3.3 Outputs of the IC 
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Thus, four general principles govern the auditory pathway. Firstly, the separation of 
information is already initiated at the first relay station, the cochlear nuclei. Secondly, the 
information is processed in highly segregated and parallel pathways dedicated to specific 
features (frequency, level and timing) of the auditory stimuli. Thirdly, there are many 
bilateral and commissural projections, such that unilateral lesions within the auditory 
pathway rarely give rise to hearing deficits in one ear (Hudspeth 2000). Finally, the auditory 
system has many descending projections from the auditory cortex to almost all brainstem 
nuclei, suggesting a bidirectional flow of information (Malmierca and Hackett 2010, 
Schofield 2010, Bajo and King 2012, Nakamoto, Mellott et al. 2013).  
1.4 Neuronal Organisation of the IC 
The five distinct cell populations in the CNC that give rise to these parallel pathways 
dedicated to the processing of frequency, level and timing have each their unique 
morphological characteristics and electrophysiological response profiles, that makes them 
readily identifiable. Virtually all activity that originates from these five populations that travel 
through the DAS, IAS and VAS is eventually projected to the IC. However, in the IC the 
unique and direct mapping of cell morphology to electrophysiological response profile no 
longer exists. The IC expresses an astonishing number of different cell types and response 
patterns depending on the subdivision in question and even within these regions a wide 
variety of cell types and responses have been reported. In spite of this complexity, some 
broad classes of neurons have been described in the IC. 
The laminar organisation of the central nucleus that provides the structural basis for the 
tonotopic organisation is observed in all species (Schreiner and Langner, 1997). In Golgi 
preparations of the rat IC, two broad classes of cells are recognised in the IC, the so called 
flat cells and less flat cells (Malmierca et al., 1993). The flat and less flat cells broadly 
correspond to the previously described disc-shaped and stellate cells described in the cat 
IC (Morest and Oliver, 1984). The flat cells have dense dendritic sprouting which is 
approximately 50 µm wide, they are oriented parallel to the incoming ascending nerve fibres 
and form one cell thick laminae (Faye-Lund and Osen, 1985). The laminae comprised of 
the flat cells are separated by interlaminar layers which are populated by the less flat cells 
which have less dense dendritic sprouting, but cover a wider area, approximately 100 µm 
1.3.4 Conclusion IC and Auditory Pathway
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(Malmierca et al., 1993). The interlaminar compartments are less distinct in the dorsal layers 
of the central nucleus and it is likely distinct subtypes exist within these two broad 
subclasses of neurons. Thus far no direct correlation between morphology and 
electrophysiological response profile has been observed (Sivaramakrishnan and Oliver, 
2001; Wallace et al., 2012).  
Other methods of classifying cells investigate the protein content of the cells. Markers to be 
discussed here are NADPH diaphorase, calcium binding proteins and the vesicular 
transporters VGLUT1 and VGLUT2.  
NADPH Diaphorase 
NADPH diaphorase was shown to label exclusively nitric oxide synthase in glutaraldehyde 
fixed preparations (Bredt et al., 1991; Dawson et al., 1991; Hope et al., 1991). NADPH 
diaphorase preparations show dense neuropil labelling in the dorsal and lateral cortex 
leaves the central nucleus virtually unlabelled, suggesting that little to no NOS is expressed 
in the central nucleus (Druga and Syka, 1993). NADPH diaphorase has been shown to 
exclusively label these three NOS proteins (Bredt et al., 1991; Dawson et al., 1991; Hope 
et al., 1991) and has enabled identification of tissues and brain-regions expressing these 
genes.  
Calcium binding proteins 
The three calcium binding proteins, calbindin D-28k, calretinin and parvalbumin are three 
of the best known members of a large superfamily of EF-hand calcium binding proteins. 
These three proteins are the most abundant fast acting cytoplasmic calcium buffers in the 
central nervous system and are often implicated in neurological disorders and age related 
decline. They have also been used extensively as cell type markers in studies of the central 
nervous system. In the cerebral cortex, the EF-hand calcium binding protein parvalbumin 
has been shown to mark a distinct group of GABAergic interneurons (Cowan et al., 1990; 
Demeulemeester et al., 1991; Schwaller et al., 2002).  
Calcium binding proteins are involved in calcium signalling and maintaining calcium 
homeostasis and can be broadly subdivided into two different classes, the calcium buffering 
class and a calcium sensor class (Schwaller, 2009). Although the boundaries between 
these classes have begun to blur, the distinction is still relevant. Calcium sensors depend 
on specific calcium levels to undergo a conformational change which acts as an on-off 
switch (Ikura, 1996). One of the most studied calcium sensors is calmodulin and this still 
serves as a prototypical calcium binding protein (Kretsinger and Wasserman, 1980). 
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Calmodulin is essential for the functioning of NOS. Whilst calcium sensor proteins undergo 
a conformational change and can alter downstream signalling, calcium buffering proteins 
show no sign of this but seem purely to regulate intracellular calcium levels (Augustine et 
al., 2003). Calbindin and calretinin have been shown to have calcium sensor functions 
whereas parvalbumin is believed to be a true calcium buffer due to the absence of a 
conformational change by binding calcium (Baldellon et al., 1998). 
In humans over 240 different EF-hand proteins have been identified thus far. Within this 
family, two calbindin proteins are known, calbindin D-9k and calbindin D-28k, where the D 
signifies their dependence on vitamin D and the numbers refer to their molecular weight in 
kDa (Schwaller, 2009). In spite of their similar names, there is little similarity between these 
two proteins. In this thesis wherever calbindin is mentioned this will refer to calbindin D-28k, 
which is closely related to calretinin.  
In the IC the calcium binding proteins calbindin, calretinin and parvalbumin have been 
shown to delineate the three subdivisions remarkably well. Parvalbumin has been shown 
to be densely expressed in the central nucleus while calbindin and calretinin are exclusively 
expressed in the dorsal and lateral cortex (Oliver, 2005a) although the specific roles of the 
cells expressing them are largely unknown.  
Vesicular transporters 
The vesicular transporters VGLUT1, VGLUT2 and VGLUT3 have been used extensively as 
markers for glutamatergic neurotransmission. Because glutamate is present in all cells, it 
has been difficult to identify glutamatergic cells. The VGLUTs are transporters responsible 
for packaging glutamate into vesicles, and as such are present only in cells which use 
glutamate as a neurotransmitter (Altschuler et al., 2008; Altschuler and Shore, 2010). There 
is no evidence for the presence of VGLUT3 positive terminals in the IC (Ito et al., 2009) and 
they will not be discussed further. Both VGLUT1 and VGLUT2 positive terminals have been 
observed in abundance in the IC (Altschuler et al., 2008; Ito et al., 2009; Altschuler and 
Shore, 2010).  
Thus far no evidence has been found suggesting that VGLUT1 is synthesized in the IC 
indicating that these terminals are projections from elsewhere, but predominantly from the 
cortex (Ito et al., 2011; Fujimoto et al., 2016). In situ hybridization studies have shown that 
only VGLUT2 is actively synthesized in the IC (Ito and Oliver, 2010; Ito et al., 2011; Fujimoto 
et al., 2016) as well as in other auditory brainstem structures. Cells receiving only VGLUT2 
terminals are therefore necessarily connections from lower level auditory structures to the 
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IC or internal connections. Cells receiving mixed terminals containing both VGLUT1 and 
VGLUT2 have been shown to originate largely from the VCN with minor contributions from 
the SOC and the nLL (Ito and Oliver, 2010). Altschuler et al. (2008) reported that large cells 
in the IC were surrounded densely by VGLUT2 positive terminals, which were later shown 
to be large GABAergic neurons in the central nucleus of the IC (Ito et al., 2009). Smaller 
GABAergic cells did not receive this dense input onto their cell bodies.  
Conclusion Cell Types in the IC 
Cell morphology and protein content can tell us about the functions cells perform, but 
neurons transmit information to the cells with which they connect, and their phenotypical 
neurotransmitter profile can tell us whether cells are excitatory or inhibitory in nature. 
Because this phenotypical neurotransmitter profile is important for this thesis this topic has 
its own section but forms a natural extension of the types of cells expressed in the IC. 
Whether a neurotransmitter exerts an excitatory or inhibitory effect on the recipient cell is 
governed by the receptor, not the signalling molecule itself. However, glutamate is 
recognised as an excitatory neurotransmitter in the adult mammalian nervous system 
whereas gamma-aminobutyric acid (GABA) and glycine mediate inhibitory signalling in the 
adult mammalian nervous system.  
1.5 Transmitter Phenotype in the IC 
It comes as no surprise that a structure that receives a diverse set of the inputs from a large 
number of distinct brain regions shows immunoreactivity for a wide variety of 
neurotransmitters, among which but not limited to glutamate, glycine, GABA, dopamine, 
serotonin and acetylcholine (Wynne et al., 1995; Winer and Schreiner, 2005a). However, 
the only two neurotransmitters synthesized in the IC are glutamate and GABA. About 20-
25% of the neurons in the IC are believed to be GABAergic (Riquelme et al., 2001; Merchán 
et al., 2005), and because there are no glycinergic cell bodies in the IC, the remaining 
neurons are believed to be glutamatergic and hence involved in excitatory 
neurotransmission. Since only GABA and glutamate are synthesized in the IC, I will focus 
the discussion on those two neurotransmitters. 
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GABA is the main inhibitory neurotransmitter in the adult nervous system of vertebrates. 
Exogenous GABA cannot penetrate the blood brain barrier and has to be produced within 
the brain. The production of GABA is governed by glutamate decarboxylase (GAD). GAD 
catalyses the decarboxylation of glutamate to GABA and carbon dioxide. In mammals two 
isoforms, GAD65 and GAD67, with distinct subcellular location are known, the numbers 
refer to their respective molecular weight in kDa. GAD67 is cytosolic and can be found 
anywhere in the cell whereas GAD65 is only found in the terminals (Esclapez et al., 1994). 
Cells expressing either or both GAD proteins are able to catalyse the reaction from 
glutamate to GABA are considered to be GABAergic. 
The IC receives ascending GABAergic and glycinergic projections from the lower brainstem 
nuclei as well as descending GABAergic projections from the auditory cortex. In addition, 
the IC contains GABAergic cell bodies that project internally and via commissural 
connections to the contralateral IC. The IC sends GABAergic ascending projections to the 
MGB and descending projections to the lower level auditory brainstem nuclei (Schofield, 
2010; Malmierca, 2010). 
GABA has been shown to play a crucial role in temporal processing and sound localisation 
in the IC (Caspary et al., 2008). GABA and glycinergic synapses in the central nucleus of 
the IC are actively involved in generating frequency-responses areas (LeBeau et al., 2001), 
as well as strongly influencing the temporal response patterns (Le Beau et al., 1996). Thus 
indicating that the IC plays an active role in shaping the auditory precepts it projects to the 
MGB.  
Also GABA projections from the IC to pedunculopontine tegmental nucleus, the laterodorsal 
tegmental nucleus and substantia nigra pars reticulata have been related to pre-pulse 
inhibition of the startle reflex (Fendt et al., 2001) and reduced GABAergic activity in the IC 
has been shown to be involved in the generation of audiogenic seizures (Faingold, 2002). 
Due to the transitory nature of sound, any system trying to capture, analyse and extract 
information from the auditory environment has only a short time window in which to do so. 
The brain goes to extraordinary lengths to capture and analyse as much information from 
the auditory environment as it can. Excitatory neurotransmission is of essential importance 
for the relay of the sound signals, transduced in the cochlea, to the auditory cortex. The 
1.5.1 GABA
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main neurotransmitter employed in excitatory neurotransmission anywhere in the 
vertebrate brain, accounting for around 90% of the total synaptic connections in the brain, 
is the amino acid glutamate (Meldrum, 2000). Glutamate has been shown to be the main 
excitatory neurotransmitter in the IC (Faingold et al., 1989; Kelly and Caspary, 2005) and 
the release of glutamate is detected and transduced by a set of glutamate receptors with 
distinct properties.  
Glutamate receptors come in two families, both of which are present in the IC, the ionotropic 
and the metabotropic receptors; both comprise a substantial number of family members 
with different properties (Meldrum, 2000). The ionotropic, ligand-gated ion channel 
receptors are fast acting, whereas the metabotropic G-coupled receptor proteins produce 
slower, longer lasting signals. Within the ionotropic family, we recognise three different 
types of ionotropic glutamate receptors which derive their name from the pharmacological 
agonists that selectively bind to these receptors (Patneau and Mayer, 1990; Dingledine et 
al., 1999; Platt, 2007). The α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) 
and N-methyl-D-aspartate (NMDA) receptors are the most abundant in the auditory 
pathway (Parks, 2000), therefore I will focus on those two and not discuss the third class of 
ionotropic glutamate receptors, the kainate receptor.  
The permeability of the AMPA and NMDA receptors to the cations calcium (Ca2+), sodium 
(Na+) and potassium (K+) is determined by the subunit composition (Dingledine et al., 1999; 
Platt, 2007). The subunit configuration of AMPA and NMDA receptors varies between brain 
areas, cells and even between individual synapses of the same cell (Martin et al., 1993; 
Law et al., 2003; Altschuler and Shore, 2010). AMPA receptors and NMDA receptors are 
usually expressed in the same cells and fulfil complimentary roles (Ma et al., 2002).  
In the auditory brainstem pathway, a specific AMPA receptor subunit composition dubbed 
‘auditory specific’ is described in all brainstem nuclei (Trussell, 1997). This specific AMPA 
subunit composition results in rapid deactivation and desensitisation and leads to a 
relatively high permeability to Ca2+ (Hollmann and Heinemann, 1994). This ‘auditory 
specific’ composition is observed in virtually all auditory brainstem nuclei but is absent in 
the IC (Schmid et al., 2001), where the AMPA subunit composition in the IC confers a low 
Ca2+ permeability.  
1.5.3 Glutamate Receptors
1.5.4 AMPA Receptors
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Although exceptional circumstances exist as discussed below, glutamate exerts its initial 
and almost instantaneous effect by binding to the AMPA receptors. Binding of glutamate to 
the AMPA receptor opens the ion channel almost instantaneously (Tzschentke, 2002) but 
AMPA receptors undergo rapid deactivation and desensitisation, the ion channels governed 
by the receptor can close within one millisecond of activation (Platt, 2007), allowing neurons 
expressing this receptor to display incredibly fast firing rates. These firing rates allow the 
auditory system the fast temporal coding required to keep up with the acoustic environment.  
In resting state conditions the NMDA receptors are blocked in a voltage dependent manner 
by extracellular magnesium (Mg2+) preventing the opening of the ion channel (Kelly and 
Zhang, 2002). The activation of the AMPA receptor causes a depolarisation of the cell 
membrane and repels the Mg2+ from the NMDA receptor allowing the glutamate, or any 
other NMDA receptor agonist, to bind to the NMDA receptor and open the ion channels 
allowing the cations calcium (Ca2+), sodium (Na+) and potassium (K+) to flow through the 
channel in a voltage dependent manner.  
NMDA receptor coupled ion channels open about 10 ms after the release of glutamate in 
the synaptic cleft and can remain open for hundreds of milliseconds, only closing when 
glutamate detaches from the receptor (Dzubay and Jahr, 1996). NMDA receptors are built 
from a variety of subunits with a mandatory GluN1 subunit and a variable mix of GluN2A, 
B, C or D and GluN3A or B subunits: although a functional receptor requires at least one 
GluN2 subunit. The NMDA receptor possesses two agonist binding sites and requires 
glycine as co-agonist to glutamate (Kleckner and Dingledine, 1988) (Johnson and Ascher, 
1987). Receptors with a blocked or unoccupied glycine binding site will not be able to 
respond to the binding of glutamate (Qian and Johnson, 2002). It is generally believed that 
glycine binds to GluN1 and glutamate to the GluN2 subunits explaining the need to have 
both a GluN1 and GluN2 subunit in a functional NMDA receptor complex (Cull-Candy et al., 
2001). NMDA receptor subunit composition in the auditory brainstem structures has been 
shown to change during maturation and aging. Young and developing auditory structures 
show high expression of GluN2A subunits which are characterised by fast but relatively 
short lived opening times of the associated ion channels, lasting tens of milliseconds. 
Mature auditory structures show less GluN2A in favour of GluN2B resulting in long opening 
times in the hundred plus millisecond range (Faingold et al., 1989; Knipper et al., 1997; 
Knipper et al., 2013; Van De Heyning et al., 2014). Gene expression studies investigating 
the different subunits show that the mRNA of the GluN1A receptor is by far the most 
1.5.5 NMDA Receptors
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expressed in the IC making up over 93% of the mRNA related to NMDA receptors 
expressed (Goebel and Poosch, 1999). The remaining 7% is reasonably equally divided 
among the other subunits with a slight preference for GluN2D and GluN3A of which the 
latter makes the receptor less permeable to calcium (Goebel and Poosch, 1999; Cull-Candy 
et al., 2001). However, these findings do not necessarily relate to the protein content of the 
cells because, due to post translational processes, mRNA expression levels do not 
translate one to one to protein content. Currently, the NMDA subunit composition at the 
protein level among the subdivisions of the IC is unknown.  
NMDA receptor activity in the cochlea and auditory brainstem pathway has been linked to 
several pathological states. Blocking NMDA functioning with an NMDA antagonist post 
noise trauma delayed the reformation of synapses and restoration of cochlear functioning 
(D'Aldin et al., 1997). Although NMDA receptor activity was shown to have neuroprotective 
effects in age related hearing loss in spiral ganglion cells (Peng et al., 2013), hyperactivity 
of this receptor has been linked to long lasting and/or permanent neuronal damage. This is 
believed to be related to prolonged influx of calcium in the cells, due to the NMDA receptor 
activity, triggering several signalling cascades and ultimately resulting in cell death (Sahley 
et al., 2013). Reducing NMDA receptor activity following noise-induced trauma has been 
shown to reduce chronic damage to the cochlea (Puel et al., 1998) and prevents salicylate-
induced tinnitus (Puel, 2007).  
The speed with which the AMPA currents are generated throughout the auditory brainstem 
pathway is important for the maintenance of high fidelity signalling and underlies the 
pathway’s fast and precise temporal coding (Trussell, 1998; Sanchez et al., 2015). AMPA 
receptors are mainly involved in the short latency responses (<20 ms), of a cell to the 
presence of glutamate, whereas the NMDA receptors are more heavily involved in 
maintaining and modulating the later, longer lasting (>100 ms) cellular response to the 
release of glutamate (Ma et al., 2002).  
Although dominated by AMPA receptor-related mechanisms, the fast spiking process in the 
IC is not completely independent of NMDA receptors and, a subset of NMDA receptors has 
been shown to be involved in fast spiking activity. Blocking these NMDA receptors, 
abolished the neurotransmission completely, including the early components of the cellular 
response, indicating that both AMPA and NMDA receptors are required for successful 
neurotransmission in the IC (Sanchez et al., 2007). The effects of the NMDA receptor on 
1.5.6 Glutamate Signalling in the IC
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the early component of the cellular response are most likely governed by subunit GluN2D 
which has a lower affinity for magnesium in resting state conditions (Kirson and Yaari, 1996) 
and in in-vitro studies has been shown to trigger action potentials without the need for 
depolarization caused by AMPA receptors (Wenzel et al., 1996) (Sivaramakrishnan and 
Oliver, 2006). In vitro studies show that NMDA receptor activity can actively regulate surface 
AMPA receptors (Noel et al., 1999; Beattie et al., 2000). In vivo studies have shown that by 
blocking NMDA mediated activity, the number of AMPA receptors are decreased (Chen et 
al., 2007).  
Even though both NMDA and AMPA receptors can be involved in the generation of 
immediate fast spiking activity, for the majority of IC neurons, it is the AMPA receptor that 
facilitates the immediate response to the release of glutamate while the NMDA receptor 
modulates this response (Bengzon et al., 1999; Altschuler and Shore, 2010). NMDA 
receptors in the IC have been shown to be an required for long term potentiation (LTP) to 
take place (Zhang and Wu, 2000). A recent study suggests that NMDA receptors in the IC 
appear to be involved in LTP and long term depression (LTD) type processes in young 
animals, although, it remains uncertain whether this is true in mature animals (Sanchez et 
al., 2015).  
The influx of calcium through the NMDA receptor is thought to underlie the involvement of 
the NMDA receptor in processes that underlie neural plasticity and subsequently facilitates 
learning and memory (Maren and Baudry, 1995; Feldman and Knudsen, 1998; Lee et al., 
2009; Li and Tsien, 2009) (Sanchez et al., 2015). Non-NMDA glutamate receptors in the IC 
have been shown to have little permeability to calcium (Dingledine et al., 1999; Meldrum, 
2000; Platt, 2007) (Pellegrini-Giampietro et al., 1997). Thus most calcium enters the cell 
through the NMDA receptor channel, triggering several secondary signalling cascades.  
The NMDA receptor is anchored in the post synaptic density via its interaction with PSD95, 
a post synaptic density scaffolding protein. PSD95, as will be discussed in Section 1.7, also 
associates nNOS and underlies the close coupling in activity observed between the NMDA 
receptor activity and nNOS activity.  
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1.6 Nitric Oxide Synthase and Nitric Oxide  
The catalysis of NO in all mammals is governed by the nitric oxide synthase (NOS) family. 
This family of proteins catalyse the enzymatic conversion of L-arginine to L-citrulline and 
NO (Alderton et al., 2001; Steinert et al., 2010). In mammals three NOS genes are 
recognised two of which derive their name from the tissues in which they were first 
identified- namely neuronal (nNOS) and endothelial (eNOS), the third NOS gene is only 
expressed under pathological circumstances and is called inducible (iNOS) (Brenman et 
al., 1996; Steinert et al., 2010; Doucet et al., 2012). Although the names eNOS and nNOS 
suggest tissue-specific expression some overlap does occur but this can be ignored for our 
current discussion.  
The three NOS genes, which have been conserved through evolution to a high degree, 
show similarity in their genomic structure suggesting a common ancestral source (Alderton 
et al., 2001). Each gene codes for a different protein with distinct properties, as illustrated 
in Figure 1-3, which depicts the three NOS isoforms and their domain structures, eNOS and 
iNOS are truncated versions of the nNOS protein. nNOS represents the complete protein 
and includes a PDZ binding motif which both eNOS and iNOS lack. The other domain 
structures of these proteins have been highly conserved, although iNOS has a different 
calmodulin domain (CaM). All three NOS isoforms contain a CaM domain but the two 
constitutive isoforms eNOS and nNOS require free calcium (Ca2+) to bind to this CaM 
domain in order to be activated (Garthwaite, 1991). Both constitutive NOS complexes are 
inactive at normal resting state cytosolic free Ca2+ levels (approximately 50nM) and 
maximally activated between 0.4 – 1.0 μM Ca2+ (Garthwaite, 1991). The iNOS isoform, on 
the other hand, has no need for calcium signals as calcium is permanently bound to its CaM 
domain keeping it in a perpetually active state. Because little eNOS is expressed in the 
brain, and iNOS is only expressed in pathological states, I will not discuss those two 
isoforms any further, but instead, focus on nNOS which is the main enzyme for NO 
production in the brain.  
1.6.1 The Nitric Oxide Synthase Protein Family
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Figure 1-3 Domain structures of nNOSα, eNOS and iNOS. The PDZ binding motif is shown in blue. The oxygenase 
domain shown in pink contains binding sites for L-Arginine (ARG), haem and tetrahydrobiopterin (BH4). The 
calmodulin domain that activates NOS in the presence of calcium is depicted in green for nNOS and eNOS but yellow 
to highlight its difference for iNOS. The reductase domain contains binding sites for NADPH which donates an 
electron to facilitate the reaction of L-Arginine to L-Citrulline and further binding sites for flavin adenine dinucleotide 
(FAD) and flavin mononucleotide (FMN). The reductase domain is shown in in purple. The auto inhibitory loop 
between the FMN regions is also displayed. The amino residue numbers at the start and end of each domain are 
shown for the human sequence.  
The nNOS protein in its complete form is a 1434 amino acid protein, encoded by a gene 
located on chromosome 12 (Alderton et al., 2001; Doucet et al., 2012). nNOS is abundantly 
expressed throughout the developing and mature central nervous system but is also 
observed in the skin, bronchial epithelium, skeletal muscles, kidney and liver cells (Alderton 
et al., 2001; Guix et al., 2005). nNOS comes in five distinct splice variants, three of which 
have been shown to be physiologically active, but only two are important for our current 
discussion. The three physiological active splice variants are depicted in Figure 1-4, but 
nNOSϒ shows little (<3%) catalytic activity under physiological conditions compared to 
nNOSα (Corso-Díaz and Krukoff, 2010) and will not be further discussed. That leaves us 
with nNOSα which is the complete original protein containing the PDZ binding motif on the 
N-terminal, and nNOSβ which is an exact copy of nNOSα except lacking a PDZ  
1.6.2 Neuronal NOS Splice Variants
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binding motif (Cho et al., 1992; Brenman et al., 1996; Doucet et al., 2012) (Figure 1-4). 
Because nNOSβ has no PDZ binding motif it cannot associate itself with PSD95 and is 
therefore coupled to NMDA receptor activity to a lesser extent. Both nNOSα and nNOSβ 
are expressed throughout the brain, but under normal circumstances nNOSα accounts for 
90% of all nNOS expression in the brain (Langnaese et al., 2007), although higher levels 
of nNOSβ are observed in the brainstem and cerebellum. 
The first nNOS knock-out study reported that nNOS knockout mice were viable without any 
obvious abnormalities in their central nervous system (Huang et al., 1993). However, by 
knocking out exon 2 of the nNOS gene, only nNOSα was affected- at the time the splice 
variants were unknown. The seemingly normal phenotype led to the discovery of nNOSβ 
which is upregulated and rescues the phenotype when nNOSα is lost (Langnaese et al., 
2007). Knock out studies with nNOSα knockouts showed how this affected NMDA receptor 
GluN1 expression. Although the mRNA expression of GluN1 was unchanged, the actual 
presence of this subunit in functional proteins was greatly diminished in the absence of 
nNOSα (Putzke et al., 2000). A full nNOS knockout, however, is also viable although it 
shows developmental problems, lower bodyweight, infertility and increased aggression 
(Gyurko et al., 2002).  
These data suggest that even though NOSβ is not associated with the NMDA receptor 
under normal circumstances, in an upregulated state it is capable of performing, at least 
partly, the necessary functions nNOSα performs. Very little data regarding the expression 
of nNOSα and nNOSβ is available. In most cells which express nNOS both variants are 
present, although in the striatum cells expressing only nNOSβ have been observed 
(Eliasson et al., 1997). nNOSβ has been shown in virtually all brain areas including the IC 
but remains under researched and there is little information about its functions under normal 
circumstances. It is currently unknown whether the isoforms nNOSα and nNOSβ perform 
different functions under normal circumstances. We know little about the expression of 
either splice variant in the IC. The one mRNA study performed thus far indicated that both 
are expressed (Eliasson et al., 1997), but took the IC as a whole, and no efforts thus far 
have been made to study the expression of either splice variant in the different subdivisions 
of the IC. The in situ hybridization studies also tell us little about the protein content of the 
cells, since owing to post translational processing, the mRNA content of a cell does not 
directly translate to protein content.  
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Figure 1-4 nNOS physiological active splice variants, nNOSα is the only splice variant containing a PDZ binding 
motif (blue). The oxygenase domain shown in pink contains binding sites for L-Arginine (ARG), haem and 
tetrahydrobiopterin (BH4). The calmodulin domain that activates NOS in the presence of calcium is depicted in green. 
The reductase domain contains binding sites for NADPH which donates an electron to facilitate the reaction of L-
Arginine to L-Citrulline and further binding sites for flavin adenine dinucleotide (FAD) and flavin mononucleotide 
(FMN). The reductase domain is shown in in purple. The auto inhibitory loop between the FMN regions is also 
displayed. The amino residue numbers at the start and end of each domain are shown for the human sequence. 
NOS proteins catalyse the synthesis of NO and citrulline from L-Arginine (L-Arg), NADPH 
and O2 by the following reaction (Feng, 2012): 
L-arginine + 3 NADPH + 3 H+ + 4 O2 → 3 NADP+ + L-citrulline + NO + 3 H2O 
The L-arginine, H+ and O2 bind to the oxygenase domain, whereas the NADPH binds on 
the reductase domain of the protein. The NADPH functions as the electron donor that allows 
the conversion of L-arginine to N-hydroxy-L-arginine and subsequently to L-citrulline, NO 
and H2O. Quite remarkable is the fact that the NOS proteins produce such high levels of 
NO while the reaction could just as easily lead to the production of other potentially 
damaging reactive oxygen species; how the NOS proteins accomplish this level of 
specificity is currently unknown (Santolini, 2011).  
NOS proteins are inactive in their monomeric state (Zhou and Zhu, 2009) because a NOS 
monomer is unable to transfer the electron obtained from NADPH at the reductase domain 
through its calmodulin (CaM) domain to the oxygenase domain (Santolini et al., 2001; 
Santolini, 2011). However, the CaM domain undergoes a conformational change upon the 
binding of Ca2+ and this allows the NOS protein to fold and bind another NOS molecule thus 
forming a stable and active homodimeric structure (Marletta, 1993; Zhou and Zhu, 2009). 
1.6.3 NO Formation 
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Figure 1-5 shows the nNOSα dimeric structure formation and the electron transfer this 
arrangement allows (Figure 1-5C). This explains the calcium dependency of nNOS activity. 
Currently, it is unknown whether heterodimers of nNOSα/nNOSβ are functional or even 
occur in vivo, but both splice variants are expressed in the IC and this could potentially be 
an interesting line of research.  
 
Figure 1-5 sequence depicting the formation of the nNOS homodimeric complex. A. Two inactive nNOSα proteins 
requiring Ca2+ to be activated. B. upon the binding of Ca2+ both nNOSα proteins undergo a conformational change, 
allowing them to bind to each other as displayed in panel C. C. nNOSα homodimer structure where the electrons 
obtained from the NADPH are transferred to the oxygenase domain of the other nNOS monomer. The conformational 
change due to calcium binding to the CaM domain is essential for this step to take place. NOS proteins are unable 
to pass electrons onto their own oxygenase domains. PDZ domains in blue, the reductase domains with the NADPH 
electron transfer, in purple, the CaM modules in green and the oxygenase domains in pink, Ca2+ in white and NO in 
yellow.  
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Because NO is a reactive diatomic gas with a half-life of a few seconds (Cary et al., 2006) 
it is not constrained by the synaptic or intracellular environment. Due it its gaseous nature 
NO has the capacity to freely diffuse through cell membranes potentially reaching targets 
far from the production site. It does not follow the ‘normal’ rules that apply to 
neurotransmitters and messenger molecules, thus far NO is always considered a co-
transmitter, a messenger molecule operating alongside the main neurotransmitter operating 
in that cell (e.g. glutamate or GABA). NO has often been described as a possible volume 
transmitter, and models predicted diffusion over considerable distances from its site of 
production. However, more recent studies and predictions suggest that the production of 
NO is strictly regulated and only produced in picomolar concentrations (Hall and 
Garthwaite, 2009; Wood et al., 2011; Garthwaite, 2016). NO cannot be stored in vesicles 
and has to be generated when required, the solubility of NO in water is limited to 1mM but 
due to its gaseous nature it diffuses readily through cell membranes and thus has the 
potential to exert its effect over an extended area (Garthwaite, 1991). 
Figure 1-6 shows the many targets that NO has been shown to regulate. It is unlikely that 
NO is performing all these functions in all cells and it seems more plausible to assume that 
different cell types utilise NO for different functions.  
NOS is the first target of NO 
The first target of NO is the NOS protein itself. At physiological temperatures, the NO 
produced binds to the Fe+ haem domain of NOS that normally binds O2. While NO is bound 
to the haem, oxygen cannot bind, and the reaction that produces NO is temporarily blocked 
(Salerno, 2008). This results in NO being produced in pulses which suggests that 
information transmission is taking place (Salerno, 2008; Salerno and Ghosh, 2009).  
 
1.6.4 Targets of Nitric Oxide
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Figure 1-6 Schematic overview of NO and the potential targets it has. NO acts on many ion channels, the most 
important ones are drawn, via its action on sGC but can perform functions independent of sGC action which are 
listed in the bottom right. Adapted from Steinert et al (2010). Abbreviations: AMPA-R (AMPA receptor), NMDA-R 
(NMDA receptor), NO (Nitric Oxide), sGC (soluble Guanylate Cyclase), PKG (protein Kinase G), Kv3.1 (voltage gated 
potassium channel), Nav (voltage gated sodium channel), Cav (voltage gated calcium channel), CNG (cyclic 
nucleotide gated ion channels), IK (Adenosine Triphosphate (ATP) sensitive potassium channel), Kv1 (voltage gated 
potassium channel). 
Soluble guanylate cyclase is the main target of nitric oxide 
Soluble guanylyl cyclase (sGC) has been shown to be the main target of NO in most brain 
regions, although some regions show NOS positive labelling but no sGC positive labelling 
suggesting that NO does not always regulate sGC (Schmidt et al., 1992) and presumably 
acts via a different intracellular mechanism. sGC is composed of two subunits that both 
come in a variety of splice variants, interestingly though the splice variant most expressed 
in the brain is the α2β1 which also has a PDZ domain and is known to associate with PSD95 
PDZ domain 3 (Russwurm et al., 2001), thus strongly suggesting that sGC is part of a NOS-
PSD95-NMDA receptor signalling complex. The binding of NO to sGC switches on the 
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conversion of GTP to cGMP (Ahern et al., 2002; Garthwaite, 2005). cGMP acts as a second 
messenger and its main function is the activation of the protein kinases which then, in turn, 
phosphorylate other proteins (e.g. Kv 3.1, Cav), as depicted in Figure 1-6.  
Remarkable is the high specificity with which sGC is able to detect NO over O2 and CO 
since sGC employs the same haem domain for binding NO as haemoglobin uses for binding 
O2. Yet sGC manages to detect nanomolar concentrations of NO in the constant presence 
of millimolar concentrations of O2 (Cary et al., 2006). This is accomplished by sGC 
undergoing a conformational change upon binding of NO to its haem but not by binding CO 
or O2. Any diatomic gas containing oxygen in the form of XO where X can be either N, C or 
another O can bind to the haem in either a bend or linear configuration. The configuration 
of choice is dependent on the electrons in the * orbitals of the XO molecule. CO has empty 
* orbits and the electrons from the Fe in the haem flow to empty *CO and this molecule 
is most stably bound in a linear configuration which is thus its ‘preferred’ binding pattern. 
Oxygen has 2 electrons and NO 1 in the * orbitals and hence they bind more stably to sGC 
in a bend configuration. Because NO has only one electron combined with its ‘preferred’ 
bend binding to the haem will alter the stability of the tertiary structure of the sGC protein 
which than undergoes its conformational change. So O2 and CO bind with equal affinity to 
sGC as NO, but only NO binds in the right configuration, destabilising and hence folding 
the protein to its active state (Poulos, 2006).  
In vivo studies have suggested that sGC/cGMP pathway exists in two different states: a 
tonic and an acute state (Kurtz and Wagner, 1998; Cals-Grierson and Ormerod, 2004). 
During normal resting state conditions, steady state levels of NO are produced and occupy 
the haem domain of sGC (Cary et al., 2006). In vitro experiments show that 80% haem 
occupation by NO produces only 10% catalytic activity in sGC (Russwurm and Koesling, 
2004). Dissociation of NO from the haem has been shown to be slow and NO level 
dependent. When bursts of NO occur the excess NO binds to an as yet unidentified part of 
sGC producing a hundred fold times more cGMP(Cary et al., 2006) (Zhao and Marletta, 
1997; Zhao et al., 1999). Taken together this means that sGC is kept in a low though 
activated state during resting state conditions, but is capable of detecting increasing pulses 
of NO. Thus normal steady state activity generated in the auditory pathway may only cause 
small amounts of NO to be produced, while over excitation may result in the high levels of 
NO that result in an acute adjustment of the synaptic strength.  
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Other potential targets of nitric oxide 
Another route via which NO is believed to influence cellular activity is S-nitrosylation. 
However, this requires high amounts of NO to be present and although iNOS is able to 
produce the required amount of NO, this mechanism probably does not operate in vivo 
under non-pathological conditions. Evidence suggests that nNOS only produces picomolar 
concentrations of NO (Hall and Garthwaite, 2009; Wood et al., 2011) while S-nitrosylation 
requires orders of magnitude higher concentrations of NO (Steinert et al., 2010).  
NO production in the brain is believed to be involved with LTP and LTD and through these 
mechanisms, to be important for memory and learning (Boxall and Garthwaite, 1996; 
Garthwaite, 2008; Steinert et al., 2010; Hardingham et al., 2013). Different hypothesis about 
the role NO performs in these processes exist. Most prominent is the hypothesis that NO 
acts as a retrograde messenger from the post synaptic domain to the presynaptic domain 
(Steinert et al., 2010). In the cerebellum, a presynaptic role has been established (Jacoby 
et al., 2001). NO diffusion back to the presynaptic environment has been shown to affect 
presynaptic calcium-dependent potassium channels (Ahern et al., 1999) resulting in 
modulation of presynaptic glutamate and GABA release. In order for this to work, the NO 
produced must be able to target the presynaptic domain with great precision and speed, 
the nNOS protein must, therefore, be tightly coupled to the receptors transducing the 
glutamate signals, the only nNOS protein known to associate itself directly with the 
glutamate receptor NMDA is nNOSα. However, alternative hypotheses have been 
proposed that suggest the main function of NO in LTP is targeted at postsynaptic sites and 
not presynaptic (Malenka and Bear, 2004). These hypotheses suggest that synaptic 
plasticity is achieved by altering the post synaptic currents, for example by modulating 
voltage gated ion channels (Ahern et al., 2002). NO has been shown to be able to induce 
phosphorylation of a range of ion channels, as depicted in Figure 1-6, as well as affecting 
the trafficking of AMPA and NMDA receptors through the cell to the active synaptic zone, 
thereby further regulating the synaptic strength.  
Recent evidence shows that NO targets post synaptic potassium channels (e.g. Kv1 and 
Kv3) in the medial nucleus of the trapezoid body (Steinert et al., 2008). Increased 
expression of cGMP by increased NO levels was followed by a reduction in functional Kv3 
potassium channels. This resulted in prolonged action potential duration, an effect that was 
blocked by NMDA receptor antagonists, nNOS and sGC inhibitors, and was absent in nNOS 
knockout mice (Steinert et al., 2008). Although the largest effects were observed in the 
potassium channels, modulation of sodium channels, AMPA and NMDA receptors was also 
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observed. It has been suggested that this mechanism could act as a gain control reducing 
action potential transmission during periods of high activity. Thus, although NO has the 
potential to function as a retrograde messenger, that is almost certainly not its only function.  
Conclusion nitric oxide 
Most studies have been focused on nNOSα which is coupled to the NMDA receptor activity 
and is believed to be expressed in greater abundance compared to nNOSβ. However, the 
expression levels of nNOSβ mRNA are higher in the brainstem and midbrain compared to 
the cortical and hippocampal regions where most functional nNOS studies have been 
performed (Eliasson et al., 1997). Thus currently little is known about the function of nNOSβ 
in the brain and we know even less about its potential function in the IC. We know it is 
expressed in the IC, but not in which subdivisions and whether there is a contrast to be 
made with nNOSα.  
To summarise we can conclude that NO has several potential targets but mainly exerts its 
effects by binding to sGC. Most targets of NO lead directly or indirectly to changes in 
synaptic strength. NO binds both to sGC in the pre and post synaptic domain, but due to 
sGC having a PDZ binding motif like nNOS, most of the NO will most likely bind to sGC 
postsynaptically. NO temporarily inhibits nNOS leading to pulses of NO. Large bursts of NO 
bind to a non-haem domain of sGC, increasing cGMP production a hundred fold. nNOSα 
does not produce enough NO to function as a volume transmitter. However, nNOSβ 
although less directly influenced by the NMDA receptor activity, could possibly function as 
volume transmitter.  
1.7 Scaffolding Protein PSD95 Essential in Effective NMDA receptor 
Activity 
The postsynaptic density (PSD) is, as the name suggests, located in the postsynaptic part 
of the synapse. This membrane associating mega-organelle is located in the head of the 
dendritic spines and is required for postsynaptic signal transduction (Doucet et al., 2012). 
The PSD ensures that receptor proteins in the active zone of the post-synaptic domain are 
aligned with the presynaptic active zone. In addition, it provides a framework to connect the 
receptor proteins and their second messenger proteins to one another (Hering and Sheng, 
2001). There are four PSD family members that derive their name from their molecular 
weight, I will focus on PSD95 due to its involvement with the NMDA receptor and nNOSα. 
PSD95 is functional as a monomer but can form multimers with other PSD95 proteins and 
interacts both with ionotropic and metabotropic glutamate receptors and regulates their 
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coupling to downstream second messengers (Scannevin and Huganir, 2000). An example 
of such an arrangement is depicted in Figure 1-6, where the interaction between PSD95, 
the NMDA receptor and the nitric oxide synthase protein (nNOSα) is depicted. In order for 
calcium influx into the cell to function as a signal carrier, intracellular calcium receptors need 
to be within 50 nm of the ion channel (Augustine et al., 2003), PSD95 enables downstream 
targets of the calcium influx to be closely linked to the ion channels. PSD95 associates with 
receptor proteins via PDZ binding domains. PSD95 has three of these domains and these 
domains allow proteins that contain a PDZ binding motif to associate themselves with it 
(Dev, 2004; Feng and Zhang, 2009). Because PSD95 has the ability to associate with many 
proteins, including other PSD95 molecules it is often referred to as a scaffolding protein, 
providing a structure on which other proteins can attach (Scannevin and Huganir, 2000). 
The PDZ domain 1 and 2 of PSD95 are in close proximity to one another and form a rigid 
structure (Feng and Zhang, 2009; Doucet et al., 2012). NMDA receptors bind preferentially 
and most stably to PDZ domain 1 and rarely to domain 2 (Kornau et al., 1995; Niethammer 
et al., 1996) while nNOSα preferably binds to PDZ domain 2 (Brenman et al., 1996). These 
preferential binding patterns bring the NMDA receptor and the nNOSα protein in close 
proximity to one another. There is the strong suggestion that at least one subunit 
composition of sGC can interact with PDZ domain3 of PSD95 (Russwurm et al., 2001), and 
thus form a multi-protein signalling complex, effectively forming a NO receptor producing 
cGMP in direct response to the NMDA receptor activity.  
1.8 Tinnitus and NOS 
NOS expression in the auditory brainstem pathway has been linked to tinnitus. Animal 
models of tinnitus showed increased expression of NOS in the VCN (Zheng et al., 2006) 
(Coomber et al., 2015). Also, acamprosate, an NMDA receptor antagonist has been shown 
to have some efficacy as a treatment for tinnitus (Elgoyhen and Langguth, 2010; Langguth 
and Elgoyhen, 2011). Since NMDA receptor activity influences the activation of NOS, this 
suggests that NOS might be involved in the development of tinnitus.  
The word tinnitus meaning the conscious perception of a phantom sound in the absence of 
a corresponding acoustic stimulus (Schaette, 2014), is derived from the Latin tinnire which 
translates as ‘to ring’ (Berger and Coomber, 2015). Most of us have experienced transient 
tinnitus after exposure to loud sounds, for example after visiting nightclubs or attending 
concerts. Though annoying, transient tinnitus rarely has a major impact on the sufferer. 
1.8.1 Tinnitus
Tinnitus and NOS  Ι  35 
Chronic tinnitus is a widespread disorder, with estimates suggesting that 10 to 15% of the 
world’s population is suffering from a chronic (>6 months) form of tinnitus and for 3-4% of 
the population this impacts on quality of life (Schaette, 2014). Although tinnitus comes in a 
wide variety of sounds like ringing, buzzing, cricket like hissing, whistling and humming, the 
high pitched tone is most often reported (Lockwood et al., 2002). Tinnitus is necessarily a 
subjective phenomenon. In more than 90% of the cases, no physical cause for the tinnitus 
percept can be found, this most prevalent form is often called either subjective or idiopathic 
tinnitus.  
About 30% of people suffering from hearing loss develop tinnitus (Lockwood et al., 2002; 
Eggermont and Roberts, 2015), and tinnitus patients often match the pitch of their tinnitus 
percept to the frequencies at which their hearing is impaired (Kaltenbach, 2011; Schaette, 
2014; Vogler et al., 2014). Other common causes of tinnitus are acoustic trauma, ototoxic 
drugs (e.g. salicylate), head and neck injuries (Elgoyhen and Langguth, 2010) and drugs 
that lower serotonin levels (Belli et al., 2012).  
Treatment of the hearing loss, if possible, does often reduce the experienced tinnitus 
(Schaette, 2014). However hearing loss, based on audiometric thresholds, is not a 
requirement for the persistence of tinnitus, about 15% of the people experiencing chronic 
tinnitus display normal audiograms (Eggermont and Roberts, 2015). Strong evidence that 
loss of sensory input (i.e. hearing loss) can cause tinnitus comes from studies that had 
participants wear a silicon earplug for a week. Eleven out of 18 participants experienced 
tinnitus in the plugged ear, the perception of tinnitus gradually disappeared after removal 
of the plug (Schaette et al., 2012). Further evidence for the link between tinnitus and hearing 
loss comes from patients with otosclerosis in which corrective surgery has been shown to 
improve or even abolish the perception of tinnitus in almost all patients (Schaette, 2014). It 
appears that the auditory system increases the gain to compensate for the reduction of 
input, which in turn may give rise to tinnitus (Eggermont and Roberts, 2004; Sun et al., 
2009). Recent fMRI data in human patients showed increased activity in resting state 
networks in tinnitus patients implicating increased activity in the IC and Heschl’s gyrus 
(Leaver et al., 2016).  
Many studies have shown tinnitus to be comorbid with depression, anxiety and insomnia 
(Lockwood et al., 2002; Hébert et al., 2012a; Hébert et al., 2012b). Currently, no cure is 
available to treat tinnitus, although the depression and anxiety often accompanying tinnitus 
can be treated with high success rates.  
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Diagnosing and measuring subjective tinnitus in an objective manner in humans is currently 
impossible. Attempts in defining a measurable, reliable and repeatable outcome measure 
for tinnitus are so far unsuccessful (Dobie, 1999) (Basile et al., 2013). It is hard to objectively 
compare the tinnitus percept of one person to that of another; it is also impossible to 
objectively track the progress, either worsening or improving, of the disorder over time. The 
subjectivity of ‘measuring’ the tinnitus experienced by the patient has hampered drug 
testing in clinical trials. Tinnitus treatment suffers from placebo effects often masking any 
possible drug effect (Dobie, 1999). Usually, the treatment goals target the relief of 
symptoms and management of associated distress (Elgoyhen and Langguth, 2010).  
Early research towards the neural underpinnings of tinnitus in the late 1970s and early 
1980s focused heavily on the peripheral auditory sense organs as the origin of tinnitus 
(Kaltenbach, 2011). A major shift in the paradigm came when House and Brackmann 
showed in 1981 that the tinnitus percept continues in around half of patients after sectioning 
of the eighth nerve (House and Brackmann, 1981). Suggesting that plastic changes beyond 
the cochlea are important mediators of tinnitus. It has since become increasingly clear that, 
although the initial onset of tinnitus may be caused by damage to the cochlea or inner ear, 
tinnitus itself is caused by aberrant processing in the brain and not by (persistent) defects 
of the ear (Roberts et al., 2010; Knipper et al., 2013). Injection of lidocaine intravenously 
results in a temporary relief of the tinnitus percept in 70% of patients (Duckert and Rees, 
1983), this indicates that tinnitus is a neuronal activity driven disorder (Elgoyhen and 
Langguth, 2010; Langguth and Elgoyhen, 2011).  
Changes in auditory brainstem responses (ABR) indicate that multiple centres in the 
auditory brainstem pathway are affected (Schaette, 2014). There is growing evidence that 
tinnitus percepts are caused or at the very least associated with hyperactivity in neural 
activity within the DCN, the IC and the AC (Dehmel et al., 2012; Robertson et al., 2013; 
Vogler et al., 2014) (Manabe et al., 1997; Bauer et al., 2000; Bauer et al., 2008). This 
hyperactivity is often linked to a shift in the excitatory/inhibitory balance within the auditory 
pathway (Bauer et al., 2000; Elgoyhen and Langguth, 2010). An fMRI study investigating 
the entire auditory pathway showed increased activity in tinnitus patients in the IC, AC and 
MGB (Smits et al., 2007) thus suggesting that the tinnitus originates in these ‘higher’ 
auditory structures. Whether the IC is generating the tinnitus, or merely passing on the 
aberrant neuronal activity generated elsewhere in the auditory pathway, is currently an 
open question. Although, given its strategic position in the auditory pathway, and its 
1.8.2 Mechanisms of Tinnitus 
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involvement in processing virtually all ascending information, the IC might be a particularly 
important structure for the generation of tinnitus.  
Animal models have been used to study the hyperactivity phenomena in more detail. The 
increased activity is usually observed in frequency specific regions close to frequencies in 
which the hearing loss occurs. This hyperactivity develops over time, with no change in the 
spontaneous firing rate observed immediately after the noise trauma but developing in the 
days and weeks after the trauma (Dong et al., 2010a; Dong et al., 2010b) and possibly 
leaving a window of opportunity for treatment. As is the case with any other disorders, some 
individuals may be more predisposed than others. Ahlf et al. (2012), showed that gerbils 
that developed tinnitus after noise trauma had lower auditory brainstem and cortical 
responses before the noise induction compared to animals that did not develop tinnitus 
(Ahlf et al., 2012).  
 Unilateral noise-induced trauma results in bilateral changes in the IC. Increased 
spontaneous activity can last up to weeks after the event. Interestingly the gene expression 
of NMDA subunit 1 (GluN1) is decreased immediately after the noise trauma but returns 
back to normal levels after four weeks (Dong et al., 2010b). This suggests that NMDA 
mediated activity might be involved in observed increases in spontaneous activity and 
therefore could be involved in the development of chronic tinnitus.  
The subjective nature of tinnitus makes proving the presence of tinnitus in animals difficult. 
In recent years methods to verify the presence of tinnitus in animals have been developed. 
One of the first animal models to investigate tinnitus was developed by Jastreboff et al., 
(Jastreboff and Sasaki, 1986; Jastreboff et al., 1988) and used salicylate to induce tinnitus. 
Later tests to verify the presence of tinnitus in animals were always validated using 
salicylate, because of its reliability in inducing tinnitus (Berger et al., 2013; Kaltenbach, 
2011; Turner et al., 2006).  
Although the pharmacologically induced tinnitus possibly has a different mechanism via 
which it induces tinnitus compared to acoustic trauma, both result in an indistinguishable 
perception of tinnitus. The fact that salicylate is possibly acting directly on the brain in 
generating the tinnitus makes this a powerful method, because it allows us to directly target 
specific structures in the auditory pathway.  
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Subjective tinnitus is notoriously difficult to investigate in humans but even harder to asses 
in animals. Salicylate, chemically related to aspirin (acetylsalicylic acid), one of the world’s 
oldest, and still one of the most widely used analgesics, has been long known to be ototoxic 
in high doses reliably causing transient / reversible tinnitus in humans (Sée, 1877; Day et 
al., 1989). Systemic administration of sodium salicylate in animal models has been used to 
induce temporary tinnitus (Evans et al., 1981; Jastreboff and Sasaki, 1986; Jastreboff et 
al., 1988) and validate behavioural models of tinnitus (Kizawa et al., 2010; Berger et al., 
2013). The mechanism via which salicylate induces tinnitus has yet to be fully clarified. 
Studies have shown that systemic administration of salicylate may impact directly onto the 
peripheral and central auditory structures. 
Salicylate application most commonly causes an increase of the spontaneous neuronal 
discharge in the absence of any auditory stimulation, throughout the auditory pathway 
(Guitton et al., 2003; Ma et al., 2006; Hwang et al., 2011). Besides the increase in 
spontaneous discharge in the central auditory structures, at the periphery of the auditory 
pathway reductions in cochlear blood flow (Didier et al., 1993), a reduction in outer hair cell 
mobility (Shehata et al., 1991), via blocking of the motor protein prestin, and direct activation 
of NMDA receptors in the cochlea (Guitton et al., 2003) have been reported. Because 
systemic administration of salicylate affects the entire animal, modes of action can be 
difficult to disentangle. Application of salicylate directly onto the round window of the 
cochlea results in a decreased output from the cochlea to the auditory nerve (Sun et al., 
2009), which is the opposite effect when applied systemically. These findings have been 
interpreted as ruling out the cochlea out as a source of the increased spontaneous 
discharge that propagates throughout the central auditory system after systemic salicylate 
application.  
Direct application of salicylate in vitro and in vivo has demonstrated that salicylate can have 
a direct effect on neuronal firing in the IC (Basta and Ernst, 2004; Patel and Zhang, 2014) . 
Three hours after salicylate injection a reduction in energy consumption, as measured by 
2-DG uptake (Wallhäusser-Franke et al., 1996) and an increase in c-fos (Wallhäusser-
Franke, 1997) as well as a decrease in GABA receptors in the IC but not in other non-
auditory brain structures have been reported (Butt et al., 2016). Further evidence for 
salicylate acting directly on brain tissue comes from iontophoretic studies, in which 
salicylate is directly applied to the cell recorded. A recent study showed that salicylate can 
induce hyperactivity by iontophoretic application to neurons in the IC (Patel and Zhang, 
1.8.3 Salicylate 
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2014). So in summary, salicylate appears to reduce the spontaneous firing rate in most 
auditory structures (Ochi and Eggermont, 1996; Yang et al., 2007; Wei et al., 2010; Zhang 
et al., 2011) except for the auditory nerve, the secondary auditory cortex and the IC, in 
these three structures spontaneous firing rates are increased (Stypulkowski, 1990; Manabe 
et al., 1997; Eggermont and Kenmochi, 1998; Patel and Zhang, 2014; Eggermont and 
Roberts, 2015). Interestingly, chronic dosing of salicylate leads to metabolic changes in IC. 
These changes are reversible by stopping the salicylate treatment (Yi et al., 2016).  
Both noise induced, as well as salicylate-induced, tinnitus have a close relationship to 
NMDA mediated activity (Peng et al., 2003; Ruel et al., 2008). Ruel showed that 
spontaneous firing, as well as sound driven responses in, in vivo recordings in auditory 
nerve fibres in adult guinea pigs, were increased when perfused with salicylate; applying 
an irreversible NMDA antagonist, MK-801, abolished the observed effects. The obvious 
connection between the NMDA receptor and NOS makes NO signalling a viable candidate 
to be involved in the generation of tinnitus.  
1.9 Aims and Hypotheses 
As identified in the Introduction, many gaps exist in our knowledge about nNOS and nitric 
oxide in the IC and their role in auditory processing. The following aims and hypotheses will 
be addressed in this thesis: 
1. nNOS has been shown to be present in IC, but we have a limited understanding of 
its distribution, co-expression with other proteins and neurotransmitter phenotype. I 
am to answer the following questions:  
 Does nNOS co-localise with other markers that enable us to identify nNOS 
neurons?  
 Is nNOS limited to neurons of a particular neurotransmitter phenotype?  
 Is there evidence in the IC for the occurrence of the two splice variants of 
nNOS reported elsewhere in the brain?  
2. Our current knowledge about the physiology of the NMDA receptor in the IC is 
sparse and even less is known about the role it plays in auditory processing in-vivo. 
Evidence suggests that nNOS activity is often closely associated with NMDA 
receptor activity. Thus I aim to : 
 Determine if selective activation of NMDA receptors influences spontaneous 
activity and acoustically driven neural responses in the IC. 
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 Test the hypothesis that NO signalling participates in spontaneous activity 
and acoustic driven neural responses in the IC.  
 Test the hypothesis that effects of NMDA receptor activity in the IC are 
mediated by the NO signalling cascade.  
3. Salicylate has often been used in inducing and studying tinnitus but the mechanisms 
by which this drug induces tinnitus are poorly understood. Previous studies have 
not looked at salicylate effects over a longer time scale recorded from the same unit, 
nor have they been able to untangle direct and indirect effects of salicylate on the 
IC. Also, the link between salicylate and the NMDA receptor activity in other auditory 
structures raised the question about whether direct effects of salicylate on the IC 
might be mediated by the NO signalling pathway. Thus the aims for this topic are: 
 Determine the time course of the effects of systemically administered salicylate 
on neural activity recorded in the IC over the course of several hours  
 Compare and contrast the effects of systemic and local administration of 
salicylate on spontaneous activity and acoustically driven neural responses in 
the IC. 
 Test the hypothesis that salicylate induced effects on neuronal activity in the IC 
are influenced by NO signalling 
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Chapter  2. Methods 
This chapter describes the general methods applicable to all immunohistochemistry and in 
vivo electrophysiological experiments. Some more specific details are described in the 
methods section of the relevant chapters. 
2.1 Animals and Ethics 
All experiments reported here were performed in accordance with the terms and conditions 
as they apply to all licences issued by the UK Home Office under the Animals (Scientific 
Procedures) Act 1986 under Project Licence PPL 70/7831 issued to Adrian Rees. All 
experiments were performed in laboratory environments approved by the Comparative 
Biology Centre (CBC) at Newcastle University and the Home Office. 
2.2 Immunohistochemistry 
Lister-hooded rats, males only (200-300g) were either obtained from Charles River, ordered 
specifically for this study, or were left over after non-invasive behavioural experiments. 
Animals were housed in groups of 2-4 living under standard conditions, with a twelve-hour 
light‐dark cycle, a constant temperature (22 °C ± 2 °C) and cage enrichment. Food and 
water were given ad libitum. Animals that had been delivered from Charles River were given 
2-3 days to acclimatise before being used in experiments. Efforts were made to reduce 
animal numbers and prevent all forms of animal suffering. 
Animals used for immunohistochemistry received a lethal intraperitoneal (IP) injection of 
sodium pentobarbital (3.75 ml/kg). Under this terminal anaesthesia, animals were perfused 
through the left ventricle initially with 0.9% saline buffer with heparin (4 I.U. per ml) followed 
by a 4% paraformaldehyde (PFA) solution in 0.1 M PBS (137mM NaCl, 2.7mM KCl, 
10mM Na2HPO4, 2mM KH2PO4). The brains were removed from the skull and post-fixed 
overnight at room temperature in the 4% PFA solution. After post-fixation, to cryoprotect 
the tissue the brains were transferred to 30% sucrose in 0.1M PBS solution and stored at 
4 °C until they sank. Coronal 40 µm sections were cut on a freezing microtome or cryostat 
starting at the caudal end of the IC. Sections were collected into 0.1 M PBS in 24 well 
plates. If sections were to be stored, the PBS was replaced by an antifreeze solution (30% 
2.2.1 Animals 
2.2.2 Perfusion, Sectioning and Storage
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Sucrose w/v, 30% ethylene glycol w/v and 0.01 % polyvinyl-pyrrolidone (PVP-40) in 0.1M 
PBS) and the sections were stored at -20 °C.  
All procedures were performed at room temperature unless otherwise stated. The required 
sections were transferred from the antifreeze solution to a new 24 well plate, the sections 
were washed 3x 10 minutes in 0.1M PBS. To reduce the autofluorescence caused by 
tissue-bound free aldehyde groups and reveal the epitopes, an antigen retrieval step was 
performed. Sections were incubated in a 1% sodium borohydride solution in 0.1 M PBS for 
20 minutes on a shaker plate and then washed 3 x 10 minutes in 0.1M PBS. To further 
reduce autofluorescence, sections were incubated in a 50 mM glycine solution in 0.1M PBS 
for 20 minutes (the glycine binds to free aldehyde groups thereby preventing unspecific 
binding of the antibody to these ‘sticky’ ends). After the glycine incubation, sections were 
washed 3 x 10 minutes in 0.1M PBS before being placed in a block buffer of 0.1M PBS 
containing 0.1% gelatin and 5% serum of the host species in which the secondary 
antibodies are raised. For some primary antibodies, 0.3% of Triton-X was added to this 
buffer, see Table 2-1 for a complete overview. Triton is a detergent which punctures the 
membranes and so allows access of antibodies to the interior of the cell, however, it can 
destroy the epitope of membrane-bound proteins. Thus, for some of the primary antibodies, 
better results were obtained by leaving Triton out of the buffer, while others performed better 
with the addition of Triton. Particular the antibodies targeting the NOS protein performed 
better in the absence of Triton. In double labelling experiments occasionally Triton and No 
Triton antibodies would be paired, here the Triton was left out, or reduced to 0.003%. 
Sections were incubated in this block buffer for at least two hours at room temperature. 
Antibody dilutions were made in the same block buffer. Sections were incubated in the 
antibody solution either overnight at 4 °C or 48 hours at 4 °C see Table 2-1 for the specific 
details for each antibody. In double labelling experiments, both antibodies were added at 
the same time, and the longer of the two incubation periods was used. A negative control 
using the same protocol, excluding the primary antibody was included in all experiments. 
All incubations and wash steps were performed on plate shakers to constantly agitate the 
contents of the wells.  
 
 
2.2.3 Immunolabelling protocol
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Table 2-1 Primary antibodies used in the experiments. For each individual antibody, information is given about the 
clone, the host, the manufacturer, dilution range, the optimised incubation times and whether triton was added to 
the block buffer. The following abbreviations have been used: SYSY (Synaptic Systems), 48H (48 hours), O.N. 
(Overnight). 
Target  Host  Dilution Supplier Clone Incubation Block 
buffer 
nNOS Mouse 1:250 Sigma N2280 48h - 4 °C No Triton 
nNOS Rabbit 1:250 Santa Cruz SC-648 48h - 4 °C No Triton 
Vglut1 Rabbit 1:2000 SYSY 135 303 o.n. - 4 °C Triton 
Vglut2 Rabbit 1:2000 SYSY 135 403 o.n. - 4 °C Triton 
Parvalbumin Mouse 1:2000 Sigma Parv-19 o.n. - 4 °C Triton 
Calbindin-
D28K 
Mouse 1:1000 Sigma CB-955 o.n. - 4 °C Triton 
Calretinin Mouse 1:1000 Millipore MAB1568 o.n. - 4 °C Triton 
GABA Rabbit 1:1000 Sigma A2052 48h - 4 °C Triton 
GAD65/67 Goat 1:1000 Santa Cruz SC7513 o.n. - 4 °C No Triton 
PSD95 Mouse 1:500 Thermo 
Scientific 
MA1-046 o.n. - 4 °C Triton 
Once the primary antibody incubation was completed, the sections were washed 3 x for 10 
minutes in 0.1M PBS. Sections retrieved from the 4 °C environment were allowed to warm 
up to room temperature before being washed.  
Secondary antibody solutions were prepared in the previously described block buffer. 
Different secondary antibodies have been used to allow for different combinations of 
primary antibodies see Table 2-2. Where possible, in double fluorescent protocols both 
secondary antibodies were raised in the same host species. The secondary antibodies 
either had a fluorescent label or a biotin label attached to them. Sections were incubated in 
secondary antibodies for two hours at room temperature before being washed 3 x 10 
minutes in 0.1M PBS. When biotinylated antibodies were used a third, one-hour incubation 
step was needed in which a fluorescent avidin was added. The fluorescent avidin binds to 
the biotin tail of the biotinylated secondary antibody.  
Negative controls were used in which the primary antibody was omitted to control for non-
specific binding of the secondary antibody. For the biotinylated protocol another control 
omitting the secondary antibody was used as well to control for unspecific binding of 
fluorescent avidin. To label the nuclei the sections were incubated for 10 minutes in a 
2.2.4 Primary antibodies 
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solution containing 4',6-diamidino-2-phenylindole (DAPI), a DNA labelling dye binding to A-
T rich regions. Sections were incubated for 10 minutes in 0.1 M PBS containing 1 in 10.000 
parts of DAPI and washed 3x 10 minutes in 0.1M PBS. Sections were then mounted on 
glass slides and air dried for approximately an hour before being coverslipped using 
Vectashield mounting medium hard set.  
Table 2-2 Secondary antibodies used 
Host Target  Dilution Supplier Label 
Goat Mouse 1:500 Life Technologies Alexa 488 
Goat Rabbit 1:500 Life Technologies Alexa 568 
Donkey Goat 1:500 Santa Cruz Rhodamine 
Goat Rabbit 1:500 Vector Biotinylated 
Goat Mouse 1:500 Vector Biotinylated 
Mouse Goat 1:500 Vector Biotinylated 
 Biotin 1:500 Vector Rhodamine Avidin D 
 Biotin 1:500 Vector Fluorescein Avidin D 
 
In double immunofluorescent experiments, ideally, it is best to use primary antibodies that 
have been raised in different host species. To allow for multiple combinations, two different 
NOS antibodies were used one raised in mouse produced by Sigma and another raised in 
rabbit produced by Santa Cruz. To verify that both antibodies have the same affinity for 
NOS using the same protocol, I directly compared both antibodies in the same tissue. 
Figure 2-1 shows the result of this immunohistochemistry experiment and both antibodies 
clearly label the same cells and subcellular compartments. 
Sections were imaged on a Zeiss AxioImager with an automated stage or a Nikon NiE 
upright fluorescence. Both are wide field microscopes with a wide range of filter settings 
allowing multi-channel acquisition and automated stages allowing for Z-stack image 
acquisition. The Zeiss Axiometer also allowed for the acquisition of mosaic imaging. All 
sections to be analysed were first imaged at 10x magnification using the Zeiss Axiometer 
and the IC was reconstructed from sections using the mosaic function. Areas of interest in 
the dorsal cortex, lateral cortex and central nucleus were located within these mosaic 
images and imaged at 40x, 63x or 100x magnification.  
2.2.5 Microscopy
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Whenever required, z-stacks of these regions or individual cells could be acquired at high 
power, thus allowing 3D rendering.  
 
 
Figure 2-1 Double labelling with two different nNOS antibodies showing identical cell labelling. The left column 
shows images resulting from the nNOS antibody raised in rabbit obtained from Santa Cruz. In the second column 
shows labelling with the antibody against nNOS raised in mouse obtained from Sigma. In the third column, the 
previous two images are merged. The three rows show increased magnification levels, the scale bar indicates 50 
µm. Images were obtained from the dorsal cortex in rostral IC. 
All images were subjected to offline processing using Fiji (Schindelin et al., 2012) which is 
the complete version of ImageJ (Schindelin et al., 2015) with all plugins installed. Image 
files were loaded, the colour channels were split in red, green and blue and a background 
subtraction with a rolling ball radius of 100 pixels was performed on each channel. Channels 
were stored separately before being put together to study colocalisation. For 3D rendering 
and multi-dimensional image analysis the functions Z-project (for the maximum intensity 
projection), orthogonal views and the 3D viewer provided by Fiji were used.  
50 µM 
50 µM 
50 µM 
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2.3 In Vivo Electrophysiology & Microdialysis 
The in vivo electrophysiology experiments all involved the combination of multi-electrode 
electrophysiological recording and reverse microdialysis. This section describes the 
surgery, the electrophysiology and the microdialysis parts separately followed by the 
experimental protocol.  
All experiments reported here were performed on adult pigmented guinea pigs, bred at the 
CBC, Newcastle University. In total 42 guinea pigs were used (11 male, 31 female) aged 
between 2 and 6 months, weighing between 372-912g. Animals were housed in groups of 
2-6 living under standard conditions, with a twelve-hour light‐dark cycle, a constant 
temperature (20 °C ± 2 °C) and cage enrichment. Food and water were given ad libitum. 
The standard diet of food pellets was supplemented daily servings of fresh fruit. 
Two different anaesthetic protocols were used, due to one anaesthetic, Hypnorm (0.315 
mg Fentanyl citrate and 10 mg Fluanisone per ml), being off the market for a considerable 
time. A summary of the anaesthetics used is supplied in Table 2-3. 
All animals were anaesthetised using an IP injection of urethane (1mg/kg in a 20 % solution, 
dissolved in 0.1M PBS). In the first eight experiments, this initial anaesthetic was followed 
by an intramuscular injection in the gluteus maximus of 0.2 ml of Hypnorm containing, 
Fentanyl citrate and Fluanisone (®Veta Pharma). The depth of anaesthesia was checked 
at regular intervals during the experiment by testing the pedal reflex. When necessary 
supplementary doses of 0.15 ml Hypnorm were administered. In the latter 34 experiments, 
the urethane was supplemented by an IP injection of fentanyl (0.3 mg/kg) and an 
intramuscular injection in the hind leg of midazolam (5mg/kg). When necessary an extra full 
dose of fentanyl was administered IP. In this anaesthetic protocol, the animals were actively 
pumped with 100% oxygen, due to the respiratory depressant effects of fentanyl. All guinea 
pigs were given a subcutaneous injection of atropine sulphate (0.05 mg/kg) to suppress 
bronchial secretion. 
2.3.1 Animals 
2.3.2 Anaesthesia Induction and Maintenance
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Table 2-3 Anaesthetics used 
Anaesthetic  Initial dose Top up dose Concentration No. Experiments  
Urethane 1 g/kg  1g/5ml (20%) 51 
Hypnorm .2 ml 0.15 ml  17 
Fentanyl 0.3 mg/kg 0.3 mg/kg 0.05mg/ml 34 
Midazolam 5mg/kg  5mg/ml 34 
2.3.3 Surgery 
The animal’s head and neck were shaved in preparation for surgery. The animal was 
allowed to breathe freely at this point but was supplied with oxygen enriched air. A 
tracheotomy was performed and a polyethylene cannula was inserted into the animal’s 
trachea to allow for active ventilation with oxygen. The tragus of the outer ear was surgically 
removed from both ears to facilitate the fitting of the ear bars. The animal was then brought 
into a sound insulated room and placed on a heating pad controlled by the output of a rectal 
thermometer (Harvard Apparatus). The animal’s core temperature was maintained between 
37 °C and 38 °C. The animal was fitted in a stereotaxic frame using ear bars with perspex 
specula into which removable headphones could be inserted. Care was taken to ensure 
that the specula were inserted in the auditory canal with a clear view of the tympanic 
membrane. Once the animal was fixed in the frame, in animals that were ventilated the 
tracheal tube was attached to a ventilator and the animal ventilated with 100% oxygen. 
A single scalp incision was made from rostral to the caudal over the midline of the skull the 
skin was retracted and the muscles overlying the cranium scraped away. All further 
procedures took place using an operating microscope to ensure minimal damage to the 
brain surface and blood vessels. Using a hand drill and a rongeur, a craniotomy was 
performed over predefined coordinates overlying the IC. The dura was then removed using 
a bent needle and a steel dental instrument. A glass Pasteur pipette, which had been heat-
treated to blunt it, was used to aspirate the cortex overlying the IC. All cortex above the IC 
was removed to enable a clear sight of the dorsal surface of the IC. The microdialysis probe 
(described in 2.3.5 below), was inserted mid IC on the rostral-caudal axis 0.5 mm lateral 
from the midline with a 10 ° angle, angled away from the midline Figure 2-2. The electrode 
(described in 2.3.4 below) was placed rostral to the microdialysis probe, but as close as 
physically possible without coming in contact with it. The electrode was inserted vertically.  
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The angled microdialysis probe and straight electrode configuration allowed both devices 
to be placed in close proximity to one another, without compromising each other’s 
functionality.  
 
Figure 2-2 Schematic drawing of the microdialysis probe and multi-electrode recording probe in the IC. The dialysis 
probe was inserted at a 10° angle, away from the midline, placed caudal from the electrode.  
To record the multiunit neurophysiological signals, probes with multichannel microelectrode 
arrays (NeuroNexus) were used. In all experiments, a single shank electrode fitted with a 
32 channel linear microelectrode array was employed (A1x32-10mm-100-177-A32 50). The 
electrode sites on this particular probe configuration were spaced 100 µm apart, giving the 
probe a functional recording depth of 3.2 mm. This particular configuration was chosen 
because it allowed recordings to be obtained through the several frequency laminae of the 
CNIC simultaneously. The electrode was placed in a NN32AC headstage (Tucker Davis 
Technologies (TDT), Alachua, Florida) connected to a PZ2-32 channel Preamplifier (TDT) 
which fed the signals to a RZ2 BioAmp Processor (TDT) which was connected and 
controlled by a PC running custom made Matlab scripts on which the data was stored for 
later offline analysis. The sampling rate was set at 24.414 kHz 
2.3.4 Electrode 
32 channel microelectrode Microdialysis probe 
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The microdialysis probes were hand made and used once. The microdialysis probes were 
manufactured by glueing three pieces of hollow steel with a diameter of 0.5 mm (Goodfellow 
stainless steel (AISI 304 (Fe/Cr18/Ni10) diameter 0.5mm, wall thickness 0.06mm) together 
in a Y-shaped body as depicted in Figure 2-3. A silica fused fibre (110μm/170 μm, SGE 
analytical Science, Australia) was threaded through the short ends of the probe. One of the 
fibres, the inlet, extended out of the bottom of the probe’s body, while the outlet fibre stayed 
inside the body of the probe. The probe was completed by a semipermeable membrane 
(Hospal AN-69), allowing diffusion of molecules up to 10 kDa. 
 
Figure 2-3 Schematic drawing of the microdialysis probe 
The semipermeable membrane lets molecules diffuse down their concentration gradient, 
allowing the microdialysis probes to be used in reversed dialysis. The probes were used to 
deliver drugs locally into the areas of interest. The drugs used, all manipulated different 
stages in NOS signalling pathway. Every experiment started with baseline recording lasting 
at least an hour in which only normal artificial cerebrospinal fluid (aCSF) (140 mM NaCl, 3 
mM KCl, 707 µM Na2HPO4, 272 µM NaHPO4 and 1mM MgCl2, 10 mM D-glucose (C6H12O6), 
240 µM CaCl2) was perfused through the probe at a constant rate of 2 µl /min. After this 
baseline condition one or multiple types of bioactive molecules could be pumped through 
the probe; every drug condition was always followed by an aCSF washout condition in 
which only aCSF was pumped through the probe. The aCSF and the drug dilutions used in 
a particular experiment were all freshly made on the day of the experiment. Once the 
2.3.5 Microdialysis 
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microdialysis probe was inserted care was taken to ensure a constant flow rate through the 
probe. Syringe pumps (Harvard apparatus) with four slots for 2.5 ml disposable syringes 
were used. Syringes were loaded with aCSF and aCSF containing drugs at the start of the 
experiment. Non-sterile Portex tubing, inner diameter 0.5 mm, were attached to the 
syringes. Care was taken to fill the lines and avoid any air bubbles. Syringes were placed 
on the syringe pump and ran throughout the experiment to allow for smooth transition 
between drug conditions. A connecting piece of tubing permanently attached to the dialysis 
probe was used as an inlet to the probe. Lines from the syringes were manually coupled 
and uncoupled when switching between drug conditions, the connecting tube ensured that 
the dialysis probe was undisturbed. All drugs used are listed in Table 2-4, specific 
concentrations are discussed in the relevant chapters. 
Table 2-4 Drugs used in the microdialysis probe. 
Drug name Function Company Product code FW 
NMDA NMDA receptor agonist  Sigma M3262 147.13 
L-MeArg Blocking endogenous NO production Cambridge Bioscience CAY10005031 248.3 
ODQ Blocking sGC Santa Cruz SC-200325A 187.15 
Sodium 
salicylate 
Tinnitus inducing agent Sigma S3007-500G 160.10 
 
The stimuli were presented using Sony MDR 464 earphones, each housed in an alloy 
enclosure which fitted in the Perspex speculum inserted into the animal’s ear canal (Rees 
et al., 1997). The output of the system was calibrated using a 1⁄8 inch Bruel and Kjaer 4138 
microphone, a Type 2639 preamplifier, and Type 2610 measuring amplifier. The 
microphone was seated in a small coupler made from silicon tubing that sealed the narrow 
end of the speculum. The maximum output of the system was approximately flat from 0.1 
to 9 kHz (100 ± 8 dB SPL) and then fell with a slope of ~20 dB/octave to give a maximum 
output at 16 kHz of ~80 dB SPL from both the left and right earphones (Figure 2-4).  
2.3.6 Sound Stimuli 
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Figure 2-4 Maximum output of earphones Measured in small tubing coupler with Bruel & Kjaer Type 4138 1/8 inch 
microphone, Type 2639 Preamplifier and Type 2610 Measuring Amplifier.  
Pure tone stimuli were generated by a Tucker-Davis Technologies System Z6 at a 
sampling rate of 97.656 kHz controlled by a custom made Matlab code (kindly made 
available by Dr Nicholas Lesica, UCL). This software allowed the user to set frequency 
and sound level parameters within fixed ranges which could then be presented in a 
random fashion. All stimuli had a duration of 75 ms while the response was recorded over 
a period of 150 ms starting with the onset of the stimulus at time 0, repetition rate 6.6 Hz. 
Data were recorded by a TDT System comprising a PZ2-32 Channel preamplifier and a Z2 
Z6 at a sampling rate of 24.414 kHz. All data recorded per stimulus set was stored in a 
separate data files for offline analysis.  
The activity recorded in these experiments is multi-unit activity comprised of the summed 
activity of all cells in the proximity of the electrode. The measures taken from the electrode 
sites are therefore a combination of multiple sources. 
Frequency response area 
A way of capturing the frequency response at a recording site is obtaining the frequency 
response area (FRA). Many possible combinations of frequency and sound level within a 
given range are presented to the animal in a pseudo-random fashion. The frequency range 
for the FRA‘s in all experiments ranged from 128 Hz to 16384 Hz with a stepwise fixed 
increase of 7% between frequencies. The sounds levels (represented as attenuations from 
the maximum level of the stimulus ranged from 5- 85 dB separated in steps of 5 dB. Each 
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of the 1296 possible combinations of frequency and attenuation represents one pixel in the 
overall FRA matrix. In these experiments, every combination of frequency and attenuation 
level was presented once. Though prone to noise, the FRA provides us with an excellent 
overview of a multiunit cluster’s sensitivity over a wide range of frequencies and levels. In 
order to capture and describe the possible changes over time over a wide range of 
frequencies, FRAs were captured at regular intervals during each experiment. The CF 
calculated does not represent the CF of one single cell but should be thought of as CF of 
the activity at the recording site. 
PSTH 
Once the microdialysis probe and electrode were inserted, the headphones were slotted 
into the hollow ear bars to allow for auditory stimuli to be presented to the animal. To ensure 
recordings were made from the central nucleus, a set of FRA recordings was made. The 
tonotopic sequence was inspected to ensure that a wide frequency range was captured. If 
necessary the electrode would be moved up or down, to capture as many unique 
frequencies as possible. Once the electrode was in the best position a set of baseline 
recordings with the dialysis probe perfused with aCSF was obtained. These baseline 
recordings lasted for at least an hour after the last electrode movement and consisted of 
repeated measures of PSTHs and FRA’s. The raw digitised neurophysiological responses 
were stored in individual datafiles. After baseline recordings the drugs were perfused 
through the probe in sequence and the responses to the same auditory stimuli as presented 
in the baseline recording were recorded during the application of each drug. The protocols 
for the different drugs are described in the relevant chapters.  
PSTH analysis gives detailed information about the firing pattern of multi-units over the 
duration of the stimulus. PSTH traces in these experiments were collected by summing the
response over 150 repeats of the same frequency and attenuation level. To allow for 
comparisons between animals and study possible adaptations in auditory processing over
a wide range of frequencies, in each experiment five fixed frequencies were presented at
two different attenuation levels. The frequencies chosen were 256 Hz, 512 Hz, 1024 Hz, 
2048 Hz and 4096 Hz all of which were presented at two different attenuation levels around
30 and 60 dB. All PSTH frequencies and attenuation levels were set and then presented in
a pseudo-random order to avoid adaptation. 120 dB attenuation trials or silent trials 
recording spontaneous activity were interspersed in this sequences. 
2.3.7 General Experimental Protocol 
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When the full protocol of baseline, drug and washout recordings had been performed the 
animal was killed by an IP injection of sodium pentobarbitone (2ml/kg). 
2.4 Data Analysis 
To process the data collected the basic processing steps were automated using custom 
written Matlab scripts, developed by me. I will give short descriptions of the different scripts 
and their functions and workings where deemed necessary.  
Every set of stimuli presented whether it was FRA or a PSTH were stored in individual 
blocks, containing the multi-unit data recorded from all 32 electrodes. The custom made 
Matlab scripts were used to extract the data from the tanks into Matlab (.mat) files 
containing the raw multi-unit data traces of, stimulus parameter information and time 
stamps. A threshold was applied to the raw time series to extract the spiking activity. One 
FRA from the baseline period was selected and the standard deviation was calculated of 
the activity in the 120dB attenuation row of the FRA matrix. The threshold was set at 2.5x 
the standard deviation of this spontaneous activity. The threshold level was calculated for 
every individual electrode and applied to the raw multi-unit data collected from that channel 
in the experiment. All spikes passing the threshold were stored together with their stimulus 
information and timestamps in .mat files. The FRA and PSTH give complementary 
information but take different forms and require different post-processing steps.  
PSTH data analysis 
Raw multi-unit data sampled at 24 bins/ms were aggregated into 1 ms bins in a linear array. 
Each PSTH trace is a summation of 150 trial repeats. The PSTH trace can be divided in a 
number of different segments. The PSTH stimulus lasted 75 ms while the PSTH trace was 
recorded over a period of 150 ms starting with the onset of the stimulus at time 0. Due to 
latency within the auditory pathway, activity evoked by the stimulus begins in the IC around 
~12-18 ms. This first block, marked in the figure with number 1, is spontaneous, non-
stimulus driven, activity and will be referred to as pre-stimulus activity. The biggest peak in 
activity in the multi-unit PSTH marks the stimulus onset, marked in Figure 2-5 by the red 
arrow. This onset peak is quantified by capturing all spikes occurring in a 10 ms time 
window, starting from the beginning of the onset peak. To detect the onset peak a standard 
Matlab peak detection function was used, which was set to detect the first peak occurring 
between 10 and 20 ms. 
2.3.8 Termination of Experiment
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In blocks where no onset peak was detected, which is the case for spontaneous activity 
and or for stimuli which evoked no driven response, the onset time was set at 15 ms. 
Sound driven spikes are the spikes fired during the duration of the stimulus. The sound 
driven activity is obtained by summing all the spikes between the onset peak plus 80 ms 
(marked in Figure 2-5 by the line labelled 2). The additional 5 ms over the length of the 
stimulus duration was to ensure the whole of the driven response was captured. The latter 
part of the multi-unit PSTH trace, marked in the graph by the number 3 is post-stimulus 
activity.  
 
Figure 2-5 Example PSTH trace where 1 denotes the baseline / spontaneous activity, 2 is the stimulus driven part of 
the PSTH response, area 3 represents the offset activity. The red arrow indicates the onset peak.  
All spike counts collected for the different bins, pre-stimulus, onset, sound driven and post 
stimulus were translated to ratios from the original baseline. 
To study auditory processing over a wide range of frequencies and to permit comparison 
between animals, the electrodes best representing five fixed PSTH frequencies, 256 Hz, 
512 Hz, 1024 Hz, 2048 Hz and 4096 Hz were analysed. These electrodes will be called 
‘best frequency electrodes’. An electrode was selected as the best electrode for a given 
frequency if it recorded the highest number of sound driven spikes in response to this 
frequency. The frequency represented by this multi-unit activity will be referred to as the 
best frequency (BF). A Matlab script was employed to loop through all PSTH blocks, 
channels and PSTH stimuli presentations to find the electrode that responded best to a 
frequency.  
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FRA analysis 
FRAs were captured at regular intervals during the experiment. FRAs obtained in each 
experiment consisted of a single repeat and randomly occurring noise can therefore have 
quite a big impact on the value of a single pixel in the FRA matrix. To create a more robust 
baseline two baseline FRAs were averaged post-hoc to create a new baseline.  
FRAs can be characterised in a number of ways but most commonly used are the active 
area and the characteristic frequency (CF). The CF in this thesis is the CF of the multi-unit 
activity and represents the frequency at which the multi-unit is still responding to the lowest 
attenuation or smallest sound intensity, in Figure 2-6 a FRA is displayed and the CF 
marked. 
 
Figure 2-6 Example FRA, the colour scale represents the number of spikes.  
A Matlab script was used to determine the CF of every FRA captured in the experiment. 
This script calculated the mean and standard deviation from the highest attenuation level 
of the FRA. A threshold of the mean plus three times the standard deviation was applied to 
the entire FRA to determine those pixels representing sound driven activity, this step 
creates a binary image of pixels representing spontaneous or sound driven responses. In 
calculating the excitatory area any area smaller than 25 pixels was ignored. To calculate 
the size of the excitatory region of the FRA all cells that survived these thresholding and 
segmentation steps were summed to obtain the excitatory area. The same binary matrix 
was used to find the CF and its corresponding attenuation. The CF defined as the lowest 
pixel on the Y-axis (attenuation levels) to be included in the binary FRA.  
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Differences in the patterns of activity observed between FRAs provide clues about changes 
in responsivity in the auditory system and contrasting systemic and local applications of 
drugs in the IC allow us to disentangle where in the pathway this drug exerts its effects. 
Figure 2-7 shows an example FRA. In the top row, three raw FRAs from different time points 
in the experiment are depicted. Changes in the FRA are evident but are sometimes difficult 
to identify. To highlight the changes and permit their quantification the FRAs were analysed 
as follows: the baseline FRA was subtracted from every other FRA in the experiment, 
resulting in the subtracted FRAs displayed in the 2nd row. Blue always represents a 
reduction in activity, whereas red represents increased activity. Note that reductions are 
often smaller than the increases. In order to capture the changes in area and be able to 
describe them in a systematic way, the subtracted FRAs were subjected to a thresholding 
step. For each pixel in the subtracted FRA, when the change in spiking in either direction 
was larger than the average spontaneous firing rate (calculated as above from the baseline) 
the pixel was set to 1 if the firing rate for the pixel did not exceed the threshold it was set to 
0. This process produced a binary version of the subtracted FRA. To avoid random single 
pixels in the binary image from contributing to the area calculations a segmentation step 
was included. Areas consisting of six or more connected pixels were included in the area 
calculations. The total areas for decreased and increased activity were calculated by adding 
up the number of pixels remaining. These two binary FRA’s were superimposed, as 
displayed in the third row. The firing rates associated with each pixel in the binary FRA were 
then used to calculate the magnitude of the change in either direction in each pixel. An 
average magnitude change over the entire area was then calculated. The size of the 
increased and decreased areas, as well as the individual pixel magnitude values and 
average magnitude in each area, were stored in separate Matlab files for later analysis.  
A way of depicting what the magnitude measure extracts from the FRA is best illustrated in 
Figure 2-8. The traditional 2D view of the FRA is a top view of a 3D image, in which the 
colours indicate the magnitude of change. By tilting the figure by 90° as depicted in panel 
B, the 3D aspect of the figure becomes apparent. The magnitude measures, established 
the average change in either direction as indicated in the flattened FRA in panel C.  
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Figure 2-7 Example of FRA analysis. Top row: raw FRAs. Middle row: subtracted FRA following subtraction of the 
spontaneous rate from the raw FRA. Bottom row: a binary FRAs clearly showing areas where firing rate has 
increased or decreased. 
 
 
Figure 2-8 Illustration of the information extracted from the subtracted FRA. P A shows a subtracted FRA Figure. B 
this plot has been tilted through 90° to reveal the 3D aspect of the figure. C the magnitude of the increase and 
decrease in firing rate n is indicated by the arrows.  
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Chapter  3. Cytoarchitecture and Phenotypic Features of 
nNOS Expressing Cells       
3.1 Introduction 
The presence of nNOS in the IC is established, but we have a limited understanding about 
what function these cells perform let alone how nNOS is involved. Currently, we don’t know 
whether NO functions as a trans-synaptic neurotransmitter or whether it functions as a 
second messenger within the cells that produce it. Given the long evolutionary history and 
different splice variants of nNOS which occur it might perform both functions. One way of 
gaining insight into the functional properties of the nNOS positive cells of the IC is by 
studying their distribution, and their features. The aims of the studies presented in this 
chapter were listed in Chapter 1 but can be summarised as the aim to characterise nNOS 
positive neurons in the IC in terms of their distribution in the subdivisions of the IC and their 
expression along the rostral-caudal axis, their neurotransmitter phenotype, the presence of 
calcium binding proteins within them, and the types and origins of the inputs that innervate 
them.  
Neurons can be characterised by many different properties but an important determinant of 
their function is the neurotransmitter utilised by the neuron. In the IC both excitatory 
(glutamatergic) and inhibitory (GABAergic) neurons are observed. Virtually all neurons 
present in the IC fall within either one of those two categories. Although some studies have 
reported around 10% of the cells to be uncategorised by either of those two labels (Wu et 
al., 2008; Fujimoto et al., 2016), it is currently unclear what these cells represent. Although 
other projections (e.g. serotonin, dopamine, acetylcholine and glycine) originating from 
different brain areas terminate in the IC, as discussed in the Introduction (Chapter 1), none 
of these have cell bodies in the IC.  
As described in Chapter 1 in more detail, nNOS is dependent on calcium binding to 
calmodulin in order for it to become active and catalyse the synthesis of NO. The calcium 
binding proteins calbindin and calretinin have been described in IC as having a similar gross 
regional distribution to nNOS (i.e. high expression in cortices and low expression in the 
central nucleus), whereas parvalbumin shows an ‘inverse’ distribution. It is unclear which, 
if any, of the calcium binding proteins are expressed in nNOS containing neurons. Given 
the need for tight calcium regulation in nNOS expressing neurons, it was hypothesized that 
such cells also employ one or more calcium binding proteins to regulate the amount of free 
calcium in the intracellular environment. Because little is known about the cells expressing 
60  Ι  Cytoarchitecture and Phenotypic Features of nNOS Expressing Cells 
calcium binding proteins they were subjected to a similar investigation as the nNOS 
expressing cells, with the aim of learning more about these cells investigating their 
phenotypical make up and expression along rostral-caudal axis of the IC.  
Knowing whether nNOS expressing cells in a region are predominantly GABAergic or 
glutamatergic is of interest because the IC is an integrating structure where several streams 
of excitation and inhibition converge. Therefore understanding where the projections that 
the nNOS positive neurons receive originate from would be of value and mark a step 
forward in our understanding of the functioning of these cells. The vesicular transport 
proteins have been used as markers for glutamate transmission, but they only label in 
terminals, not cell bodies. Both VGLUT1 and VGLUT2 terminals have been observed in the 
IC but only VGLUT2 mRNA expression has been observed in the IC (Altschuler et al., 
2008). Although there is an abundance of VGLUT1 positive terminals in the IC, these do 
not originate from cells with cell bodies in the IC (Ito et al., 2011; Fujimoto et al., 2016). 
These two markers give clues about the sources of input and can potentially help to 
distinguish different subtypes of nNOS expressing cells.  
Expression of these proteins has been described in all major subdivisions of the IC showing 
an overlap in areas of distribution (Paxinos et al., 1980). Thus far the presence of nNOS 
and calcium binding protein expressing neurons have been shown in overlapping 
subdivisions of the IC, but no extensive study of whether these proteins show co-expression 
in the same cells has been conducted. 
To sum up, the questions addressed in this chapter:  
1. In what subdivisions of the IC are nNOS labelled cells observed and is there a 
change along the rostral-caudal axis? 
2. Are the cells expressing nNOS predominantly glutamatergic or GABAergic and are 
there gross differences to be observed between the different subdivisions? 
3. Do nNOS positive cells co-express the calcium binding proteins calbindin, calretinin 
or parvalbumin, and are there differences between subdivisions? 
4. What type of glutamatergic inputs do the cells expressing nNOS receive, can distinct 
subpopulations be discriminated by their VGLUT1 and VGLUT2 inputs? 
Owing to the number of neuronal markers used, the data reported in this chapter is 
largely descriptive in nature.  
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3.2 Methods 
The immunohistochemical protocol, including the specific antibodies used in these studies 
have been described in detail in Chapter 2. All studies in this chapter were performed in 
adult, Lister-hooded rats, males only (200-300g). In these experiments, the IC was cut in 
40 µm coronal sections caudal to rostral. Every fourth section was taken for a specific set 
of immuno-labelling experiments. This enabled the expression of the proteins to be 
characterised along the rostral-caudal axis through the IC at an interval of 160 µm. Thus 
the IC from one animal gave rise to four different sets of double immunofluorescent 
experiments. Labelled sections were mounted on slides and stored at 4°C in the dark to 
preserve the fluorescent labels. Imaging of the sections was performed at different 
magnifications with the appropriate filter sets as described in Chapter 2. Automated image 
acquisition protocols ensured minimal bleed through between the channels, but negative 
controls were included as an extra safeguard.  
To measure a large number of cell diameters from calbindin, calretinin, parvalbumin and 
nNOS positive cells, mosaic image files containing the appropriate labels were loaded in 
Fiji (Schindelin et al., 2012) a complete version of ImageJ with all plugins (Schindelin et al., 
2015). The colour channels were split into red, green and blue. The appropriate channel 
was selected depending on the label of interest and the other channels were stored for later 
analysis. 
The background was subtracted from the image with a rolling ball radius of 100 pixels, a 
manually adjusted threshold was applied to the mosaic images, and inspected to ensure 
that individual cells were visible. These thresholded images were stored as binary images. 
The binary image was subjected to the automated cell measuring protocol in Fiji (‘Analyze’ 
– ‘Analyze particles’). The size was set to a range between 5-120 µm and the full range of 
circularity was allowed (0.00-1.00). Fiji was instructed to return the number of cells and their 
Feret’s diameter as well as a map of the outlines of the counted cells. The outlines were 
superimposed with the original images and erroneously included counts, mainly in edge 
areas, were removed from the data table. All cell counts and diameter measurements were 
stored in SPSS. To validate the automated cell counts three sections for each label one 
taken from the caudal, middle and rostral IC were analysed manually. The manual 
measurements were compared to the automated measures to check the two methods were 
consistent.  
The statistics of the cell diameters were analysed using a two way ANOVA with cell type 
and area along the rostral caudal axis as factors. Owing to the large number of cells 
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measured, the smallest difference in diameter will appear significant, therefore for both the 
main effect and the interaction effect, only effect sizes larger than 1 µm will be reported. 
Significant main effects were followed up by post-hoc Tukey tests. For the interaction effect, 
the data file was split into the different immunohistochemical labels and one way ANOVAs 
performed with the position of the labelled cell along the rostral caudal axis as a factor. 
Again significant ANOVA results were followed up with post hoc Tukey tests.  
Some of the immunohistochemistry experiments, nNOS and calcium binding proteins and 
parvalbumin and VGLUT1 and VGLUT2 reported here were conducted as part of 
undergraduate student projects I helped to supervise. 
3.3 Results 
nNOS expression in the dorsal and lateral cortex 
Neurons showing nNOS labelling throughout the cell (diffuse labelling), including dendrites 
and proximal axons, were observed along the rostral-caudal axis of the IC in both the dorsal 
and lateral cortex. In the lateral and dorsal cortex neurons showing punctate nNOS 
expression were also observed, although impossible to distinguish in diffuse labelled cells. 
The density of nNOS positive cells was highest in the dorsal cortex near the commissure 
as seen in Figure 3-1. Cells in the dorsal cortex tended to be simpler in morphology, in the 
sense that they show little or no dendritic branching, compared to cells in the lateral cortex 
and border area of lateral cortex and central nucleus. The cells in the lateral cortex, as 
shown in the inserts in Figure 3-1 and Figure 3-2, showed a more complex morphology with 
intricate dendritic branching. An ANOVA showed that nNOS positive cells in the lateral and 
dorsal cortex varied in size by region(F(2, 6068) = 373.35, p <0.0001). Post hoc Tukey tests 
showed that nNOS cells in rostral regions were larger compared to both those in the middle 
regions Figure 3-41. 
nNOS expression in the central nucleus 
As illustrated in Figure 3-1, at lower magnifications few NOS positive cells were observed 
in the central nucleus and, those present were faintly labelled. However, at higher 
magnification punctate nNOS labelling could be seen in all subdivisions of the IC; this was 
particularly noticeable in the central nucleus due to the absence of cells with nNOS labelling 
in all cellular compartments. These nNOS ‘puncta’ appeared as bright, small but clearly 
delineated dots found in apparent association with the neuronal cell body, as indicated by 
3.3.1 nNOS Expression in the Inferior Colliculus
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the presence of DAPI labelling. Figure 3-2 illustrates the nNOS positive punctate labelling 
observed in the central nucleus. This punctate labelling is in contrast to the cells showing 
nNOS labelling throughout all cellular compartments as observed in the lateral cortex. For 
illustrative purposes in Figure 3-3 a cartoon version of this phenomenon is shown.  
 
Figure 3-1 above a thresholded mosaic image of nNOS positive labelled cells in a whole coronal IC section midway 
along the rostro-caudal length of the IC. The area outlined by the red rectangle is enlarged at the bottom left of the 
figure and individual neurons from within this area are shown enlarged to its right. 
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Figure 3-2 in the top left the nNOS distribution in the IC is shown, the scale bar indicates 500 µm. The blue and red 
boxes indicate areas in the lateral cortex and central nucleus respectively where the high magnification examples of 
nNOS positive cells were obtained. Note the complex dendritic branching and nNOS labelling throughout the cell in 
the cells observed in the lateral cortex (blue rectangle), some elements of the image are saturated in order to bring 
out the finer dendritic branching. Neurons in the central nucleus (red rectangle) exhibit nNOS puncta mainly on the 
soma, however, dendritic presence is not unlikely but more difficult to observe.  
 
Figure 3-3 Cartoon of nNOS punctate labelling. The nNOS positive punctate labelling is recognised by dense clusters 
of bright dots of nNOS labelling surrounding the soma, indicated by the nuclear label DAPI. 
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The co-labelling of PSD95 with the nNOS Puncta demonstrating a post synaptic 
location.  
To test the hypothesis that the nNOS positive puncta observed in the central nucleus of the 
IC were localised in the post synaptic density and form part of the nNOS-NMDA receptor-
PSD95 complex, immuno labelling experiments were performed with antibodies against 
nNOS and PSD95. PSD95 labelling in the central nucleus of the IC appeared as puncta 
distributed throughout the subdivisions of the IC usually outlining cell bodies, as indicated 
by DAPI. The nNOS labelled puncta were closely associated with PSD95 (Figure 3-4). 
Many PSD95 labelled puncta with no associated nNOS labelling were also observed. 
However punctate labelling is, by definition, small and extremely bright, and punctate 
labelling deeper in the tissue and out of focus in the current image is visible as diffuse 
labelling. In order to make qualified decisions whether punctate labelling was solely PSD95 
positive, solely nNOS positive or co-labelled for both, 3D rendering and layer by layer 
analysis was used (Figure 3-5). Flattening the 3D rendering as a maximum intensity 
projection as displayed in Figure 3-6 shows that virtually all the nNOS labelling is also 
PSD95 positive. Although in this view some nNOS positive only labelling still appears to 
occur, careful Z-stack layer by layer analysis illustrated in Figure 3-7 demonstrates that the 
nNOS positive puncta observed in the central nucleus are consistently co-labelled by 
PSD95.  
3.3.2 nNOS is Associated with PSD95
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Figure 3-4 one slice from a Z-stack series depicting PSD95 and nNOS punctate labelling in central nucleus of the IC. 
PSD95 without nNOS labelling are indicated by *.  
 
Figure 3-5 zoomed out view of 3D rendered cell in Figure 3-4 showing nNOS (green) and PSD95 (red) punctate 
labelling in the central nucleus of the IC. This 3D model allows rotation and every dot can be inspected in a 3D 
environment to observe whether it is co-labelled.  
PSD95 
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Figure 3-6 a maximum intensity projection from nNOS and PSD95 labelling in the central nucleus of the IC. nNOS 
positive puncta are closely associated with PSD95. The square indicates the area on which Figure 3-7 is based. 
Yellow indicates strong co-labelling of nNOS and PSD95. The red punctate labelling indicates PSD95 only labelling.  
 
Figure 3-7 five consecutive 0.5 um optical slices from the central nucleus of the IC labelled for PSD95 and nNOS. 
This image illustrates that co-labelling of PSD95 and nNOS requires layer by layer analysis because co-labelling of 
both proteins can be observed in some, but not in all layers (indicated by arrows). Images collected from the square 
in Figure 3-6. 
PSD95 
NOS 
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GABA labelling was observed throughout the IC (Figure 3-8) but the large GABAergic cells 
with a diameter >15 µm were observed exclusively in the central nucleus and border regions 
of the lateral cortex. Smaller GABAergic cells with diameters between 5 and 15 µm were 
observed throughout the dorsal and lateral cortex as well as in the central nucleus but were 
particularly abundant in the dorsal cortex near the commissure. Although GABA neuropil 
labelling was observed in the cortices the labelling thinned out considerably towards the 
outer edges.  
GAD65/67 labelling was observed throughout all subdivisions of the IC both as cellular and 
neuropil labelling with a similar distribution to GABA. GAD65/67 positive neuropil was 
observed in the lateral and dorsal cortex, as indicated in Figure 3-9. However, even though 
these regions also contain the cells showing distributed nNOS labelling, the GAD and nNOS 
markers rarely labelled the same cell. GAD positive cell body labelling was mainly observed 
in the central nucleus. Few of those GAD labelled cell bodies in the central nucleus showed 
nNOS positive puncta. Thus, the majority of the nNOS positive cells did not appear to 
express GAD, suggesting that they were glutamatergic. 
3.3.3  Different GABA Expression in Subdivisions of the IC 
Figure 3-8 mosaic images showing GABA expression along the rostral-caudal axis, a manual threshold was applied 
to these images to enhance the contrast. Caudal, mid and rostral sections of the IC are depicted from left to right. 
The scale bar indicates 500 µm. Note how the section is outlined by labelling, this appeared to be an artefact. 
3.3.4 nNOS and GAD are Rarely Co-expressed 
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Figure 3-9 a coronal section midway along the rostro-caudal length of the IC labelled for NOS and GAD65/67. Open 
arrowheads indicate cells that are both nNOS and GAD positive. Arrows indicate examples of nNOS positive cells 
that show no immunoreactivity to GAD. GAD positive neuropil labelling is indicated by *. 
Calbindin is expressed exclusively in the dorsal and lateral cortex 
Expression of calbindin was exclusively observed in the dorsal and lateral cortices of the 
IC in discreet and distinct patches. Figure 3-10 shows the calbindin expression in two 
coronal IC sections. In the inserts, higher magnifications of areas containing calbindin 
labelling are displayed. Calbindin labelling appears to be restricted to the cell nucleus. 
Calbindin labelling is restricted to the dorsal and lateral cortex and consisted of small cells 
with an average diameter of 19.50 µm with a SEM = 0.16 µm. Calbindin labelling was 
densest in the dorsal cortex especially in the region adjacent to the commissure of the IC. 
Calbindin expression was observed along the rostro-caudal axis of the IC as illustrated in 
Figure 3-11. Calbindin positive cell counts, summarised in Figure 3-40, indicated that the 
number of cells labelling positive for calbindin was highest in caudal areas of the IC and 
declined gradually towards the mid and rostral areas of the IC.  
3.3.5 Patterns of Calcium Binding Protein Expression in the IC and
Colocalisation with nNOS 
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Figure 3-10 calbindin labelling in the caudal IC, a manual threshold was applied to these images to enhance the 
contrast. Images in the black box A and C show the entire IC while the images in the red boxes show higher 
magnifications of these areas. 
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Figure 3-11 Mosaic images showing calbindin expression along rostral-caudal axis, a manual threshold was applied 
to these images to enhance the contrast. From left to right are depicted caudal, mid and rostral sections of the IC. 
The scale bar indicates 500 µm. 
Most Calbindin positive cells expressed nNOS  
Calbindin positive cells and cells with distributed nNOS labelling were both abundant in the 
dorsal and lateral cortex. Figure 3-12 shows nNOS and calbindin positive cells in the dorsal 
cortex mid-way along the rostral caudal axis of the IC. Cells were defined by having clear 
nuclear DAPI labelling. Although in some cases nNOS was faint, careful inspection showed 
that virtually all calbindin labelled cells also showed immunoreactivity for nNOS (Figure 3-12 
by closed arrowheads). However not all nNOS positive cells showed immunoreactivity for 
calbindin (Figure 3-12 open arrowheads).The same pattern of virtually all calbindin positive 
cells also being nNOS positive was observed in the lateral cortex as illustrated in Figure 
3-14 by open arrowheads. Again nNOS cells not showing any hint of calbindin were also 
present, as pointed out in Figure 3-14 by the arrows. The nNOS labelling forms circles 
around cell bodies (indicated by the DAPI labelled nuclei) both for calbindin positive and 
calbindin negative cells, both of which are illustrated at a higher magnification in Figure 
3-13. Calbindin was often only observed in the nucleus of the cell. Calbindin and nNOS 
labelling were co expressed in the same subdivisions of the IC and in the same cells but 
showed different subcellular localisations, making co-localisation sometimes hard to judge.  
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Figure 3-12 nNOS and calbindin expression in the dorsal cortex of IC. Closed arrowheads indicate nNOS positive 
cells that are also calbindin positive. Open arrowheads indicate nNOS positive cells that show no immunoreactivity 
for calbindin. 
 
Figure 3-13 higher magnification of nNOS and calbindin labelling in the dorsal cortex. In the centre is a calbindin and 
nNOS positive cell. The arrows indicate two nNOS only positive cells that show no immunoreactivity for calbindin. 
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Figure 3-14 nNOS and calbindin expression in lateral cortex. Open arrowheads show cells labelling nNOS and 
calbindin positive. Arrows point out nNOS positive cells that show no labelling for calbindin.  
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Calbindin and GABA can be co-expressed 
As described earlier, calbindin and GABA positive cells were both observed in the dorsal 
and lateral cortex of the IC. About half of the calbindin positive cells, in both cortices, also 
showed immunoreactivity for GABA (Figure 3-15).  
 
 
Figure 3-15 calbindin and GABA labelling in the dorsal cortex. Note the absence of co-labelled neurons. The scale 
bar indicates 100 µm. 
Calretinin is expressed exclusively in the dorsal and lateral cortex 
Calretinin positive cells were exclusively observed in the lateral and dorsal cortices. Figure 
3-16 shows the distribution of calretinin in the subdivisions of the IC. In the dorsal cortex 
dense calretinin labelling fanning out from the commissure is observed (Figure 3-16A and 
B). Calretinin positive cells were small cells with an incredibly similar size to calbindin cells 
with an average diameter of 19.25 µm and a SEM of 0.14µm. No differences were detected 
in the number of calretinin positive cells along the rostral-caudal axis (Figure 3-17). 
Compared to calbindin, expression of calretinin appeared less dense in the lateral cortex, 
but in the dorsal cortex similar numbers of cells labelled for calretinin and calbindin (Figure 
3-41).  
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Figure 3-16 Calretinin labelling in the caudal IC. In this region the entire IC is comprised of cortex. A manual threshold 
was applied to the images to enhance the contrast. Images in the black box A and C show the entire IC while the 
images in the red boxes show magnifications of regions of interest. Examples A and C are obtained from two different 
animals. Note that the black stripe on section C is an artefact. 
76  Ι  Cytoarchitecture and Phenotypic Features of nNOS Expressing Cells 
 
Figure 3-17 Mosaic images showing calretinin expression along the rostral-caudal axis, a manual threshold was 
applied to these images to enhance the contrast. From left to right are depicted caudal, mid and rostral sections of 
the IC. Note that in the caudal section where the IC is entirely comprised of cortex, calretinin can be observed 
throughout the section. 
Most calretinin positive cells do not express nNOS  
Although calretinin and nNOS labelled cells were both present in the same subdivisions of 
the IC, in stark contrast to calbindin, few calretinin positive cells showed co-labelling with 
nNOS. Figure 3-18 shows an area of the dorsal cortex in which both nNOS (red) and 
calretinin (green) positive cells were abundant but rarely was co-labelling within the same 
cell observed. However, as illustrated in Figure 3-19 (dorsal cortex) and Figure 3-20 (lateral 
cortex) a few cells co-express calretinin and nNOS as indicated by the open triangles in 
both figures. In the central nucleus, no calretinin cell bodies were observed.  
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Figure 3-18 nNOS and calretinin positive cells in the dorsal cortex. Note the vast majority of calretinin labelled cells 
do not express nNOS.  
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Figure 3-19 calretinin and nNOS positive cells in the dorsal cortex. The arrows indicate nNOS positive cells, the filled 
arrowheads indicate calretinin only cells and the open arrowheads indicate cells labelling positive for both nNOS 
and calretinin.  
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Figure 3-20 calretinin and nNOS positive cells in the lateral cortex. The arrows indicate nNOS positive cells, filled 
arrowheads indicate calretinin only cells, and open arrowheads indicate cells labelling positive for both nNOS and 
calretinin. 
Calretinin and GABA can be co-expressed 
As with calbindin cells, although a substantial number of calretinin positive cells did show 
immunoreactivity for GABA not all calretinin positive cells were also GABA positive. The 
majority of GABA positive cells were observed in the central nucleus where no calretinin 
labelled cells were observed. However, GABA positive cells were observed both in the 
dorsal (Figure 3-21) and lateral (Figure 3-22 ) cortex where calretinin positive cells are 
abundant. Some cells showed immunoreactivity for both labels. In the lateral cortex some 
dense calretinin positive neuropil clusters were observed (Figure 3-22). These dense 
calretinin rich clusters also showed high levels of GABA labelling, however, even in these 
regions of heightened expression both labels appear in different elements and were only 
rarely observed in the same cell. 
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Figure 3-21 calretinin and GABA labelling in the dorsal cortex. The bright dot visible in both channels and indicated 
by the arrow is an artefact. 
 
Figure 3-22 calretinin and GABA labelling in the lateral cortex. Note the regions containing dense clusters of 
calretinin positive neuropil also containing GABA positive cell bodies. 
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Parvalbumin is abundant in the central nucleus 
Parvalbumin positive cells were abundant throughout the IC, but labelling was particularly 
pronounced in the central nucleus (Figure 3-23). A wide range of morphologies were 
observed in parvalbumin labelled cells. Parvalbumin positive cells showed cytoplasmic 
labelling with some showing somatic only labelling and other cells had clear labelling of the 
axons and dendrites (Figure 3-38 and Figure 3-39). No obvious difference in the number of 
parvalbumin positive cells was observed along the rostro-caudal axis (Figure 3-24). 
Parvalbumin labelled cells were bigger compared to calbindin and calretinin labelled cells, 
with an average cell diameter of 21.34 µm, SEM = 0.11 µm. Parvalbumin cell body diameter 
did not differ along the rostral caudal axis, although the ANOVA as discussed in section 
3.3.8 returned a significant P value, the effect size was below 0.5 µm suggesting that the 
significance was driven by the large number of cells present in the sample. 
Parvalbumin is coexpressed with nNOS in the ventral CNIC 
Parvalbumin and distributed nNOS positive cells were mainly observed in different 
subdivisions and their distribution patterns showed little overlap. Very few distributed nNOS 
positive cells were observed in the central nucleus, the region where most parvalbumin was 
expressed, however in the ventral IC on the border of the central nucleus and the lateral 
cortex, co-labelling of nNOS and parvalbumin was observed in some cells. Figure 3-25 
shows a high magnification image from this ventral IC region. In this image both punctate 
and diffuse nNOS expression are observed. nNOS positive punctate labelling (squares) 
outlines both parvalbumin positive (closed arrow head) and parvalbumin negative cells 
(arrows with squares). The cells with distributed nNOS labelling (stars) are mainly 
parvalbumin negative (arrow with stars) but co-labelling does occur (open arrow head). 
nNOS positive puncta within the parvalbumin positive cells are easier to see in Figure 3-26 
(open arrowheads), however even in this image examples of cells only expressing nNOS 
can be observed (arrows). As was the case with the VGLUT2, discussed below, the nNOS 
punctate labelling was seen to be arranged in circles around presumed cell bodies 
(indicated by the presence of DAPI) which are not parvalbumin positive (arrows).  
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Figure 3-23 parvalbumin labelling in caudal (A), mid (D) and rostral (G) IC. A manually adjusted threshold was applied 
to the images to enhance the contrast. Images in the black box A and C show the entire IC while the images in the 
red boxes show magnifications of regions of interest. The examples from A, D and G obtained from three different 
animals.  
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Figure 3-24 Mosaic images showing parvalbumin expression along the rostral-caudal axis, a manual threshold was 
applied to these images to enhance the contrast. From left to right are depicted caudal, mid and rostral sections of 
the IC. The scale bar indicates 500 µm. Note how the expression is pronounced in the central nucleus and thins out 
towards the cortices. Outline drawn by hand.  
 
Figure 3-25 parvalbumin and nNOS labelled cells in ventral IC. A cell in which co-expression occurs is indicated by 
the open arrow head. The closed arrowheads shows NOS positive puncta on parvalbumin cells. nNOS only cells are 
shown by the arrows. Note that both punctate (white square) and diffuse (marked by *)  nNOS expression, are present 
in this section.  
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Figure 3-26 parvalbumin and nNOS labelling in the central nucleus. Open arrowheads show nNOS puncta in 
parvalbumin positive cells. Arrows point to cells labelled with nNOS only. 
Most, but not all, Parvalbumin cells are GABAergic 
GABA positive cells were present in all subdivisions of the IC with large GABA positive cells 
located in the central nucleus (Figure 3-27). Parvalbumin labelling was mainly observed in 
the central nucleus, although some smaller cells were observed in the dorsal cortex (Figure 
3-23). The vast majority of parvalbumin positive cells also showed immunoreactivity for 
GABA or GAD65/67, although about 30% of the parvalbumin labelled cells did not show 
immunoreactivity for GABA or GAD65/67 and are presumably glutamatergic.  
 
Figure 3-27 Mosaic low power images showing from left to right parvalbumin labelling, GABA labelling and the merge 
of the two. The scale bar indicates 500 µm. 
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Some parvalbumin cells are innervated by GAD labelled puncta 
An example of a parvalbumin positive neuron that shows no immunoreactivity for GAD65/67 
is depicted in Figure 3-28. The maximum intensity insert on the left in this image shows that 
GAD65/67 is abundant in the central nucleus but not in this parvalbumin positive cell. This 
point is further substantiated by the orthogonal views insert on the right which show the 
virtual cuts through the section along the yellow lines and this clearly demonstrates that no 
GAD65/67 is present in this parvalbumin labelled cell. Note however, that parvalbumin 
positive cells do receive GABAergic inputs on their proximal dendrites (Figure 3-29). 
 
Figure 3-28 parvalbumin and GAD65/67 labelling in the central nucleus. On the left a maximum intensity projection 
revealing the presence of GAD65/67 in the section but not in the parvalbumin cell. On the right orthogonal views 
again showing thatGAD65/67 labelling is absent from the parvalbumin positive cell.  
PV 
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Figure 3-29 high power image of a parvalbumin positive neuron in the IC that receives GAD positive puncta on its 
dendrite.  
To understand how glutamatergic projections are distributed throughout the IC I will first 
discuss the expression patterns of the vesicular transport proteins for glutamate VGLUT1 
and VGLUT2. Vesicular transporters are indicative of the glutamatergic inputs a cell 
receives, it is likely that the cell bodies of many cells giving rise to the VGLUT positive 
terminals are not in the IC. In the case of the VGLUT1 this is necessarily the case because 
VGLUT1 is not synthesised in the IC. This general expression pattern will be followed by 
inspection of VGLUT positive terminals innervating cells labelling positive for nNOS or 
calcium binding proteins. Data will be presented along the rostral-caudal axis and the main 
subdivisions of the IC. Given that no positive label for glutamate can be used, a cell is 
deemed glutamatergic due to the absence of GAD or GABA.  
VGLUT1 and VGLUT2 labelled excitatory terminals were observed throughout all 
subdivisions of the IC. In Figure 3-30 and Figure 3-31 examples of VGLUT1 and VGLUT2 
labelling along the rostral caudal axis in the same animal are shown. Labelling of VGLUT1 
and VGLUT2 was assessed by eye and appeared at low magnification to vary along the 
rostral caudal axis with denser labelling observed in the middle and caudal areas of the IC. 
3.3.6 Distribution of Glutamatergic Terminals in Subdivisions of the
IC 
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Within the caudal and middle sections, VGLUT1 shows a relatively even labelling through 
subdivisions of the IC although clusters of denser labelling were observed, marked by * in 
Figure 3-30. At higher magnification VGLUT1 appeared to associate with cell bodies as 
indicated by a VGLUT1 positive puncta forming circles around the nucleus indicated by 
DAPI labelling (Figure 3-38). No obvious consistent differences were observed between the 
subdivisions, although three out of five animals showed denser labelling in the lateral 
cortex. VGLUT2 was also abundant in all subdivisions of the IC, but showed differences 
between the subdivisions with denser labelling observed in the dorsal and lateral cortices 
and considerably less labelling in the central nucleus, as outlined in Figure 3-31. At higher 
magnification, VGLUT2 appeared to densely innervate cell bodies and processes as the 
VGLUT2 labelling was frequently arranged in circles and long chains (Figure 3-39). 
 
Figure 3-30 Mosaic images showing VGLUT1 labelled excitatory terminals along the rostral –caudal axis of the IC. 
From left to right are depicted caudal, mid and rostral sections of the IC. The scale bar indicates 500 µm. Areas 
indicated by * show cluster of denser VGLUT1 labelling. 
 
Figure 3-31 Mosaic images showingVGLUT2 labelled excitatory terminals along the rostral –caudal axis of the IC. 
From left to right are depicted caudal, mid and rostral sections of the IC. The scale bar indicates 500 µm. 
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nNOS and VGLUT1 
In Figure 3-32 nNOS and VGLUT1 in the central nucleus appeared to label different 
populations. The nNOS positive puncta in the central nucleus were not associated with 
VGLUT1 positive puncta. In the dorsal and lateral cortex the picture was more complex, in 
these subdivisions both cells with punctate and distributed nNOS labelling were observed. 
As was the case in the central nucleus, cells with solely nNOS punctate labelling did not 
appear to be innervated by VGLUT1 puncta (Figure 3-33). However, cells filled with nNOS 
labelling did show VGLUT1 labelled innervations. The VGLUT1 positive contacts were 
observed on both the soma and the dendritic branching (Figure 3-34).  
3.3.7 nNOS and Glutamatergic Input
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Figure 3-32 nNOS and VGLUT1 labelling in the central nucleus of the IC. The solid arrowheads indicate cells with 
nNOS labelling which are not associated with VGLUT1 positive puncta, none of the nNOS labelled cells appeared to 
be associated with VGLUT1. Open arrowheads indicate examples of cells receiving VGLUT1 puncta in which no 
nNOS labelling was observed.  
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Figure 3-33 nNOS and VGLUT1 labelling in the dorsal cortex. Open arrowheads indicate cells receiving VGLUT1 
innervation but showing no nNOS labelling. The solid arrowheads point out cells with nNOS labelling but no VGLUT1 
positive innervation. 
 
Figure 3-34 A, C and D show cells with nNOS labelling throughout the cell in the dorsal cortex. Open arrowheads 
indicate VGLUT1 innervated nNOS cells. Closed arrowheads indicate cells that show nNOS cells that receive no 
VGLUT1 positive innervation. Figure B shows a maximum intensity projection of a Z-stack series showing a NOS 
positive cell in the lateral cortex that is densely innervated by VGLUT1 positive terminals both on the soma and the 
dendrite, outlined by nNOS positive puncta. Note that maximum intensity projections do contain saturated pixels.  
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nNOS and VGLUT 2 
Both cells with nNOS punctate labelling and cells with distributed nNOS labelling in all sub-
divisions of the IC showed VGLUT2-labelled innervation on their somata and dendrites, 
though the latter was harder to discern. Both cells with nNOS punctate labelling and cells 
with distributed nNOS labelling were innervated by VGLUT2 positive puncta in the dorsal 
cortex (Figure 3-35). VGLUT2 labelling formed dense rings around nNOS positive cells in 
the dorsal cortex. In the lateral cortex most nNOS labelled cells, of both types, were 
encapsulated by VGLUT2 puncta, however, in this subdivision, some nNOS positive cells 
were observed not receiving any apparent VGLUT2 innervation (Figure 3-36). In the central 
nucleus, where virtually all nNOS labelling was of the punctate type most nNOS labelled 
cells received innervation from VGLUT2 positive puncta (Figure 3-37). In contrast to the 
cortices few nNOS positive cells in the central nucleus were entirely encapsulated by 
VGLUT2 terminals. 
 
Figure 3-35 nNOS and VGLUT2 in the dorsal cortex. Open arrowheads show cells with distributed nNOS labelling. 
Closed arrow head shows cell with nNOS positive puncta that is surrounded by GLUT2 positive terminals. 
VGLUT2 
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Figure 3-36 nNOS and VGLUT2 .in the lateral cortex. Open arrowheads show nNOS cells contacted by VGLUT2 
terminals. Closed arrowheads show nNOS positive cells that lack apparent VGLUT2. 
 
Figure 3-37 nNOS and VGLUT2 .in the central nucleus. The arrowheads show cells with nNOS positive puncta 
innervated by VGLUT2. 
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Parvalbumin cells in the central nucleus receive VGLUT2 but no VGLUT1 input. 
Although abundant in the central nucleus VGLUT1 labelled puncta rarely made contact with 
cells expressing parvalbumin (Figure 3-38). However, VGLUT1 labelled terminals were 
observed that appeared to encircle parvalbumin negative cell bodies (Figure 3-38). 
 
Figure 3-38 Parvalbumin positive cells and VGLUT1 positive puncta in the central nucleus. Arrowheads indicate 
parvalbumin positive cells, which did not appear to receive VGLUT1 innervation. Arrows point to parvalbumin 
negative cells that did receive VGLUT1 positive innervation. 
Parvalbumin positive cells did receive dense VGLUT2 positive innervation (Figure 3-39). 
The VGLUT2 labelled terminals formed dense clusters around the soma, dendrites and 
axons of parvalbumin positive cells in the central nucleus. Large parvalbumin positive cells 
(diameter >25 µm) appeared to be more densely innervated by VGLUT2 puncta (white 
arrows) compared to the smaller parvalbumin positive cells (closed arrowheads). Non-
parvalbumin cells outlined by dense clusters of VGLUT2 puncta (open arrowheads) were 
also seen. 
94  Ι  Cytoarchitecture and Phenotypic Features of nNOS Expressing Cells 
 
Figure 3-39 parvalbumin positive cells and VGLUT2 positive puncta in the central nucleus. Arrows indicate large 
parvalbumin cells with dense VGLUT2 innervations. Closed arrowheads indicate small PV cells and open arrowheads 
non-parvalbumin cells that receive dense VGLUT2 innervations.  
In Figure 3-40 the total cell counts within each section along the rostrocaudal axis are 
displayed for the cells expressing calbindin, calretinin, parvalbumin or nNOS.  
The total cell counts showed the relative proportions of the four cell types within each area 
along the rostro-caudal axis. In the caudal areas of the IC, which consist of only cortex there 
appeared to be equal numbers of all four cell types. However, in the middle and rostral 
areas, in which large parts of the section were central nucleus, the numbers of parvalbumin 
and nNOS cells were considerably higher than the numbers of calbindin and calretinin 
positive cells. Although in these areas few nNOS positive cells were observed in the central 
nucleus. A higher number of nNOS positive cells was observed in the dorsal and lateral 
cortex mid-way along the rostro-caudal axis of the IC. The highest number of cells 
expressing parvalbumin were observed in both mid and rostral areas of the IC. Calretinin 
and calbindin positive cells are most abundant in the caudal areas of the IC and their 
expression levels are lower in the mid and rostral areas of the IC.  
3.3.8 Parvalbumin, Calbindin, Calretinin & nNOS cell size
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Figure 3-40 cell counts for calbindin, calretinin, parvalbumin and nNOS cells along rostral caudal axis of the IC 
There were no differences in the distribution of cell diameter between the three calcium 
binding protein expressing cells (Figure 3-41). All cell types show a skewed distribution 
peaking around ~20 µm diameter but with a relatively large number of bigger cells. The 
nNOS cells show a different distribution along the rostral caudal axis with larger cells 
appearing in the middle and rostral parts of the IC.  
A two way ANOVA testing the cell diameters, revealed a main effect for area along the 
rostral caudal axis (F(2,16517) = 100.64, p < 0.0001) and a main effect for cell markers 
(F(3,16517) = 100.31, p < 0.0001) as well as an interaction effect between the two 
(F(6,16517) = 68.56, p <0.0001). 
Post hoc Tukey tests revealed that parvalbumin positive cells were bigger (21.34 µm ± 0.11 
µm) on average than the other three markers, parvalbumin vs. calbindin (1.81 µm ± 0.18 
µm), parvalbumin vs. calretinin (2.10 µm ± 0.18 µm) and parvalbumin vs. nNOS (2.49 µm 
± 0.14 µm). The differences among the other cell markers although significant had small 
effect sizes and will not be reported here. Post hoc Tukey tests for area showed that cells 
in rostral areas were larger compared to cells in the middle IC (2.00 µm ± 0.14 µm) and 
cells in caudal areas (2.81 µm ± 0.15 µm).  
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For the interaction effect calretinin, positive cells showed an increase in cell sizes along the 
rostral caudal axis with the cells in the rostral areas being larger compared to the middle 
areas (1.45 µm ± 0.38 µm) and caudal areas (2.73 µm ± 0.32 µm). nNOS positive cells 
showed even larger differences in average cell size along the rostral caudal axis with cells 
in the rostral areas again being larger compared to the middle areas (4.41 µm ± 0.21 µm) 
and the caudal areas (6.49 µm ± 0.25 µm), and cells in areas mid-way through the IC were 
bigger than the ones observed in the caudal areas (2.09 µm ± 0.22 µm). 
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Figure 3-41 relative distributions of calbindin, calretinin, parvalbumin and nNOS cells along the rostral caudal axis 
of the IC 
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3.4 Discussion 
In this Chapter, I presented immunohistochemical observations made throughout the IC. 
The following questions regarding the distribution of nNOS cells, their neurotransmitter 
phenotype, their co-expression of calcium binding proteins and the nature of afferent 
glutamatergic inputs to them were addressed: 
  1. In what subdivisions of the IC are nNOS expressing cells found and what is the 
subcellular distribution of nNOS? 
  2. What is the neurotransmitter phenotype of the nNOS expressing cells? 
  3. In what subdivisions of the IC are cells expressing the calcium binding protein 
calbindin, calretinin and parvalbumin found and are these cells GABAergic? 
  4. Do nNOS expressing cells selectively express calbindin, calretinin or parvalbumin?  
  5. Do the cells expressing nNOS or calcium binding proteins receive glutamatergic 
inputs and if so, what is the nature of these inputs? 
nNOS labelling was observed in cells in the lateral and dorsal cortex as previous reports 
have described. Here the nNOS labelling was distributed evenly through the soma and 
dendrites of the cells. One of the major findings reported in this chapter, in contrast to 
previous reports, is that nNOS was also found to be expressed in the central nucleus. In 
the central nucleus, nNOS labelling was observed in discrete puncta. This punctate 
labelling was also seen in the cortices in cells which also had distributed nNOS labelling. 
The nNOS expressed in these puncta was associated with the postsynaptic density protein 
PSD95.  
Although some nNOS positive neurons in the IC were found to express the GABAergic 
marker GAD65/67, the vast majority did not and are presumed to be glutamatergic. The 
regional expression of nNOS and the expression of both calbindin and calretinin overlap in 
the dorsal and lateral cortex, but, within cells, nNOS was rarely co-localised with calretinin. 
Calbindin expression, on the other hand, was virtually always an indicator for nNOS 
expression in that cell, although many calbindin negative nNOS cells were also observed. 
Cells with puncta and/or diffuse nNOS expression also expressed parvalbumin, but many 
parvalbumin positive cells were nNOS negative.  
The calcium binding proteins calbindin and calretinin were observed in the cortices along 
the rostral caudal axis of the IC. Calbindin cells show no difference in size along this axis 
whereas calretinin cells are larger in the rostral areas compared to the caudal areas of the 
IC. Parvalbumin positive cells were the largest cells observed throughout. Neurons showing 
Discussion  Ι  99 
positive labelling for parvalbumin, calbindin or calretinin in the IC were not always positive 
for GABA or GAD suggesting that neurons expressing calcium binding proteins in the IC 
can be glutamatergic. A finding that fits with evidence that 20% of the parvalbumin cells in 
the visual cortex are not GABAergic (Demeulemeester et al., 1991).  
Both VGLUT1 and VGLUT2 labelled terminals were found associated with the soma and 
dendrites of the nNOS filled cells in the cortices. But the punctate nNOS cells in the central 
nucleus showed a different pattern of VGLUT innervation. 
In summary, nNOS expression is observed in all divisions of the IC but with distinct 
subcellular expression patterns. Cells expressing nNOS are largely glutamatergic, but co-
labelling with GABAergic markers does occur. Cells expressing nNOS can contain either 
calbindin or parvalbumin but rarely calretinin. Cells exhibiting either the punctate or diffuse 
nNOS expression showed distinct patterns of glutamatergic innervation. 
The range of questions was chosen because currently little is known about these neurons. 
Using this wide range of markers allowed me to identify a wide range of potential markers 
for future studies. Due to the number of markers used, most of the studies reported here 
are descriptive in nature laying the groundwork for future more rigorous quantification. The 
current results have brought about exciting novel findings and provide a framework for 
future research. The phenomena to be quantified have been identified and that is a major 
step forward. 
The presence of NADPH diaphorase (which is now known to be nNOS (Bredt et al., 1991; 
Dawson et al., 1991; Hope et al., 1991; Coote and Rees, 2008)) has been recognised in 
the auditory pathway and most prominently in the IC for a long time (Herbert et al., 1991; 
Druga and Syka, 1993). In the IC, NADPH-diaphorase activity/nNOS labelling can be seen 
in cell bodies and extensive dendritic processes in some cells. Previously nNOS has been 
shown to be differentially expressed in the three subdivisions of the IC, the dorsal cortex, 
the lateral cortex and the central nucleus with little to no expression reported in the central 
nucleus (Coote and Rees, 2008). The current findings are consistent with the previous 
reports of nNOS positive cytoplasmic labelling in somata, dendrites and axons of neurons 
in the dorsal and lateral cortex (Coote and Rees, 2008). The density of nNOS positive cells 
decreases progressively in areas where the cortices blend into the central nucleus.  
3.4.1 Distinct Patterns of nNOS Labelling 
100  Ι  Cytoarchitecture and Phenotypic Features of nNOS Expressing Cells 
A major finding here is the nNOS positive punctate labelling that is not only present in the 
cortices on or in the cells with distributed cytoplasmic labelling but is also abundant in the 
central nucleus where it appears in or on the somata of cells which otherwise have no 
discernible cytoplasmic nNOS labelling. This finding has the potential to change our views 
of nNOS in the IC. The two different expression patterns strongly suggest different potential 
roles NO can play in modulating neuronal activity. The puncta were observed with both the 
nNOS antibodies used, which were raised in different species, obtained from different 
companies and raised against different epitopes, making it unlikely that the puncta are not 
related to nNOS expression. The question remains whether the nNOS puncta can be 
observed in NADPH diaphorase labelled sections, one report suggested observing 
punctate NADPH diaphorase labelling in the lateral cortex (Wu et al., 2008), but failed to 
provide any evidence for this. The NADPH diaphorase method often results in dark neuropil 
labelling making detection of small puncta difficult, possibly this method is not refined 
enough to discern small structures like puncta with great precision. Also, the product is 
soluble and may not stay in association with the site in which it is formed- in contrast to the 
antibody labelling where the fluorophore is in physical association with the antigen. 
The vast majority of these nNOS positive puncta co-localise with PSD95. PSD95 is a protein 
located in the post synaptic density and the association between the two proteins strongly 
suggests that the nNOS puncta are associated with the synapse. Wide field microscopy 
does not allow for the definitive determination of whether the nNOS puncta are pre or 
postsynaptically localized. However, given that we know that the nNOSα protein contains 
a PDZ binding domain via which it associates itself with PSD95, it is justified to assume that 
I) nNOS puncta are associated with PSD95, 2) that this nNOS is nNOSα, 3) since PSD95 
also anchors the NMDA receptor this co-labelling likely represents the nNOS-PSD95-
NMDA complex. Previous reports have suggested that nNOS might occur presynaptically 
on rare occasions (Atkinson et al., 2003; Fernández-Alvarez et al., 2011) and some of the 
nNOS puncta here could, therefore, be presynaptic. However given the current evidence 
that seems unlikely and I will assume that these nNOS puncta contain nNOSα.  
If nNOSα is associated with PSD95 and appears as puncta then this raises the question of 
which isoform of nNOS is present in the cells in the cortices which show distributed labelling 
for nNOS. The cells showing distributed nNOS labelling could, of course, be filled with 
3.4.2 Subcellular Localisation of nNOS
3.4.3 nNOSα and nNOSβ Expression in the IC
Discussion  Ι  101 
nNOSα, representing nNOSα that has yet to be transported to the postsynaptic densities 
or is currently unattached to PSD95. However, this seems an unlikely scenario because the 
cells only expressing nNOS punctate labelling show no nNOS labelling anywhere in their 
cell contents. A theoretical possibility that we cannot discard currently is the possibility that 
nNOSα and nNOSβ proteins may form functional heterodimers. The existence of these has 
never been shown in vivo and we don’t know whether this configuration could be functional, 
but the diffuse distribution of nNOS in the cells in the cortex could in theory present such a 
heterodimer complex. That, however, would still not explain why the cells in the central 
nucleus show punctate labelling only. In situ hybridization studies showed that most areas 
in the brain express mRNAs for both nNOSα and nNOSβ, although in normal physiology 
mRNA for nNOSα is detected in higher quantities compared to nNOSβ (Langnaese et al., 
2007). mRNA quantification does not, however, directly translate to protein quantities, due 
to post-translational processing, and knock-out studies suggest that nNOSβ can rescue the 
phenotype when nNOSα is lost (Langnaese et al., 2007). Some efforts have been made to 
investigate the expression of the two splice variants and they appear to occur largely in the 
same areas as well as in the cells making it harder to disentangle their roles (Eliasson et 
al., 1997; Brenman et al., 1997). Nevertheless, some cells throughout the mammalian body 
have been reported to express either nNOSα or nNOSβ (Percival et al.; Giove et al., 2009; 
Jang et al., 2015; Rothe et al., 2002; Saur et al., 2002). In skeletal muscle, nNOSβ was 
shown to be associated with the Golgi-complex that controlled its expression (Percival et 
al., 2010). Even though this finding is not in neuronal tissue, it does suggest that nNOSβ 
does have its own regulators. The two expression patterns observed in the IC may be 
related to these two different splice variants and if we hope to understand the role NO plays 
in auditory processing in the IC it is important that we are able to distinguish between them.  
Currently, no commercial antibodies targeting specifically nNOSα or nNOSβ proteins exist 
making it impossible to investigate whether different cells in the subregions of the IC 
express different nNOS splice variants at the protein level. However, custom made 
antibodies targeting nNOSα and nNOSβ have been made and successfully used in a 
previous study (Langnaese et al., 2007), demonstrating that a study of nNOSα and nNOSβ 
is feasible. In situ hybridization studies reporting nNOSα and nNOSβ mRNA levels in the 
midbrain and brain stem made no distinction between the subregions of the IC (Eliasson et 
al., 1997), future studies would benefit greatly by making this distinction. Even though it 
would not tell us how much protein is present in the cells, it would help to verify whether 
nNOSβ expression is absent in the central nucleus and strengthen the hypothesis that the 
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puncta consist of nNOSα. Regardless, even if all nNOS in the IC turns out to be nNOSα, 
the question remains why some cells are filled while others show discrete punctate labelling.  
Some nNOS positive cells do express GABA but the vast majority show no 
immunoreactivity for GABA or GAD. Because the IC has no neurons synthesizing 
dopamine, serotonin, acetylcholine or glycine hence the absence of GABA suggests that 
the cells have a glutamatergic neurotransmitter phenotype. Wu et al. (2008) combined 
NADPH diaphorase and immunofluorescent protocols labelling GABA and glutamate and 
found that 77% of the NOS positive neurons in the cortices were glutamatergic, 11% 
GABAergic and the remaining 12% of undetermined phenotype. Since glutamate is present 
in all cells due to its involvement in the Krebs cycle, the glutamatergic phenotype of neurons 
is usually inferred by their lack of labelling for GABA or other neurotransmitters. Close 
inspection of the images presented in the Wu et al. (2008) study, highlights the difficulty of 
labelling for glutamate. Some cells showed immunoreactivity for both GABA and glutamate, 
which is not unexpected but some cells showed no immunoreactivity for either marker which 
is cause for concern. Recent in situ hybridization studies (in which the presence of VGLUT2 
mRNA was used to define glutamatergic phenotype) have shown that 70-80% of the nNOS 
cells in the IC have a glutamatergic phenotype (Fujimoto et al., 2016), the authors 
suggested that the remainder are likely to be GABAergic. Because the presence of nNOS 
in the central nucleus was unknown, no study has addressed whether nNOS punctate 
labelled cells are GABAergic. When I performed the GABA studies I was unware of the 
punctate nNOS labelling in this region and hence no high power images were collected in 
the central nucleus. The currently existing low power images obtained for my studies do not 
provide enough detail to allow for accurate observations about whether nNOS positive 
punctate labelling is co-expressed with GABA markers in the same neurons, but this would 
be an important question to address in future studies.  
I have shown evidence that calbindin cells in the dorsal and lateral cortex almost always 
express nNOS while calretinin cells seldom do. Because calbindin positive cells in the IC 
virtually always express nNOS, labelling for calbindin can be used to identify at least a 
subset of nNOS cells in the IC.  
Although they have been used extensively to delineate specific subpopulations of neurons 
particularly in the cerebral cortex, relatively little is known about the function of these 
3.4.4 Some nNOS Cells in the IC are GABAergic 
3.4.5 nNOS Labelled Cells Express Calcium Binding Proteins 
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calcium binding proteins. However, recent findings suggest they are more than simple 
calcium buffers, and like calmodulin, undergo a conformational change when binding 
calcium, triggering further signalling cascades (Schwaller, 2009). Given the possibility that 
nNOSβ is expressed in the IC and presumably not directly linked to NMDA receptor activity, 
future research should address the possibility that nNOSβ is always co-expressed with one 
or more EF-hand calcium binding proteins.  
In the current set of experiments no differences between the two nNOS expression patterns 
were observed regarding the calcium binding protein content of the cells. It is likely that 
nNOSα expressing neurons also have EF-hand calcium binding protein to keep the 
intracellular levels of free calcium low. In my experiments I always tested a single calcium 
binding protein together with nNOS, but there is no reason to limit oneself to one calcium 
binding protein marker at a time. A valuable experiment would be to label the same section 
for nNOS and with a combination of at least the three calcium binding proteins described in 
this chapter to establish whether or not nNOS is always expressed in conjunction with one 
or other of these proteins.  
Parvalbumin positive cells in the neocortex have been shown to represent a unique 
population of GABAergic interneurons (Cowan et al., 1990; Demeulemeester et al., 1991). 
However, from a study in the visual cortex we know that 20% of the parvalbumin positive 
cells in V1 show no immunoreactivity for GABA (Demeulemeester et al., 1991), clearly 
illustrating that parvalbumin is not a definitive marker for GABAergic neurons in all brain 
regions.  
In this chapter, I reported that although many parvalbumin positive neurons in the IC co-
express GABA there are parvalbumin cells in the IC that are GABA negative. This agrees 
with recent findings showing that 10 % of the parvalbumin positive cells in the IC have a 
glutamatergic phenotype (Fujimoto et al., 2016). The same study demonstrated that around 
5-15% of nNOS cells in the IC express GAD67 and so can be regarded as GABAergic 
(Fujimoto et al., 2016). But all of these GABAergic nNOS cells showed immunoreactivity 
for parvalbumin (Fujimoto et al., 2016). So while not all parvalbumin positive cells in the IC 
are GABAergic, the ones that express nNOS appear to be GABAergic. Again pointing 
towards an important role for the calcium binding proteins in relation to nNOS related 
activity.  
The number of cells co-expressing parvalbumin and nNOS is low (Fujimoto et al., 2016), 
which agrees with findings reported in this chapter. The area in which cells with a diffuse 
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nNOS distribution and parvalbumin positive phenotype occur is restricted to the borders of 
the cortices and central nucleus. My results show nNOS positive punctate labelling was 
observed in parvalbumin positive cells in this border region, but these labelling experiments 
were performed before I was aware of the existence of the nNOS puncta in the central 
nucleus. New labelling studies specifically targeting this phenomenon could find more 
nNOS positive parvalbumin cells. 
The glutamatergic inputs received by neurons in the IC can be divided in ascending and 
descending connections. VGLUT1 and VGLUT2 have been shown to be markers for the 
terminals of glutamatergic cells (Altschuler et al., 2008). Since VGLUT1 and VGLUT2 are 
synthesized in different brain areas, the specific labelling can inform us from where in the 
auditory pathway a cell in the IC receives glutamatergic projections.  
VGLUT1 is not synthesized in the IC, inputs that are exclusive VGLUT1 have been shown 
to originate from the ipsilateral auditory cortex (Ito and Oliver, 2010). Cells that are 
innervated by fibers ending in terminals containing both VGLUT1 and VGLUT2 have been 
shown to originate from auditory brainstem areas but mainly from the VCN (Ito and Oliver, 
2010). VGLUT2 is not synthesized in the cortex thus these connections necessarily 
represent ascending or internal connections (Ito and Oliver, 2010). Ito and Oliver (2010) 
showed that most of the VGLUT1 observed throughout the IC represents cortical 
innervation. This underscores the central role this auditory structure has in integrating 
ascending and descending streams of information. In accordance with previous studies, I 
showed that VGLUT1 and VGLUT2 have different innervation patterns on cells in the IC. 
Although, in my current studies the VGLUT2 labelling appeared denser in the dorsal and 
lateral cortex suggesting more ascending or internal connections in these areas. However, 
previous studies have reported denser VGLUT2 innervation in the central nucleus (Ito and 
Oliver, 2010).The cells only showing nNOS puncta appear not to receive any VGLUT1 
innervation and hence appear not to receive any descending input from the cortex. The lack 
of VGLUT1 innervation in neurons with nNOS puncta is in stark contrast with the cells 
expressing diffuse nNOS labelling in the dorsal and lateral cortex which do receive dense 
VGLUT1 innervation. This distinction suggests that these cell types not only have a different 
subcellular nNOS distribution but also receive different sources of input. The diffuse nNOS 
cells in these subdivisions may receive dense corticocollicular connections from the 
auditory cortex. A key marker that should be considered in future IC studies would be 
VGAT, which labels both glycinergic and GABAergic inhibitory terminals, in conjunction with 
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VGLUT1 and VGLUT2 this marker can be used to estimate the balance between excitatory 
and inhibitory input a cell receives. In the current study data was presented showing GAD 
labelled innervation on some parvalbumin cells, however, GAD labelling tends to be more 
diffuse compared to the VGLUT1 and VGLUT2 puncta and it can be difficult to link it to the 
innervation of a specific cell.  
It is important to note that my current results have not been quantified and before further 
claims can be made about the amount of VGLUT1 and VGLUT2 innervation in the 
subdivisions of the IC, careful inspection of the sections followed by rigorous quantification 
is needed. Also, the current image acquisition was optimised on a section by section basis, 
thus luminescent quantification across sections cannot be done on the current data set. 
Keeping image parameters the same between labelling protocols will be essential.  
Given the possibility that nNOSβ is not directly dependent on NMDA receptor activity a 
question that needs to be addressed is what could regulate the activity of nNOSβ. NMDA 
receptor activity has long been linked to nNOS activity but there are many other signalling 
cascades employing calcium signals. Because free calcium is potentially dangerous to 
cells, the levels are tightly regulated. The EF-hand calcium binding proteins have been 
shown to be involved in regulating the intracellular levels of calcium in the brain (Schwaller 
et al., 2002; Schwaller, 2009). Findings indicate that calbindin and calretinin are more than 
simple calcium buffers (Schwaller et al., 2002), but are also calcium sensors, which makes 
them potentially interesting targets that could regulate other secondary messengers like 
nNOSβ. The finding from non-neuronal cells showing nNOSβ being linked to and regulated 
by the Golgi complex (Percival et al., 2010) would be a good starting point. 
The two nNOS expression patterns observed in the IC likely represent cells in which nNOS 
performs different functions. The nNOS punctate labelling is observed in all subdivisions of 
the IC, and I showed differences in the inputs the two types of nNOS cells receive. The 
activity of NOSα is dependent on NMDA receptor activity due to its close proximity to the 
NMDA receptor via their mutual interaction with PSD95. However, there is no reason to 
suspect that nNOSβ proteins are dependent on the activity of this receptor. In fact given 
the importance and multitude of functions calcium signals perform within the postsynaptic 
domain, calcium diffusion within the cell is severely limited (Augustine et al., 2003). 
Dendritic spines generate calcium signals due to the opening of ion channels governed by 
receptors like the NMDA receptor, but these signals decay within 1 µm (Augustine et al., 
3.4.7 Functional Difference Between nNOSα and nNOSβ 
106  Ι  Cytoarchitecture and Phenotypic Features of nNOS Expressing Cells 
2003). Thus it is highly unlikely that the nNOSβ located throughout the cell body is regulated 
by NMDA receptor mediated calcium signals. The different NMDA subunits have been 
shown to display a different permeability to calcium. Investigating whether the diffuse nNOS 
cells always have NMDA receptors and determining the subunit expression of these 
receptors could tell us more about their dependency on calcium. A related question to learn 
more about the nNOS puncta would be to investigate whether these puncta are associated 
with different NMDA receptor subunits compared to the diffuse nNOS expressing cells. 
Future studies also need to address to what extent nNOS is expressed in the presynaptic 
terminals which might again perform a different function from nNOS observed in the 
postsynaptic density and cytoplasm.  
Hall and Garthwaite (2009) demonstrate that NO production based on the number of NMDA 
receptors present in the active zone of a synapse only allows for the production of picomolar 
concentrations of NO (Hall and Garthwaite, 2009; Wood et al., 2011). They argue that due 
to the low quantities of NO produced by nNOSα in the active zone at any given time, it 
seems unlikely that this type of nNOS expression acts as a volume transmitter. The 
arguments made are persuasive but they hinge on the notion that nNOS is solely activated 
by the NMDA receptor activity. While this notion may be valid for the nNOSα protein, I would 
argue that the picture is far from clear or convincing with respect to the nNOSβ protein. The 
sheer quantity of nNOS present in the cells in the cortices of the IC could give them the 
ability to produce a large quantity of NO which could potentially diffuse out of the cell and 
exert its influence over a wider area.  
In the current set of results I tried to gauge whether different cell size distributions exist in 
the IC subdivision and how that differs along the rostral caudal axis for the cells expressing 
one or more of the following markers; calbindin, calretinin, parvalbumin or nNOS. The cell 
number measure showed similar distributions on the whole IC level. These cell counts were 
done as a preliminary study to investigate whether it would be worthy of further study. In 
retrospect, it would have been better to further subdivide sections into dorsal cortex, lateral 
cortex and central nucleus, but no obvious difference was observed. The total number of 
nNOS and parvalbumin cells was larger compared to the number of cells expressing 
calbindin or calretinin as expected given the more restricted distribution of such neurons 
which are mainly limited to the cortices of the IC. Though simpler in shape, the nNOS 
positive cell bodies in the rostral regions of the IC were larger compared to the nNOS 
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positive cell bodies in the mid and caudal regions. The significance of this finding is currently 
unknown. 
The cell counting exercise identified that nNOS positive neurons are bigger on average in 
the rostral regions of the IC compared to the caudal and middle regions. Besides the 
obvious differences in gross morphology the phenotype and connectivity of these NOS 
positive neurons was shown to differ tremendously, though no systematic differences were 
observed along the rostral- caudal axis of the IC.  
This chapter set out to discover more about the nNOS positive neurons in the IC. A key 
message from these experiments is that neurons expressing this protein represent a 
complex and heterogeneous population. Exciting evidence was presented demonstrating 
that different cellular expression patterns of nNOS, perhaps reflecting different splice 
variants, are present in the IC. Most significant is the finding of expression in the central 
nucleus, a region previously described as having little or no nNOS labelling. This finding 
together with the different inputs both nNOS cell types receive suggests that NO performs 
different functions in these cell populations. These findings open up new and intriguing 
questions regarding the role of NO in neuronal processing. A key issue is whether these 
different expression patterns are linked to the different nNOS splice variants which could 
potentially perform different functions within the same cells. The presence of nNOS in the 
central nucleus in a distinctly different subcellular expression pattern compared to the 
cortices dramatically alters our view of nNOS activity in the IC. 
  
3.4.9 Conclusion 
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Chapter  4. NMDA Receptor Mediated Activity in the IC 
4.1 Introduction 
In the previous chapter, I demonstrated the presence of nNOS in the central nucleus, in this 
chapter, I will present data that addresses the functional role it plays in auditory processing. 
In Chapter 3, immunohistochemical evidence was presented that in contrast to previous 
reports, nNOS is not solely present in the dorsal and lateral cortices but nNOS is abundant 
in the central nucleus of the IC. In contrast to the cortices where nNOS labelling is observed 
throughout the cell, the nNOS expression in the central nucleus is restricted to discrete 
punctate labelling. In the same chapter, evidence was put forward that the nNOS punctate 
labelling was associated with PSD95, a post synaptic scaffolding protein. Two different 
nNOS splice variants have been shown to be active in the brain, only one of which, nNOSα, 
possessing a PDZ binding motif which permits binding to PSD95 (Brenman et al., 1996). 
Thus it is likely that the punctate labelling in the central nucleus represents nNOSα. PSD95 
is known to facilitate the functional coupling of the NMDA receptor and the nNOS protein 
(Kornau et al., 1995; Niethammer et al., 1996; Brenman et al., 1996). Both proteins come 
in close proximity to one another due to their mutual PDZ binding motif interactions with the 
PDZ binding domains 1 and 2 of PSD95. This interaction allows for the formation of the 
nNOS-PSD95-NMDA receptor complex and directly couples the activity of the NMDA 
receptor to the production of NO by nNOSα.  
As discussed in Chapter 1 the central nucleus of the IC receives an enormous number of 
glutamatergic inputs from a number of auditory structures. In the previous chapter, I showed 
evidence of a wide abundance of VGLUT1 and VGLUT2, markers for glutamatergic 
terminals, in the central nucleus. Glutamate acts on different receptors with AMPA and 
NMDA receptors being the most abundant glutamate receptors in the auditory pathway 
(Parks, 2000). While AMPA receptors are coupled to Na+ selective ligand gated ion 
channels and have been shown to have low permeability to calcium, NMDA receptors have 
been shown to be Ca2+.permeable (Dingledine et al., 1999; Meldrum, 2000; Platt, 2007) 
(Pellegrini-Giampietro et al., 1997). 
In resting state conditions, the NMDA receptors are blocked in a voltage dependent manner 
by Mg2+ thus preventing the opening of the ion channel. The activation of AMPA receptors 
depolarises the cell membrane and repels the Mg2+ from the NMDA receptor allowing the 
glutamate (or other NMDA receptor agonist) to bind to the NMDA receptor opening the ion 
channel and allowing Ca2+ into the cell. As discussed in Chapter 1, nNOS is non-active at 
normal resting state calcium levels and requires an intracellular rise in free calcium levels. 
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Due to the co-labelling of PSD95 and the punctate nNOS positive labelling (Chapter 3), it 
seems justified to conclude that the punctate nNOS in the central nucleus forms an integral 
part of the nNOS-PSD95-NMDA receptor complex and that nNOS activity is directly 
dependent on calcium entering the cell due to NMDA receptor activity. NO signalling is 
entirely dependent on its production because there is no storage or release of this gaseous 
neurotransmitter. An increase in the NMDA receptor activation would, therefore, lead to an 
increased production of NO.  
In order to investigate the relation between NMDA receptors and the NO signalling cascade 
and their mutual effect on auditory processes in the IC, a series of experiments were 
designed. The experiments designed relate directly to the aims formulated at the end of 
Chapter 1. 
The aims of this chapter were to: 
 Investigate how selective activation of the NMDA receptor influences the 
spontaneous and acoustic driven response properties of the multi-unit 
activity. 
 Investigate whether and how the NO signalling cascade is participating in 
the spontaneous and acoustic driven responses of the multi-unit activity.  
 Investigate the potential link between the NMDA receptor and the NO 
signalling cascade.  
4.2 Methods 
Each experimental group consisted of three female pigmented guinea pigs aged 
approximately 2-3 months. All animals received the urethane, fentanyl and midazolam 
anaesthesia protocol as described in Chapter 2 had a multichannel electrode and 
microdialysis probe surgically implanted in the IC as described. 
4.3 Protocols 
The first protocol established a concentration response curve for NMDA (Figure 4-1A). In 
these experiments, increasing concentrations of NMDA (30, 100 and 300 µM) were 
perfused. FRA and PSTH data were collected (see Chapter 2). Perfusion of NMDA was 
alternated with aCSF to investigate whether observed effects were reversible. The dose 
response experiments were used as pilot experiments to find the optimal NMDA 
concentration that gives a robust response without completely saturating the system.  
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The second set of data reported here, pools data from the 100 µM NMDA condition from 
nine animals across all three protocols. The pooling of the data resulted in higher statistical 
power. The NMDA concentration response data and the 100 µM NMDA data provided me 
with a description of the neuronal activity in the central nucleus of the IC in response to the 
selective activation of the NMDA receptor in vivo.  
The other two protocols were designed to probe to what extent the observed NMDA effect 
was mediated by NO signalling.  
Protocol 2. Experiments started with a 45 minute perfusion of NMDA (100 µM), followed by 
a 45 minute aCSF washout. This was followed by a 20 minute perfusion of the nNOS 
inhibitor L-MeArg (1000µM) immediately followed by a 20 minute perfusion of both L-MeArg 
(1000 µM) and NMDA (100 µM). Again this was followed by a 45 minute washout. 
Protocol 3. Experiments started with a 45 minute perfusion of NMDA (100 µM), followed by 
a 45 minute aCSF washout. This was followed by a 20 minute perfusion of the sGC inhibitor 
ODQ (500 µM) immediately followed by a 20 minute perfusion of both ODQ (500 µM) and 
NMDA (100 µM). Again this was followed by a 45 minute washout. 
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Figure 4-1 Experimental protocols. A. NMDA dose response (N=3). B. NMDA & L-MeArg (N=3). C. NMDA & ODQ (N=3) 
Measures 
In the earliest experiments the frequency range with which animals were stimulated varied 
such that not all frequencies were presented to all animals in all conditions. The lowest 
frequency that was presented to all animals was 1024 Hz. Thus, the multi-unit activity 
recorded at the electrode best representing this frequency was extracted and analysed. 
The following measures were calculated;  
 Characteristic Frequency (CF)  
 Threshold attenuation at CF 
 Spontaneous activity 
 PSTH onset response 
 PSTH sustained response 
 PSTH total driven response 
 FRA area of increased activity 
4.3.1 Data Analysis and Statistics
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 FRA magnitude of increased activity 
 FRA area of decreased activity 
 FRA magnitude of decreased activity 
The methods for deriving the above listed measures are described in detail in Chapter 2. 
The CF was determined objectively by use of a custom written Matlab algorithm, written by 
me. 
Contrasts 
All data analysed was expressed as a ratio to baseline.  
The first analysis in this chapter focussed on the NMDA concentration response protocol, 
depicted in Figure 4-1 A. Here a within subjects contrast was used. The NMDA perfusions 
(block 2, 4 and 6 in Figure 4-1A) were compared to the original aCSF baseline (block 1 in 
Figure 4-1A). Each NMDA perfusion was also compared to the aCSF perfusion before and 
after it. The data used in the analysis was obtained 45 minutes into the respective perfusion. 
For the 100 µM NMDA experiments, data recorded at 20 minutes into the NMDA perfusion 
condition were used. This allowed determination of whether NMDA effects saturate over 
time, also this allowed for future comparisons between the NMDA only and NMDA + L-
MeArg or NMDA + ODQ. 
The second analysis investigated the effect of L-MeArg on auditory processing in the IC. 
The experimental protocol is depicted in Figure 4-1B, again employing a within subjects 
contrast. The L-MeArg perfusion (block 4 Figure 4-1B) was compared to the preceding 
aCSF perfusion (block 3 Figure 4-1B) and the following aCSF washout (block 6 Figure 
4-1B), note that there was NMDA perfusion in between the L-MeArg block and the aCSF 
washout (block 5 Figure 4-1B). 
The third analysis investigated the effect of ODQ on auditory processing in the IC. The 
experimental protocol is depicted in Figure 4-1C and matches protocol B. The ODQ 
perfusion (block 4 Figure 4-1C) was compared to the preceding aCSF perfusion (block 3 
Figure 4-1C) and the following aCSF washout (block 6 Figure 4-1C). Note that there was 
NMDA perfusion in between the ODQ block and the aCSF washout (block 5 Figure 4-1C). 
In the fourth analysis, a mixed design with a between and a within subjects contrast was 
used. For the between subjects the 100 µM NMDA perfusion block 4 protocol A was 
contrasted with the NMDA + L-MeArg perfusion (block 5 protocol B) and NMDA + ODQ 
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perfusion (block 5 protocol C). The within contrast (baseline, NMDA, washout) included 
blocks 3, 4 and 5 from protocol A, and blocks 4, 5 and 6 from protocols B and C.  
Following this mixed design, for both protocol 2 and 3, a within animal contrast was 
performed over all conditions. 
Statistical analysis 
Data in which the effect of one drug was studied were analysed using a one-way repeated 
measures ANOVA in which the different experimental conditions over time were entered as 
the within subjects factor. When significant main effects for these experimental conditions 
were obtained, post hoc t-tests were used with a Bonferroni correction. NMDA perfusions 
were compared to the original baseline, the aCSF washout preceding the NMDA perfusion 
and the aCSF washout following the NMDA perfusion. Significant differences between 
conditions are expressed as a mean difference in ratio between conditions and its standard 
error. 
Data investigating the possible interaction between the NO modulators (L-MeArg or ODQ) 
and NMDA were analysed with a two-way mixed design ANOVA in which the experimental 
condition was entered as the within subjects factor and the presence/absence of the NO 
modulator as the between subjects factor. From this two-way mixed ANOVA, only 
significant interaction effects are reported, because the main effects in a mixed design can 
be misleading. A significant interaction was followed up by three one-way ANOVAs on the 
three experimental conditions comparing the different groups (NMDA + aCSF, NMDA + L-
MeArg and NMDA + ODQ). Significant main effects from this one-way ANOVA were 
followed up by a post hoc Tukey test. Significant differences between groups are expressed 
as a mean difference (M) between groups and the standard error (SEM). 
To enable a within animal comparison for this data, all conditions from the experimental 
protocols (Figure 4-1B and C) were included in a one way ANOVA. Significant main effects 
were followed up by post hoc t-tests testing the baseline (block 1) against the NMDA (only) 
(block 2), the NMDA (only)(block 2) against the aCSF washout (block 3) and the aCSF 
washout (block 3) against the NMDA + NO modulator (L-MeArg or ODQ) (block 5).   
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4.4 Results 
FRA measures 
NMDA caused a concentration-dependent increase in activity. The effects of local perfusion 
of NMDA were evident not only at or near the CF of the multiunit activity but were observed 
across the FRA a wide range of frequencies and attenuations (see Figure 4-2). Data 
reported in this chapter was obtained from the electrode best responding to 1024 Hz, but 
similar effects were observed on different electrodes (data not shown). Formal analysis of 
the effects of NMDA on measures taken from the FRA are reported below. 
Characteristic frequency and threshold attenuation 
Local perfusion of increasing concentrations of NMDA into the IC did not alter the CF of the 
multi-unit activity recorded on the electrode (Figure 4-2, Figure 4-4A). The CF was 
determined objectively using a software algorithm. A one way ANOVA showed no 
significant effect of condition (F(6,12) = 0.462, p = 0.687 (Figure 4-4A). The threshold 
attenuation at CF was also unchanged in response to the increasing concentrations of 
NMDA (Figure 4-2B) as evidenced by the fact that there was no significant effect of 
condition (F(6,12) = 0.712, p = 0.647) (Figure 4-4B). 
Spontaneous activity 
Local perfusion of NMDA into the IC resulted in an increase in the spontaneous activity 
(obtained from the lowest attenuation level of the FRA) which was concentration dependent 
and only partially reversible. Thus the one way ANOVA showed a significant effect of the 
experimental condition (F(6,12) = 9.70, p = 0.001) (Figure 4-4C). Post hoc tests revealed 
that the spontaneous activity during NMDA perfusion was significantly higher compared to 
that during the perfusion of aCSF at the start of the experiment (original baseline) both after 
local perfusion of 100 µM NMDA (2.22 ± 0.07 (3)) and local perfusion of 300 µM NMDA 
(3.03 ± 0.39 (3)). Spontaneous activity was significantly lower after 45 minutes of aCSF 
washout following the local perfusion of 300 µM NMDA (-0.62 ± 0.20 (3)). The spontaneous 
activity during the local perfusion of 300 µM NMDA was also significantly higher than during 
the aCSF washout condition preceding it (1.92 ± 0.39 (3)).  
4.4.1 Local Perfusion of NMDA Increases Neuronal Activity in a
Concentration Dependent Manner 
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PSTH measures 
An example of the PSTH data recorded in the NMDA dose response experiments is shown 
in Figure 4-3. This figure shows the aCSF baseline recording, subsequent perfusions of 30 
µM, 100 µM and 300 µM NMDA interspersed with aCSF washout conditions. Measures 
derived from the PSTH are detailed below: 
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Figure 4-2. Example FRA showing the effect of three different concentrations of NMDA perfused into IC. The original 
FRA for each block shown in the left column while the right column shows the baseline FRA subtraction from the 
block in question. Note how following perfusion of higher concentrations of NMDA, increased activity (red pixels) is 
seen across the whole FRA although it is most concentrated in the sound driven part of the FRA. Note also how the 
CF and threshold at CF as well as the overall shape of the FRA appear unchanged. 
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Figure 4-3 example PSTH data for the aCSF baseline, 30, 100 and 300 µM NMDA interspersed with aCSF washout 
conditions all data recorded at 45 minutes perfusion. T stands for the total number of spikes, D for the driven number 
of spikes and O for the number of spikes in the onset peak. 
PSTH total driven activity 
Local perfusion of NMDA significantly increased the total driven activity in a concentration-
dependent manner (F(6,12) = 11.79, p <0.001) (Figure 4-4D). The post hoc tests showed 
significant increases in driven activity between the original baseline and both 100 µM NMDA 
(2.05 ± 0.14 (3)) and 300 µM NMDA (2.64 ± 0.37(3)). Total driven activity was significantly 
lower after 45 minutes of aCSF washout following the local perfusion of 300 µM NMDA 
(-0.87 ± 0.18(3)) but not after 100 µM NMDA. The differences between both the NMDA 
blocks and the aCSF blocks immediately preceding them were not significant after the 
Bonferroni correction was applied. To examine whether the effect of NMDA was specific to 
different parts of the PSTH, the activity in the first 10 ms of the onset peak (Onset activity) 
and a 10 ms block during the sustained response was examined. 
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PSTH onset activity 
Local perfusion of NMDA caused an increase in the onset peak activity (F(6,12) = 22.25, p 
< 0.001) (Figure 4-4E). The post hoc tests showed significant differences between the 
original baseline and both 100 µM NMDA (1.63 ± 0.13 (3)) and 300 µM NMDA (2.63 ± 0.28 
(3)). Total onset activity was significantly decreased after the 45 minute aCSF washout 
following the local perfusion of 300 µM NMDA (-1.10 ± 0.43 (3)) but no significant change 
was observed following the 100 µM washout. The differences between both the NMDA 
blocks and the aCSF blocks preceding them were not significant after the Bonferroni 
correction.  
PSTH sustained activity 
Local perfusion of NMDA increased the sustained activity (F(6,12) = 9.36, p = 0.001) (Figure 
4-4F). The post hoc tests showed significant differences between the original baseline and 
both 100 µM NMDA (2.14 ± 0.26(3)) and 300 µM NMDA (2.84 ± 0.17 (3)). Following the 
local perfusion of 100 µM NMDA, a 45 minute aCSF washout failed to significantly reduce 
sustained activity. However, following the local perfusion of 300 µM NMDA a 45 minute 
aCSF washout resulted in a significant reduction in sustained activity (-1.12 ± 0.61 (3)). The 
total sustained activity increased significantly between the 300 µM NMDA condition and the 
aCSF block preceding it (2.36 ± 0.10 (3)). 
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Figure 4-4 NMDA dose response curve for measures of spontaneous and sound-driven neuronal firing in the IC 
(N=3). The individual data points are given for each animal plus the mean across animals is shown as the dashed 
black line. A. CF changes. B. Attenuation at the CF. C. Spontaneous activity. D. PSTH onset activity. E. PSTH 
sustained sound-driven response. F. PSTH total sound-driven activity. Significant post hoc contrasts p<0.05 are 
indicated by A) vs original baseline, B) vs preceding aCSF block, C) vs following aCSF block 
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The dose response studies (reported in section 4.4.1 above) revealed that the lowest 
concentration to consistently increase spontaneous and sound-driven neuronal activity in 
the IC was 100 µM NMDA (45 minutes). This concentration was therefore chosen to assess 
the effects of NOS modulators on the response to NMDA. To substantiate the findings that 
NMDA increases spontaneous and sound-driven neuronal firing in the IC but does not alter 
the CF or threshold attenuation, all NOS modulator experiments began with a 45 minute 
100 µM NMDA perfusion (Figure 4-1A Block 4, 1B Block 2 and 1C Block 2). Investigating 
the data showed that NMDA reached its maximum effect 10-15 minutes after starting the 
perfusion. To allow comparisons with NOS modulator experiments, in this section the data 
recorded 20 minutes after the start of the local perfusion of 100 µM NMDA were analysed 
and are reported. Note that the data from the washout block was recorded 70 minutes later 
(25 minutes remaining NMDA + 45 minutes aCSF washout).  
FRA measures 
Characteristic frequency and threshold attenuation 
Consistent with the observation from study 1, the local perfusion of 100 µM NMDA (20 
minutes) had no effect on CF (Figure 4-6A) or on the threshold attenuation at CF (Figure 
4-6B). Thus, the ANOVA showed no significant effect of condition on either CF (F(2,16) = 
0.085, p =0.919) or threshold (F(2,16) = 2.08, p = 0.162).  
Spontaneous activity 
Spontaneous activity (taken from the lowest attenuation in the FRA) increased significantly 
in response to 100 µM NMDA (20 minutes) (Figure 4-6C). There was a significant main 
effect for the condition (F(2,16) = 37.73, p <0.001) the post hoc tests showed that the 
spontaneous activity in the 100 µM NMDA condition was significantly higher than in the 
preceding aCSF condition (2.46 ± 0.21). The recorded activity during the aCSF washout 
condition varied considerably between animals and was not statistically different from 
NMDA condition. 
  
4.4.2 Local Perfusion of 100 µM NMDA Increases Neuronal Activity
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PSTH measures 
An example of the PSTH data recorded in the NMDA experiments is shown in Figure 4-5. 
This figure shows the baseline recording, a 20 minute perfusion of 100 µM NMDA, 40 
minute perfusion of 100 µM NMDA and the washout condition.  
This figure also illustrates that the NMDA evoked increase is present at 20 minutes and 
does not increase further up to 40 minutes of perfusion.  
 
Figure 4-5 PSTH data for the baseline, 100 µM NMDA condition at 20 and 45 minutes and the washout condition. T 
stands for total number of spikes, D for the driven number of spikes and O for the number of spikes in the onset 
peak. This figure also illustrates that the NMDA evoked increase is present at 20 min and does not increase further 
up to 40 minutes of perfusion, also note the partial reversal during the aCSF washout.  
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Total driven response 
NMDA (20 minutes) increased the total sound driven response (F(2,16) = 8.81, p = 0.003) 
(Figure 4-6D). The post hoc tests showed that total driven activity was higher during NMDA 
perfusion compared to the aCSF condition (1.93 ± 0.16 (9)). The sound driven response 
was significantly reduced after the 45 minute aCSF washout compared to the 20 minute 
NMDA perfusion (-0.98 ± 0.37 (9)). To examine whether the effect of NMDA was specific 
to different parts of the PSTH, the activity in the first 10 ms of the onset peak (Onset activity) 
and a 10 ms block during the sustained response was examined. 
Onset activity 
NMDA (20 minutes) increased the onset response significantly (F(2,16) = 54.89, p < 0.001) 
(Figure 4-6E). Post hoc tests showed that the onset activity in the NMDA condition was 
significantly higher compared to the preceding aCSF condition (1.76 ± 0.06 (9)). The aCSF 
washout (45 minutes) caused a decline in the observed onset activity compared to the 
NMDA condition (-0.83 ± 0.27 (9)).  
Sustained activity 
Local NMDA (20 minutes) perfusion caused an increase in the sustained response (F(2,16) 
= 17.15, p < 0.001) (Figure 4-6F). The post hoc tests showed that the sustained response 
increased in response to the NMDA perfusion compared to the preceding aCSF baseline 
(2.19 ± 0.22 (9)). The washout condition varied considerably between animals and was 
therefore not statistically different from NMDA condition, although the overall trend was a 
decline in sustained activity during the washout.  
124  Ι  NMDA Receptor Mediated Activity in the IC 
 
Figure 4-6 Effects of 100 µM NMDA for several pure tone response measures of neuronal firing in the IC. The 
individual data points are shown per animal, with the mean by the black dashed line. A. CF. B. threshold at CF. C. 
Spontaneous activity. D. PSTH onset activity. E. PSTH sustained driven response. F. PSTH total sound driven 
activity. Significant post hoc contrasts p<0.05 are indicated by A) vs original baseline, B) vs preceding aCSF block, 
C) vs following aCSF block. 
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As discussed in Chapter 1, NO signalling may act through two different modes of action, a 
tonic low concentration state and a short pulsed high concentration state. In order to 
investigate whether NO signalling has an influence on normal auditory processing in the IC, 
the NOS inhibitor L-MeArg was perfused in the IC. 
PSTH measures 
An example of the PSTH data recorded in the L-MeArg experiments is shown in Figure 4-7. 
This figure shows the baseline recording, a 20 minute perfusion of 1000 µM L-MeArg the 
washout condition, note that there was an L-MeArg + NMDA condition in between the 
L-MeArg and the washout condition. There were no significant changes in measures taken 
from the PSTH: driven response (F(1,2) = 6.50, p = 0.126) (Figure 4-8D) onset response 
(F(1,2) = 0.01, p = 0.996) (Figure 4-8E) and the sustained response (F(1,2) = 0.01, p = 
0.992) (Figure 4-8F). 
 
Figure 4-7 PSTH data for the aCSF baseline, 1000 µM L-MeArg and aCSF washout condition. T stands for the total 
number of spikes, D for the driven number of spikes and O for the number of spikes in the onset peak.  
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Figure 4-8 Effects of L-MeArg on neuronal firing in the IC, activity recorded on the electrode recording multi-unit 
clusters responding best to stimulation of 1024 Hz. A. CF B. Attenuation on which the CF was obtained C. 
Spontaneous activity D. PSTH total activity E. PSTH sound driven activity F. PSTH Onset activity. There were no 
significant post hoc contrasts. 
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FRA measures 
The PSTH analysis performed at 1024 Hz, reported above, revealed no significant changes 
in neuronal activity due to the perfusion of L-MeArg in the IC. The FRA permits investigation 
of a wider range of frequencies and attenuations on the same electrode. In Figure 4-9 the 
original FRA (left column) and the result of subtracting the baseline FRA (right column) are 
shown for the aCSF baseline and the L-MeArg condition, examples come from two different 
animals. Some pixels representing different frequencies did show changes in activity, but 
no systematic statistically significant consistent patterns were observed during the 
perfusion of L-MeArg.  
The local perfusion of L-MeArg in the central nucleus of the IC had little effect on the 
measures of neuronal firing recorded (Figure 4-8). The CF did not change significantly 
(F(1,2) = 3.47, p = 0.203) (Figure 4-8A) and the threshold attenuation at CF was also 
unaffected, (F(1,2) = .031, p = 0.877) (Figure 4-8B). Similarly, the 20 minute perfusion of 
L-MeArg produced no systematic change in spontaneous activity (F(1,2) = .351, p = 0.614) 
(Figure 4-8C). 
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Figure 4-9 FRAs collected at baseline and during the perfusion of 1000 µM L-MeArg. Shown in the left column are 
the original FRAs, in the right column the baseline FRA is subtracted from the L-MeArg block. The top example 
originates from GP4, the bottom example from GP6. 
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As discussed in the Introduction, sGC - the main downstream receptor target of NO remains 
in a stable low active state under normal conditions producing solid but low levels of cGMP 
due to the tonic levels of NO binding to the haem domain of sGC. The uncoupling of NO 
from the haem of sGC is slow and the blocking of NO production by L-MeArg may leave 
the low level activity of sGC in place. To investigate whether this tonic state of sGC might 
contribute to normal auditory processing in the IC, ODQ, a drug that blocks sGC was 
perfused in the IC through a microdialysis probe, thereby inhibiting the functioning of sGC.  
PSTH Measures 
An example of the PSTH data recorded in the ODQ experiments is shown in Figure 4-10. 
This figure shows the baseline recording, a 20 minute perfusion of 500 µM ODQ and the 
washout condition, note that there was an ODQ + NMDA condition in between the ODQ 
and the washout condition. The perfusion of ODQ also failed to induce any systematic 
changes in neuronal firing in the IC. No changes were observed in any of the three 
measures obtained from the PSTHs. Thus there was no significant effect of condition for 
total driven activity (F(1,2) = 0.399, p = 0.592) (Figure 4-11D), onset (F(1,2) = 0.144, p = 
0.741) (Figure 4-11E) or sustained (F(1,2) = 0.274, p = 0.653) (Figure 4-11F). 
 
Figure 4-10 PSTH data for the aCSF baseline, 500 µM ODQ and aCSF washout condition. T stands for the total number 
of spikes, D for the driven number of spikes and O for the number of spikes in the onset peak. 
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Figure 4-11 Effects of ODQ on neuronal firing in the IC, activity recorded on the electrode recording multi-unit 
clusters responding best to stimulation of 1024 Hz. A. CF B. Attenuation at which the CF was obtained C. 
Spontaneous activity D. PSTH onset activity E. PSTH sustained activity F. PSTH total driven activity. There were no 
significant post hoc contrasts. 
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FRA measures 
The PSTH analysis performed at 1024 Hz, reported above, revealed no significant changes 
in neuronal activity due to the perfusion of ODQ in the IC. As discussed before, the 
subtracted FRA allows me to investigate a wider range of frequencies and attenuations on 
the same electrode. In Figure 4-12 the original FRA (left column) and the result of 
subtracting the baseline FRA (right column), are shown for the aCSF baseline and the ODQ 
condition, examples come from two different animals and randomly selected electrodes to 
illustrate that the lack of effect was observed on different electrodes. A few pixels 
representing different frequencies did show a change in activity, but no systematic 
statistically significant patterns were observed during the perfusion of ODQ. Due to the lack 
of any systematic change, no further analysis was applied to this data.  
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Figure 4-12 FRAs recorded during the perfusion of 500 µM ODQ. In the left column, the original FRAs are displayed, 
in the right column the baseline FRA is subtracted from the current condition. The top example originates from GP7 
the bottom example from GP8. 
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The results presented in sections 4.4.3 and 4.4.4 show that local perfusion in the IC of the 
NO modulators L-MeArg and ODQ did not have an effect on recorded multi-unit activity and 
suggest spontaneous and sound-driven activity are not mediated by tonic levels of NO. As 
discussed in Chapter 1 increasing NMDA receptor mediated activity will lead to an increase 
in NO which will trigger sGC to increase its cGMP production a hundredfold. Here I tested 
whether increasing the NMDA mediated activity in response to sound can be attenuated by 
co-perfusing either L-MeArg or ODQ with the NMDA.  
FRA measures  
Characteristic Frequency and threshold attenuation 
Previously I showed that the perfusion of NMDA, L-MeArg and ODQ individually have no 
effect on the CF (Figure 4-14A) or threshold attenuation at CF (Figure 4-14B). The 
combination of either NO modulator with NMDA also failed to significantly alter CF and 
threshold of the multi-unit activity at CF. 
Spontaneous activity 
The perfusion of 100 µM NMDA in the IC increased the spontaneous firing rate (see section 
4.4.2) this effect was blocked by the co-perfusion of either L-MeArg or ODQ as depicted in 
Figure 4-14C. The two way ANOVA showed a significant interaction term (F(4,12) = 4.452, 
p < 0.020). The one way between groups ANOVAs showed that the groups did not 
statistically differ from each other during the aCSF baseline or the washout condition, but 
they did differ significantly in the NMDA (alone or +L-MeArg/ODQ) condition (F(2,6) = 
14.793, p < 0.005). Post hoc tests showed that the NMDA (alone) group had a higher 
spontaneous firing rate than either the NMDA + L-MeArg group (2.15 ± 0.221) or the NMDA 
+ ODQ group (1.95 ± 0.221). The NMDA+L-MeArg and NMDA+ODQ groups did not differ 
significantly from each other. 
PSTH measures 
An example of the PSTH data recorded in the NMDA+L-MeArg protocol is shown in Figure 
4-13. This figure shows the baseline recording, a 20 minute perfusion of 100 µM NMDA, 20 
minute perfusion of L-MeArg followed by 20 minutes of L-MeArg and NMDA, interspersed 
with aCSF washout conditions.  
4.4.5 L-MeArg and ODQ modulate the NMDA Effect
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Figure 4-13 PSTH data for the aCSF baseline, 100 µM NMDA, aCSF washout, 500 µM L-MeArg, 500 µM L-MeArg + 100 
µM NMDA and the aCSF washout condition. T stands for the total number of spikes, D for the driven number of 
spikes and O for the number of spikes in the onset peak. 
Total driven activity 
The perfusion of 100 µM NMDA in the IC increased the total driven activity (see section 
4.4.2). This increase in total driven activity was blocked when either L-MeArg or ODQ were 
co-perfused with the NMDA, as depicted in Figure 4-14D. The two way ANOVA showed a 
significant interaction term (F(4,12) = 7.751, p < 0.003). The one way between groups 
ANOVAs showed that the groups did not differ during the baseline or washout conditions, 
but during the NMDA (alone or +L-MeArg/ODQ) condition there was a significant difference 
between the groups (F(2,6) = 14.126, p < 0.005). Post-hoc tests showed that the NMDA 
(aCSF) group had a greater total driven response than either the NMDA + L-MeArg group 
(2.09 ± 0.233) or the NMDA + ODQ group (2.05 ± 0.233). The NMDA+L-MeArg and 
NMDA+ODQ groups did not differ significantly from each other.  
To examine whether the observed effect could be observed in the different parts of the 
PSTH, the activity in the first 10 ms of the onset peak (Onset activity) and a 10 ms block 
during the sustained response were examined. 
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Onset response 
Previously the local perfusion of NMDA in the IC increased the onset response. There was 
no such increase when the NMDA was co-perfused with either L-MeArg or ODQ (F(4,12) = 
5.397, p < 0.010) (Figure 4-14E). The one way between groups ANOVAs showed that 
groups did not differ during the aCSF baseline and washout condition but the groups proved 
to be different from each other in the NMDA (alone or +L-MeArg/ODQ) block (F(2,6) = 
9.863, p < 0.013). In this condition, the NMDA (alone) group had a significantly greater 
onset peak compared to the NMDA+L-MeArg group (2.05 ± 0.27) and the NMDA + ODQ 
group (2.06 ± 0.25). The NMDA+L-MeArg and NMDA+ODQ groups did not differ 
significantly from each other.  
Sustained driven activity 
The direct perfusion of 100 µM NMDA into the IC also increased the sustained activity (see 
section 4.4.2). However, when the NMDA was co-perfused with either L-MeArg or ODQ, 
there was no increase-sustained activity. A two way ANOVA showed a significant 
interaction term (F(4,12) = 4.727, p = 0.016) (Figure 4-14F). One way between groups 
ANOVAs showed that the three groups did not differ significantly during the aCSF baseline 
or washout condition but in the NMDA (alone +L-MeArg/ODQ) condition the groups differed 
significantly (F(2,6) = 6.779, p = 0.029). Post hoc tests revealed that the NMDA (alone) 
group had a greater sustained response than either the NMDA + L-MeArg group (2.55 ± 
0.484) or the NMDA + ODQ group (2.535 ± 0.484). The NMDA+L-MeArg and NMDA+ODQ 
groups did not differ significantly from each other. 
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Figure 4-14 Interaction effects between NMDA and the NO modulators L-MeArg and ODQ on neuronal firing in the 
IC, activity recorded on electrode recording multi-unit clusters responding best to stimulation of 1024 Hz. Note that 
the lines represent groups means, aCSF n=3, L-MeArg n=3 and ODQ n=3. A. CF B. Threshold attenuation at CF C. 
Spontaneous activity D. PSTH total activity E. PSTH total sound driven activity F. PSTH Onset activity. Note the break 
in the x-axis to indicate the difference between washout conditions between the experiments (Figure 4-1). Significant 
post hoc contrasts between groups are indicated by *. 
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In addition to the between groups analysis, the data from the L-MeArg and ODQ 
experiments was subject to a one way within groups ANOVA such that the effect of the 
initial perfusion of NMDA alone could be compared with the effect of the perfusion of NMDA 
plus L-MeArg/ODQ. 
Entering all the drug conditions from the L-MeArg experimental protocol (Figure 4-1B) and 
running a series of one-way within subjects ANOVA’s for the spontaneous, total driven, 
onset and sustained response shows how neuronal activity changed over time under the 
different local perfusion conditions (Figure 4-15).  
L-MeArg: spontaneous activity 
A one-way within group ANOVA showed that spontaneous activity varied significantly 
between the different drug conditions (F(5,10)=12.02, p < 0.001) (Figure 4-15A). Post hoc 
tests showed that the local perfusion of NMDA (20 minutes) increased the spontaneous 
activity (2.78 ± 0.39 (3)). Spontaneous activity during the NMDA + L-MeArg (20 minutes) 
condition was not significantly increased compared to the aCSF washout and the L-MeArg 
block preceding it. Spontaneous activity did not significantly decrease during the aCSF 
washout condition (45 minutes).  
L-MeArg: driven activity 
Driven activity increased during NMDA and reduced again during washout. However there 
was no increase when NMDA was perfused with L-MeArg. A one-way within group ANOVA 
showed that total driven activity changed significantly between the different drug conditions 
(F(5,10)=13.038, p < 0.001) (Figure 4-15B). Post hoc tests showed that the local perfusion 
of NMDA (20 minutes) increased the total driven activity (1.66 ± 0.20 (3)). Total driven 
activity was significantly decreased during the aCSF washout condition (45 minutes) (-1.80 
± 0.21 (3)). The total driven activity during NMDA + L-MeArg (20 minutes) did not show a 
significant increase compared to that during the aCSF washout and the L-MeArg block 
preceding it.  
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L-MeArg: onset activity 
A one-way within group ANOVA showed that the onset activity changed significantly 
between the different drug conditions (F(5,10)= 9.185,p < 0.002) ( Figure 4-15C). Post hoc 
tests showed that the local perfusion of NMDA (20 minutes) increased the onset activity 
(1.92 ± 0.22 (3)) and this was significantly decreased during the aCSF washout condition 
(45 minutes) (-1.91 ± 0.39 (3)). However, there was no significant increase in onset activity 
during perfusion of NMDA + L-MeArg (20 minutes) compared to that during the aCSF 
washout and the L-MeArg block preceding it. 
L-MeArg: sustained activity 
A one-way within group ANOVA showed that the sustained activity changed significantly 
between the different drug conditions (F(5,10)= 3.955, p < 0.031)(Figure 4-15D). Post hoc 
tests showed that the local perfusion of NMDA (20 minutes) increased the sustained activity 
(1.90 ± 0.14), this was not significantly decreased during the aCSF washout condition (45 
minutes). There was no significant increase in onset activity during perfusion of NMDA + 
L-MeArg (20 minutes) compared to that during the aCSF washout and the L-MeArg block 
preceding it. 
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Figure 4-15 neuronal responses in the IC under different local drug perfusion conditions. Each experiment starts off 
with aCSF, followed by 100 µM NMDA, a washout, L-MeArg, NMDA+L-MeArg and another aCSF washout. The 
individual data points are given per animal plus the mean across animals in the dashed black line. A. Spontaneous 
activity. B. PSTH total sound driven activity C. PSTH onset activity. D. PSTH sustained driven response. Significant 
post hoc contrasts p<0.05 are indicated by A) vs original baseline, B) vs preceding aCSF block, C) vs following aCSF 
block. 
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Entering all the drug conditions from the ODQ experimental protocol (Figure 4-1C) and 
running a series of one-way within subjects ANOVA’s on the spontaneous, total driven, 
onset and sustained response shows how neuronal activity changed over time under the 
different perfusion conditions (Figure 4-16).  
ODQ: spontaneous activity 
Spontaneous activity differed significantly between the different drug conditions 
(F(5,10)=8.041, p < 0.003)( Figure 4-16A). Post hoc tests showed that the local perfusion 
of NMDA (20 minutes) increased the spontaneous activity (2.56 ± 0.49 (3)). No significant 
decrease in the spontaneous activity was observed during the aCSF washout condition (45 
minutes). However, no significant increase in spontaneous activity was observed during the 
perfusion of NMDA + ODQ (20 minutes) compared to the aCSF washout block preceding 
it.  
ODQ: driven activity 
Total driven activity changed significantly between the different drug conditions 
(F(5,10)=4.703, p < 0.018)( Figure 4-16B). Post hoc tests showed that the local perfusion 
of NMDA (20 minutes) increased the total driven activity (1.91 ± 0.39). The total driven 
activity significantly decreased during the aCSF washout condition (45 minutes) (-1.75 ± 
0.36). There was no increase in total driven activity in response to the perfusion of NMDA 
+ ODQ (20 minutes) compared to the aCSF washout and the ODQ block preceding it.  
ODQ: onset activity 
The onset activity changed significantly between the different drug conditions (F(5,10)= 
12.146,p <0.001)( Figure 4-16C). Post hoc tests showed that the local perfusion of NMDA 
(20 minutes) increased the onset activity (1.79 ± 0.21 (3)). The onset activity was 
significantly decreased (-1.76 ± 0.19 (3)) during the aCSF washout condition (45 minutes). 
The perfusion of NMDA + ODQ (20 minutes) did not show a significant increase in onset 
activity compared to the aCSF washout and the ODQ block preceding it. 
ODQ: sustained activity 
The sustained activity changed significantly between the different drug conditions (F(5,10)= 
5.733, p < 0.009)( Figure 4-16D). Post hoc tests showed that the local perfusion of NMDA 
(20 minutes) increased the sustained activity (2.03 ± 0.28). No significant decrease in the 
sustained activity was observed during the aCSF washout condition (45 minutes). However, 
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no significant increase was observed in the sustained activity during the perfusion of NMDA 
+ ODQ (20 minutes) compared to the aCSF washout and the ODQ block preceding it. 
 
Figure 4-16 neuronal responses in the IC under different local drug perfusion conditions. Each experiment starts off 
with aCSF, followed by 100 µM NMDA, a washout, L-ODQ, NMDA+ODQ and another aCSF washout. The individual 
data points are given per animal plus the mean across animals in the dashed black line. A. Spontaneous activity. B. 
PSTH total sound driven activity C. PSTH onset activity. D. PSTH sustained driven response. Significant post hoc 
contrasts p<0.05 are indicated by A) vs original baseline, B) vs preceding aCSF block, C) vs following aCSF block. 
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4.5 Discussion 
The immunohistochemistry observations described in chapter 3 showed that nNOS is 
present in the central nucleus and associates with PSD95 and glutamatergic terminals 
suggesting that the functions of glutamate, NMDA receptor and NO are mechanistically 
linked in the central nucleus. The experiments presented here sought to i) determine the 
role of NMDA receptor mediated transmission in the central nucleus of the IC, ii) determine 
whether there is tonic NO transmission participating in auditory processing and iii) whether 
the effects of NMDA receptor activation are mediated wholly or in part by NO and, if so, via 
what intracellular mechanism. 
The data presented in the current chapter revealed new knowledge about the role of NMDA 
receptor mediated activity and NO signalling in auditory processing. NMDA mimics the 
effect of endogenous glutamate on the NMDA receptor but has no influence on the other 
glutamate receptors (e.g. AMPA receptors). Therefore the local perfusion of NMDA in the 
IC via a microdialysis probe provides a unique window on the role the NMDA receptor plays 
in the processing of auditory stimuli in the IC. It was found that NMDA increases both 
spontaneous activity and acoustically evoked activity in the IC, and does so in a 
concentration dependent manner. Remarkably though, the CF and the threshold sensitivity 
at CF of the multi-unit activity are unaffected by the local perfusion of NMDA in the IC. The 
local perfusion of the NOS blocking agent L-MeArg did not alter spontaneous or acoustically 
evoked multi-unit activity recorded in the IC, suggesting that there is no tonic NO 
transmission. Further substantiating this conclusion is the finding that blocking sGC with 
ODQ did not alter the spontaneous or acoustically evoked multi-unit activity. More 
importantly though, is the finding that the robust NMDA mediated increase in both 
spontaneous and acoustically evoked multi-unit activity is abolished by blocking the 
production of NO by the co-perfusion of L-MeArg, indicating that the effect of NMDA is 
mediated via NO. The observation that blocking the sGC pathway by co-perfusing ODQ 
with the NMDA also resulted in the loss of the NMDA response is consistent with the notion 
that NMDA-stimulated NO transmission is acting through sGC. 
The local perfusion of NMDA in the IC proved to produce a robust, reliable and consistent 
increase in neuronal activity, which could both be observed in the FRA and the PSTH 
measurements. The FRA gives insights on effects occurring over a range of frequencies 
and attenuation levels, whereas the PSTH shows which part of the response (spontaneous, 
onset or sustained) is affected, all of which have potentially different underlying 
mechanisms.  
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In the current concentration response experiment, higher concentrations of NMDA evoked 
increasing responses. The exact amount of NMDA delivered to the tissue via the dialysis 
probe is unknown, but diffusion of molecules through the membrane is inversely related to 
the flow rate. As an estimate based on literature with comparable flow rates to that used 
here, approximately 10-20% of the original concentration will reach the immediate area 
surrounding of the probe (Chefer et al., 2009). The higher the concentration in the probe, 
the steeper the concentration gradient will be, higher concentrations will diffuse more 
quickly. Also concentration in the tissue decreases as a cubic function of distance from the 
probe (Foeller et al., 2001), making the region influenced uncertain. The lowest NMDA 
concentration, 30 µM of NMDA, did not result in significant increases, but this was mainly 
due to variability between the animals. This lowest concentration might be more susceptible 
to variations in the placement of the dialysis probe relative to the recording electrode. The 
higher concentrations of NMDA, 100 µM and 300 µM, resulted in increasing magnitudes 
and a prolonged duration of the observed NMDA effect. The 100 µM NMDA concentration 
increased both the spontaneous activity and the neuronal response to sound stimulation in 
the central nucleus, both reached a stable new plateau within 10-15 minutes of switching 
on the perfusion. Prolonged exposure (45 minutes) did not increase the observed effects, 
suggesting that the concentration of NMDA had plateaued around the recording electrode.  
Stopping the NMDA perfusion and switching it for aCSF did reverse the onset and total 
driven activity in all animals, but for the spontaneous and sustained activity the washouts 
were more variable between animals and this is perhaps suggesting that these responses 
stem from a different underlying mechanism. Increased NMDA receptor activity has been 
reported to lead to excitotoxicity, due to the receptor’s high permeability to calcium (Sattler 
and Tymianski, 2001) however, both the reversibility of some measures and the observation 
that increasing concentrations evoked increasing effects without an apparent ceiling 
suggests that the NMDA concentrations used did not result in excitotoxicity.  
Studies employing selective AMPA and NMDA receptor antagonists have revealed that 
acoustic stimulation evokes neuronal activity in the IC via the glutamatergic stimulation of 
both AMPA and NMDA receptors (Faingold et al., 1989; Kelly and Zhang, 2002; Ma et al., 
2002). AMPA receptors appear to mediate the early (20 ms) but not the sustained (20 – 
120 ms) response to acoustic stimuli in most neurons in the IC (Zhang & Kelly, 2001; Ma 
et al., 2002). However, there is some disagreement about whether NMDA receptors 
contribute to the onset response or are solely mediators of the sustained response. Thus, 
two studies reported that blocking NMDA receptors in the central nucleus reduced the 
sustained response substantially in most cells but had little effect on the onset component 
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of the response (Zhang & Kelly, 2001; Ma et al., 2002). However, a more recent study found 
that blocking NMDA receptors consistently decreased the later components of the response 
but also decreased the onset component in many units (Sanchez et al., 2007).  
Patch clamp studies in IC slices have shown that responses to NMDA are voltage 
dependent (Ma et al., 2001) suggesting that AMPA receptor activation (via acoustic 
stimulation) might be essential for NMDA receptors to be activated. However, in line with 
the present data, Faingold showed that NMDA increases both acoustically evoked and 
spontaneous firing of the majority of neurons in the central nucleus (Faingold et al., 1989). 
These increases in spontaneous activity observed suggest that either there is tonic 
activation of IC neurons via AMPA receptors such that they are in a depolarized state where 
NMDA receptors can be activated, or that there are NMDA receptors present which do not 
display a voltage dependent Mg2+ blockade. In line with the first Faingold, reported that 
NMDA antagonists decreased spontaneous activity.  
Previous research suggests that acoustic stimulation of neurons in the IC activates both 
AMPA and NMDA receptors for all stimuli above attenuation threshold (Zhang and Kelly, 
2001). Blocking AMPA receptors reduced both the early (20 ms) and sustained (20 – 120 
ms) response to acoustic stimuli in most neurons in the IC, although, in a subset of neurons, 
responses were completely blocked (Zhang & Kelly, 2001; Ma et al., 2002). Blocking NMDA 
receptors in the central nucleus reduced the sustained response substantially (>50% 
reduction) in at least 75 % of the cells recorded, but showed little effect on the onset 
component of the response (Zhang and Kelly, 2001; Ma et al., 2002). However, in closer 
agreement with the current findings is a more recent study applying NMDA antagonists 
using iontophoresis but sampling a larger number of cells, this study found that blocking 
NMDA receptors has a variable effect on the onset component but always decreases the 
later components of the response (Sanchez et al., 2007).  
In the current study instead of blocking the NMDA receptors, they were artificially stimulated 
by the local perfusion of NMDA in the central nucleus. Effects were observed both on 
spontaneous and acoustically driven activity. Within the acoustically driven activity, 
increases were observed both on the early and sustained components of the response. 
Although currently little is known about the NMDA subunit expression in the different 
regions of the IC, in situ hybridization studies have shown that mRNAs for all known 
subunits are expressed in the central nucleus (Goebel and Poosch, 1999). The effects of 
NMDA on the early component of the response observed in the current experiments may 
be governed by NMDA receptors containing the GluN2D subunit that has a lower affinity 
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for magnesium under resting state conditions, compared to the other subunits, (Kirson and 
Yaari, 1996) and has been shown to trigger action potentials without the need for 
depolarization caused by AMPA receptors (Wenzel et al., 1996; Sivaramakrishnan and 
Oliver, 2006). By using the microdialysis probe a large amount of NMDA was present 
throughout the central nucleus of the IC affecting not just one single cell but the entire 
population, including both glutamatergic and GABAergic cells. This could have shifted the 
normal excitatory/inhibitory balance, which may account for the finding that the biggest 
change occurred on the onset peak. Also, the NMDA perfusion lasted much longer than the 
iontophoretic studies, the changes observed here could be due to the enduring presence 
of NMDA triggering synaptic changes. The later experiments blocking the production of NO 
and blocking the sGC signalling pathway do suggest that the NO-sGC signalling pathway 
is underlying the increase in activity. The NO signalling pathway has been shown to be 
involved with altering the available receptors.  
It was of note that the spontaneous activity and sustained part of the acoustically evoked 
responses did not return to baseline after being enhanced by NMDA, whereas both the 
onset and total driven response do. Firstly, this suggests that the total driven activity is 
dominated by the onset response. Moreover, it suggests that the sustained response, which 
is lower compared to the onset response may be more susceptible to changes in 
spontaneous firing. The observation that higher doses of NMDA show more robust 
significantly statistical washout effects support this interpretation. Both types of activity 
increased to the same extent in relative terms. But in real numbers, the acoustic driven 
response saw a much larger increase. Spontaneous rates in a given time window increased 
from 10-15 spikes to 30-45 spikes, while acoustically evoked spikes in the same time 
window increased from 200 to 600 spikes on average. The sustained response has fewer 
spikes compared to the onset response, and the number of spontaneous spikes occurring 
in this time window will affect this part of the response more than the onset part. Higher 
concentrations of NMDA increased the onset response dramatically and can, therefore, be 
more easily washed out and detected with N =3.  
The fact that (onset) acoustically driven activity returned to baseline whereas the 
spontaneous did not, suggests that a different mechanism is operating. One possibility is 
that the persistent increase in spontaneous activity observed may be related to changed 
synaptic strength which propagates higher spontaneous activity.  
The fact that all PSTH measures reported here increased in response to NMDA is a finding 
that requires further investigation. The question that needs addressing is whether the 
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spontaneous activity is raised to such an extent that the driven activity rides on top of it. As 
mentioned above, GluN2D subunits have been shown to be less prone to the voltage 
dependent magnesium blockade and may impact on the increase in spontaneous activity 
and early response components. A way of investigating whether this is the case is to use a 
selective antagonist for this specific subunit together with local NMDA perfusion. Another 
possible experiment to investigate the Mg2+ dependence of the NMDA receptors in the 
central nucleus is perfusing NMDA in a Mg2+ free aCSF. 
As noted above, local perfusion of NMDA evoked a robust increase in both spontaneous 
and acoustically evoked neuronal activity. Co-perfusion of L-MeArg with the NMDA 
completely abolished the NMDA evoked increase. This was evident in a within group as 
well as a between group analysis. L-MeArg is a non-selective NOS blocker, it functions by 
competing with L-arginine for binding sites on the NOS protein. L-MeArg cannot be 
converted to L-citrulline and hence stops the production of NO during the time it is bound 
to the NOS protein.  
Although the concentration of L-MeArg in the brain tissue in the present experiments is 
unknown, we can assume the concentration outside the probe is around 10% of that in the 
probe (i.e. 100 µM). Thus, it is likely that this will result in complete inhibition of L-arginine 
binding to nNOS and hence complete inhibition of NO production. Although the 
concentration response relationship was not explored here, it seems likely that even lower 
concentrations would completely block nNOS. Importantly, a slice study investigating direct 
effects of L-MeArg on neuronal tissue concluded that perfusion of 100 µM L-MeArg 
significantly reduces the amount of NO produced in the brain in response to NMDA receptor 
mediated activity (Kendrick et al., 1996). These data also suggest that NMDA receptor 
mediated glutamate transmission in the central nucleus of the IC is NO dependent. 
In the current experiments co-perfusion with ODQ also prevented the NMDA evoked 
increase in neuronal activity. This finding not only strengthens but extends the L-MeArg 
findings. ODQ is a small bioactive molecule that competitively binds to the haem domain of 
sGC - the main downstream target of NO. ODQ prevents the binding of NO and thus stops 
sGC from undergoing a conformational change that switches on cGMP production. Here 
ODQ was perfused at a concentration of 500 µM. Schrammel and colleagues showed 
substantive blockade of sGC by ODQ in the micromolar range suggesting the concentration 
used here would cause complete inhibition of sGC. Even though NO has the capacity to 
regulate a whole host of other processes, this finding clearly demonstrates that the NO 
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dependency of the NMDA receptor mediated glutamate activity is mediated via NO acting 
on sGC. 
Although the effects of NMDA perfusion on both spontaneous and sound driven activity 
were blocked by L-MeArg and by ODQ, in the current study blocking the production of NO 
or sGC in the absence of NMDA had no discernible effect on neuronal activity in the IC. 
This suggests that under normal circumstances, tonic NO levels are not involved in driving 
the spontaneous or acoustically evoked activity in the central nucleus. Although it is 
possible that changes in neuronal activity were present but were too subtle to observe with 
three animals. 
NMDA receptor activation has been shown to regulate the surface AMPA receptors and 
can reduce the number of AMPA receptors during acute noise trauma which has been 
linked to an increased and faster recovery (Chen et al., 2007). The mechanism via which 
NMDA receptor activity alters the number of AMPA receptors and the future response is 
likely to be NO signalling acting on sGC. Evidence has been reported demonstrating that 
under normal condition low levels of NO bind to the haem of sGC which keeps the protein 
in a low activity state (Hopper & Garthwaite, 2006; Salerno, 2008; Salerno & Ghosh, 2009), 
presumably maintaining a homeostasis in synaptic strength. Increases in NO 
concentrations have been shown to bind to a second site on sGC amplifying its production 
of cGMP a hundredfold (Cary et al., 2006), presumably leading to adaptations of synaptic 
strength by altering available receptors. A mechanism allowing quick alteration of the 
synaptic strength would be beneficial in the auditory system that constantly has to scale its 
responses to an ever changing acoustic environment. Thus glutamate signals transduced 
by NMDA receptors lead to an increase in NO that is sensed by sGC which in turn produces 
cGMP which can lead to an increase or decreased future response due to its involvement 
in trafficking of AMPA and NMDA receptors. 
Apart from the concentration response experiments, all experiments started with a 100 µM 
NMDA perfusion. Doing this allowed me to check for proper dialysis probe and electrode 
placement within the IC and gave N=9 for the 100 µM NMDA condition, resulting in a greater 
statistical power. However, manipulating the neuronal activity in the IC with NMDA prior to 
the perfusion of L-MeArg and ODQ, may have altered the state of the system and no ‘pure’ 
L-MeArg or ODQ measurements were obtained, limiting the observations made on the 
spontaneous activity. However, this is unlikely to have affected the acoustically evoked 
response because the effects there washed out during prolonged aCSF perfusion. The 
current protocol was chosen because it allowed every animal to serve as its own control 
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and reduce variance in measurements. Improper dialysis probe placement or a faulty probe 
would have been detected by the lack of a NMDA effect.  
Very few studies have investigated NO signalling in a functional context. But the studies 
that have, consistently show, as did the current study, that there is a relationship between 
the NMDA receptor activity, NO production, and sGC. Although no studies directly 
investigating the function of NO in auditory processing have been performed, scientists 
investigating flight reactions in rats perfused exogenous NO in the central nucleus which 
resulted in an increase in flight behaviours in the animals (De Araújo Moreira et al., 2003) 
thus showing that exogenous NO can influence activity in the central nucleus.  
The FRAs in the current study showed that NMDA-induced increases in neuronal activity 
were not limited to the CF of the multi-unit activity but were part of an increase in activity 
across a wide range of attenuation levels and frequencies. The FRA analysis revealed no 
changes of CF or threshold sensitivity at CF nor any other morphological changes in the 
FRA. The lack of systematic findings in the FRA analysis in the dose response experiment 
could be due to the number of animals included. However, the subsequent analysis of 100 
µM NMDA, which included nine animals, also failed to find any systematic effects. With N=3 
effects can be missed but with N=9 this scenario seems less likely, especially in 
experiments with experimental animals that are closely genetically related and live under 
similar circumstances. However, the FRA analysis only allowed areas of changed activity 
containing at least five pixels in the analysis, this, however, could have led to the exclusion 
of quite a few changed single pixels. Another measure that could have been valuable but 
was not performed here would be calculating the total number of changed pixels, and 
possibly relating this to the side of the CF on which they occur. However, the CF does not 
usually fall in the middle of the frequency range and observations here would need to be 
corrected for the number of available pixels on either side of the CF.  
Sound duration appears to be encoded in the IC by clusters of spikes around the onset and 
offset of a neuron’s response to auditory stimuli instead of being coded by the entire spike 
activity (Yin et al., 2008). This phenomenon is mainly observed in neurons that show 
duration sensitivity and appears to be driven by GABA dampening the AMPA driven 
response (Yin et al., 2008). In the current experiments occasionally changes in offset 
activity were observed in response to L-MeArg and or ODQ perfusion in the IC. These 
findings were, however, rare and may depend on finding the duration sensitive neurons 
which appear to be rare and weaker in their response in non-echo locating animals. Studies 
in echo-locating animals have reported 30-60% of the cells in the central nucleus of the IC 
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to be duration sensitive while in guinea pigs this number is below 20% (Wang et al., 2006; 
Yin et al., 2008). However collecting more examples of these neurons and studying the 
effects of NO modulators could provide us with new interesting insights. The influence of 
both NO modulators on off-set responses again suggests the involvement of NO in altering 
the synaptic strength.  
The current findings do support a role for NO signalling in the local circuitry of the IC. The 
finding that blocking NO production with L-MeArg or blocking its binding to sGC prevents 
the otherwise robust increase in neuronal activity in response to the perfusion of NMDA, 
clearly illustrates that NMDA receptor mediated glutamate activity in the IC is dependent on 
NO acting via sGC. The subsequent influence of cGMP on the trafficking of AMPA and 
NMDA receptors would explain the observed phenomena. Although, this aspect of the 
mechanism remains to be investigated. These findings strengthen the conclusion from the 
immunohistochemistry chapter that the nNOS observed in the central nucleus is indeed 
nNOSα and depending on the NMDA receptor activity. The current study is the first to show 
functional evidence of NO signalling in auditory processing in the IC in an in vivo setting.  
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Chapter  5. Salicylate Mediated Activity in the IC 
5.1 Introduction 
Chapter 3 focussed on the localisation of NOS in the IC, explored the neurotransmitter 
phenotype of cells that express NOS and examined the co-localisation of neurons 
expressing nNOS with other proteins. Evidence was presented that nNOS is present in the 
central nucleus. The nNOS puncta in the central nucleus are likely a part of the nNOS-
PSD95-NMDA receptor complex, hence in Chapter 4, I focussed on the functional role 
NMDA receptors and nNOS have in auditory processing in the IC. NMDA receptor activation 
was shown to increase spontaneous and sound-driven activity and to do so via a 
mechanism involving NO and sGC. 
Salicylate used therapeutically at high doses has long been known to induce the side effect 
of tinnitus in humans. Evidence from behavioural studies indicates that salicylate reliably 
and consistently induces tinnitus in rodents (Evans et al., 1981; Jastreboff and Sasaki, 
1986; Jastreboff et al., 1988) and, although its mode of action probably differs from that of 
noise trauma in some respects, in other respects they would be expected to share a 
common mechanism. Both noise induced and salicylate induced tinnitus are associated 
with increased NMDA receptor mediated activity in the auditory pathway (Peng et al., 2003; 
Ruel et al., 2008; Bing et al., 2015). 
Studies have shown that systemic application of salicylate may impact directly on both 
peripheral and central auditory structures. Systemic salicylate administration causes an 
increase of the spontaneous activity (neuronal discharge in the absence of any auditory 
stimulation), throughout the auditory pathway (Guitton et al., 2003; Ma et al., 2006; Hwang 
et al., 2011), including in the IC (Jastreboff and Sasaki, 1986). Given the myriad ascending 
and descending connections of the IC, this hyperactivity could be generated in one or more 
of several locations in the auditory pathway and be transmitted to the IC. However, it has 
been reported that direct application of salicylate to the IC in vitro increases the firing activity 
of the majority of neurones in the central nucleus of the IC (Basta and Ernst, 2004; Patel 
and Zhang, 2014) Patel and Zhang also showed direct effects of salicylate in the IC in vivo 
although they recorded only in the dorsal cortex of the IC.  
Salicylate has a wide range of effects on many physiological processes (Jastreboff and 
Sasaki, 1986; Jastreboff et al., 1988; Vane and Botting, 2003. The issue with systemically 
applied salicylate in experiments reported thus far is that the salicylate potentially affects 
the entire physiology including the auditory brainstem pathway of the animal and 
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determining the origin of its effect has been problematic. Also, findings reported thus far are 
based on recordings from a selection of individual cells before salicylate and a new group 
of individual cells after systemic salicylate treatment. Usually there is a gap between the 
administration and the second set of recordings of at least two or three hours because 
behavioural animal models have shown that this is the time it takes for salicylate to induce 
tinnitus(Jastreboff, 1994). The advantage of the multiunit approach used in these 
experiments is that the same cluster of units is recorded throughout the whole experiment. 
No recordings of changes in neuronal activity in the IC during this period are currently 
available, the fact that an increase in spontaneous activity is the end result three hours after 
systemic salicylate treatment means we cannot see how these effects develop. Changes 
are likely to occur over time and the onset and time course of these effects could be telling 
in determining how it affects the auditory pathway. Salicylate uptake rates differ between 
tissues and the uptake into the brain is especially slow due to salicylate having a low lipid 
solubility at physiological pH levels which hinders its crossing of the blood brain barrier 
(Bannwarth et al., 1986). The strong binding of salicylate to the protein albumin is another 
rate limiting factor for salicylate reaching the brain (Reed and Palmisano, 1975; Jastreboff 
et al., 1986). Together these factors result in a half-life permeation from plasma levels to 
cerebrospinal fluid of about two hours in rats (Brodie et al., 1960). During this time, however, 
salicylate is already affecting the lowest levels of the auditory pathway. Evidence has been 
found for the stiffening of the outer hair cells, mechano-sensory changes in the cochlea 
(Cazals, 2000), a loss of absolute sensitivity of the auditory nerve and immediate effects on 
the NMDA receptors of the cochlea (Guitton et al., 2003).  
Studies suggest that both noise-induced and salicylate-induced tinnitus are associated with 
increased NMDA receptor mediated activity in the auditory pathway (Peng et al., 2003; Ruel 
et al., 2008) (Bing et al., 2015). Thus, Ruel showed that salicylate-induced increases in 
spontaneous firing and sound driven responses in auditory nerve fibres were abolished by 
co-perfusion of the non-competitive NMDA receptor antagonist, MK-801 (Ruel et al., 2008). 
Abnormalities have been observed in NMDA receptor mediated signalling in animal models 
of tinnitus at several sites along the auditory pathway (Guitton et al., 2003; Ruel et al., 2008; 
Hwang et al., 2011). As demonstrated in the previous chapter and by others, NMDA 
receptors are important mediators of certain aspects of auditory processing in the IC. Thus 
salicylate induced changes in NMDA receptor mediated signalling in the IC could impact on 
neuronal activity and might underlie the percept of tinnitus. The connection between the 
NMDA receptor activity and nNOSα makes NO signalling a viable candidate to be involved 
in the generation of tinnitus. 
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The questions to be addressed here are, does salicylate affect spontaneous and/or sound 
driven neuronal activity in the central nucleus of the IC in vivo, and if so, is the effect 
mediated locally or indirectly, and does the mechanism involve the NMDA/NO pathway? 
Thus in order to extend previous reports that systemic administered salicylate induces 
increases in spontaneous activity in the IC and study the time course of these effects during 
the build-up of salicylate concentrations, the first experiment partly replicates previous 
experiments in which single cell electrophysiological recordings were obtained before and 
after the administration of a high dose (200 mg/kg) of salicylate via a single systemic 
injection. 
Direct application of salicylate in the IC has been limited to iontophoretic studies, which 
allow direct application of salicylate on a single cell. In Chapter 4 a microdialysis probe was 
successfully used to deliver NMDA to the IC, this method allows us to study the effects of 
drugs on larger neuronal populations over the course of many hours. Thus a second 
experiment was designed, in which a microdialysis probe was used to deliver salicylate 
directly into the central nucleus of the IC. The observations made in these recordings will 
be directly compared with those in which salicylate was administered systemically. In both 
sets of experiments the electrode remained in place throughout the experiment and the 
multi-unit activity from the same location was followed before and after the salicylate 
administration.  
5.2 Methods 
Two different experimental modes of salicylate delivery were employed to study the effects 
of salicylate on auditory processing in the IC. In the first set of experiments salicylate was 
given in a single IP injection. In the second set of experiments salicylate was perfused 
locally into the central nucleus of the IC using a microdialysis probe. All animals were 
subjected to the same anaesthetic and surgical procedures, including the insertion of the 
microdialysis probe as described in Chapter 2. During pilot experiments it became apparent 
that some guinea pigs are sensitive to a large dose of salicylate and stop breathing in 
response to it. To avoid complications and premature death, the animals were artificially 
respired with 100% medical oxygen. For all experiments, electrophysiological recordings 
were obtained at baseline level in the absence of drug with aCSF flowing through the 
dialysis probe at the standard speed of 2µL/min. As in previous experiments the recordings 
were collected for the PSTH and FRA stimulus sets, as described in Chapter 2. To ensure 
5.2.1 Experimental Procedure
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stable and consistent recordings baseline recordings were collected for at least an hour 
after insertion of the electrode in the IC. Data was collected continually throughout the day, 
but for the analysis blocks spaced an hour apart were extracted. 
Systemic administration of salicylate 
In the systemic salicylate experiment seven pigmented guinea pigs (two male) were used. 
To allow comparisons with previous and future microdialysis experiments, dialysis probes 
were implanted and aCSF was perfused during the experiment. A graphic representation 
of the experimental protocol is shown in Figure 5-1. After the baseline hour, the animals 
received a single IP injection of sodium salicylate (200 mg/kg at 4ml/kg in 0.1 M PBS). 
Electrophysiological recordings were continually collected from this time for up to seven 
hours (n=4), after which the experiment was terminated. In four out of the seven 
experiments aCSF was perfused throughout the entire experiment, while in the other three, 
L-MeArg (1000 µM) in aCSF was perfused from the end of hour 3 until the end of the 
experiment at hour 6. 
 
Figure 5-1 Experimental protocol for the salicylate IP experiments. The red lines mark key time points in the 
experiment. The initial baseline block in blue is followed by the salicylate injection, from that point onwards the short 
red lines mark the hours post salicylate and are the points included in the data analysis. The blue line indicates the 
constant flow of aCSF through the dialysis probe (n=4). The other three animals were additionally perfused with L-
MeArg (1000 µM) via the probe between hour 3 and 6 as indicated by the yellow bar (n=3). 
Local administration of salicylate via microdialysis probe 
In the protocol for the local administration of salicylate three pigmented guinea pigs (all 
female) were used. In Figure 5-2 the experimental protocol is depicted. After baseline 
recordings, the perfusion was switched from aCSF to 0.1 mM sodium salicylate in aCSF for 
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two hours. The salicylate concentration was then increased to 1 mM for two hours followed 
by a further increase to 10 mM for another hour. After five hours of salicylate dialysis at 
these concentrations, the perfusion was switched to 10mM salicylate plus 1mM L-MeArg. 
PSTH and FRA recordings were obtained continually throughout the experiment.  
 
Figure 5-2 Experimental protocol for the local administration of salicylate (Sal) via a microdialysis probe. The red 
lines mark key time points in the experiment, included in the data analysis. In the baseline condition aCSF was 
perfused via the probe. After the initial baseline recordings, increasing concentrations of salicylate were perfused 
through the probe, as shown by the orange gradient. After five hours salicylate (10 mM) and L-MeArg (1 mM) was 
perfused as indicated by the orange yellow stripes 
Data was extracted for five electrodes along the tonotopic axis each representing the best 
response at the following frequencies, 256, 512, 1024, 2048 and 4096 Hz. The measures 
listed in Table 5-1 were calculated from data recorded simultaneously on all five electrodes.  
Table 5-1 Measures used in salicylate experiments. The measures are grouped according to their analysis source, 
either PSTH or FRA. 
FRA PSTH 
Characteristic Frequency (CF) Total driven activity at BF- low attenuation (30dB) 
Threshold attenuation at CF Total driven activity at BF- high attenuation (50 dB) 
Area of increased activity Onset activity at BF- low attenuation (30 dB) 
Magnitude of increased activity Onset activity at BF- high attenuation (50dB) 
Area of decreased activity Spontaneous activity at 120 dB attenuation 
Magnitude of decreased activity  
5.2.2 Data Analysis 
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All measures were obtained at regular intervals over the course of the experiment, therefore 
all data were analysed using a one way repeated measures ANOVA (RM ANOVA) with 
time (pre and post salicylate) and electrode location (best frequency of the recording site) 
as within-subjects factors.  
The total group of animals in the systemic salicylate experiments consisted of seven 
animals. All of them received the same dose of salicylate after the baseline recordings, the 
same recordings were made in all seven animals for the next three hours post salicylate 
administration. At that point, three animals received L-MeArg perfusion via the dialysis 
probe while the others remained on an aCSF perfusion. Thus, for the systemic salicylate 
experiments two separate ANOVAs were performed. One over the first three hours using 
the full data set from seven guinea pigs and one over the seven hour post salicylate dataset 
including only four animals. In the local salicylate experiment all three animals followed the 
same protocol with incremental concentrations of salicylate being perfused via the dialysis 
probe. Thus, for the local salicylate experiments one ANOVA was performed over all 
available time periods.  
Because the focus in these experiments was on the overall effect of salicylate on neuronal 
responses in the IC, and the difference between the individual hours was of little interest, 
the decision was made to restrict the ANOVA results to test for specific patterns existing 
within the data. The test of within subjects contrast is part of the RM ANOVA output and 
tests for the presence of a linear, quadratic, cubic or higher order polynomial relationship 
that describes the neural response as a function of time over the course of the experiment. 
Of main interest in this instance were the potential linear and quadratic relationships. The 
linear relationship tests whether a linear non-zero relationship is present, indicating that 
there is either an increasing or decreasing change in firing over time. A quadratic 
relationship suggests a more complex change occurs over time, for example, an increase 
in activity in the first hours followed by a decline, a significant quadratic relationship would 
describe this inflexion.  
When a significant linear relationship was obtained for a factor, the partial eta squared 
measure (ŋ2) was used as an estimate of the percentage variance explained by this 
relationship. Partial ŋ2 values of 0.02 were considered small, 0.13 moderate and anything 
larger than 0.26 was considered large (Cohen, 1977). Significant linear main effects were 
followed by a regression analysis to determine the slope of the linear relationship which 
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allowed comparisons of slopes between conditions. The regressions were forced through 
the origin to remove the constant from the regression equation leaving the coefficient 
determining the slope of the relationship.  
Because quadratic and cubic relationships are difficult to conceptualise and even harder to 
express in numbers, when such a relationship was detected, the graphs were used to 
describe and illustrate the relationship. Higher order polynomials indicate complex patterns 
and require a priori hypothesis to be considered and were therefore ignored. 
5.3 Results 
A typical response to the systemic administration of salicylate, observed on virtually all 
electrodes is shown in Figure 5-3. A reduction in the initial response followed by an increase 
in sound driven activity and spontaneous activity in the later hours of the experiment are 
clearly visible in the binary FRAs where the original baseline is subtracted. Areas with 
increased activity appear in red and areas of decreased activity in blue. Typically, the 
decrease in activity is mainly observed on low frequency side of CF whereas the increase 
in activity is usually observed around the CF and in the higher frequencies. Some random 
points of increased activity can also be observed throughout the FRA which suggests an 
increase in spontaneous activity over time, this is particularly evident at 6 and 7 hours. 
 
Figure 5-3 in the top left the original baseline FRA is shown, all subsequent FRAs are with baseline subtracted FRAs 
for each hour after systemic salicylate administration. Blue pixels represent decreases whereas red pixels represent 
increases in activity. The white outline traces the original FRA outline. 
5.3.1 Systemic Administration of Salicylate
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Characteristic frequency increased in response to salicylate 
Systemic administration of salicylate (200 mg/kg) caused an upward shift in the CF which 
was evident at all frequencies (all electrodes) and increased over time. The shift of the CF 
in response to systemically administered salicylate is clearly visible in all animals (Figure 
5-4) and all electrode locations (Figure 5-5). A significant change in the CF was observed 
after systemic salicylate administration, as shown by the significant non zero linear 
relationship that was detected for the CF in the first three hours after salicylate treatment 
(n=7) (F(1,6) = 7.14, p = 0.037 with ŋ2 =0.543). The regression analysis showed a positive 
linear relationship over time, demonstrating an upward shift of the CF. No main effect for 
electrode location or interaction effect was detected over this time. The increase in CF was 
also observed over the longer time course of seven hours (n=4) (F(1,3) = 50.51, p = 0.006 
with ŋ2 = .944). The regression analysis showed a strong positive relationship indicating that 
salicylate caused a constant upward shift of the CF over seven hours post salicylate 
administration. No significant main effect for electrode location or interaction effect was 
observed.  
 
Figure 5-4 compound CF shift averaged across electrodes at each time point, expressed as a ratio to the baseline 
(red line). The grey bars displays the mean shift across animals, the coloured symbols represent data from individual 
animals for each time point. 
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Figure 5-5 CF shift averaged across animals plotted for each electrode location CF is expressed as a ratio to the 
baseline. 
Threshold attenuation at CF was not affected by salicylate 
The threshold attenuation of the response did not change over time in response to systemic 
salicylate. Figure 5-6 and Figure 5-7 shows the attenuation levels at each time point, for 
each guinea pig (Figure 5-6) and each electrode (Figure 5-7) note that there is no 
systematic divergence from the baseline attenuation. ANOVA showed no significant linear 
or quadratic relationships for time post salicylate administration, electrode or the interaction 
between the two over either the three or the seven hour time period.  
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Figure 5-6 the threshold attenuation at CF averaged across frequencies. The grey bars indicate average across 
animals.  
 
Figure 5-7 Threshold attenuation at CF plotted per electrode location averaged across animals.  
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Salicylate-induced areas of increased activity 
Salicylate administration resulted in the gradual appearance of regions of increased activity 
in the FRAs measured on all electrodes. Figure 5-8 shows the subtracted and thresholded 
(binary) FRA, only showing increased activity in this instance, from a single animal for one 
electrode (E2, CF 512), this analysis shows which pixels, representing a combination of the 
stimulus frequency and level, have increased their firing rate compared to baseline. The 
region of increased activity which in this case starts 1 h after systemic salicylate 
administration increases in size (number of pixels) over the following 6 hours. The latency 
and rate at which these regions appear varied between animals as is clear by inspecting 
the three hour point in Figure 5-9, but all animals developed large clusters of increased 
activity at later times which were firmly established at seven hours post salicylate.  
 
Figure 5-8 in the top left the original baseline FRA is shown, all subsequent FRAs are with baseline subtracted FRA 
and binarised to only show the regions of increase for each hour after systemic salicylate administration. This time 
series shows the gradual growth of the region of increased activity. The white line traces the outline of the original 
FRA. 
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Figure 5-9 Binary baseline-subtracted FRAs depicting the cluster of increased activity from all 7 experiments at hour 
3, the time point at which the two experimental protocols diverged and hour 7 for the four salicylate--only 
experiments. Animals receiving L-MeArg perfusion from hour 3 onwards are displayed in the top row and are 
highlighted by the yellow frame. The experiment numbers are given in the numbers on the graph.  
I examined how the size of the cluster of increased activity (defined by the thresholding and 
connectivity parameters described in Chapter 2 (section 2.4 above) varied over time after 
salicylate injection. An ANOVA including seven animals and only data at baseline and the 
first three hours post-salicylate showed that the regions of increased activity grew 
significantly over the first three hours. Thus there was a significant non-zero linear 
relationship for time (F(1,6) = 8.81, p = 0.025. ŋ2 = 0.60). Regression analysis showed a β 
coefficient of 34.59 for this three hour time series. No further polynomial relationships were 
detected over time implying that there was no plateau or inflexion in the data, thus indicating 
a positive linear increase over time. No significant relationships were detected for electrode 
location or the interaction between electrode location and time.  
A further ANOVA including data from four animals at baseline and all seven hours post 
salicylate administration showed that the area of the clusters of increased activity grew as 
indicated by a significant non-zero linear relationship for time post salicylate administration 
(F(1,3) = 15.64, p = 0.029, ŋ2 = 0.839). The regression analysis revealed a β coefficient of 
51.22 which is a strong positive coefficient indicating a linear relationship. The coefficient 
over the seven hours is higher compared to the coefficient over the three hours indicating 
that the increase observed is stronger in later hours, an observation that is evident in Figure 
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5-10 and Figure 5-11. Figure 5-10 highlights the individual differences in the effect between 
animals and one animal does not follow the overall observed pattern. No significant main 
effect was detected for the frequency or the interaction between condition and frequency. 
These data show that salicylate causes an increase in activity over an increased number 
of frequencies and attenuations measured in the FRA, irrespective of the electrode location 
(Figure 5-11).  
Having established that salicylate causes an increase in the response of IC neurons to 
sound stimuli over a progressively widening range of frequency and levels, it is next 
necessary to quantify this increase.  
 
Figure 5-10 The coloured triangles represent the number of pixels in the area of increased activity (in the binary 
baseline subtracted FRA) averaged across electrodes for each individual animal at the different time points post 
salicylate injection. The mean of all animals per time point is indicated by the grey lines. 
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Figure 5-11 The number of pixels making up the areas of expanded activity in the binary subtracted FRA plotted over 
time, averaged across the seven animals, plotted for the different electrode locations.  
Magnitude of increased activity  
In addition to the size of the area, I also examined the relative increase in activity compared 
to the original baseline within the defined area relative to baseline. The magnitude changed 
significantly over the first three hours post salicylate (F(1,6) = 154.18, p < 0.001, ŋ2 = 0.963). 
The β coefficient from the regression analysis indicated a positive linear relationship over 
time, consistent with an increase in magnitude over time. No main effect for electrode 
location or interaction effect was observed. The picture was more complex when all seven 
hours post salicylate were taken into account (Figure 5-13). This analysis showed that the 
relative magnitude varied over time (F(1,3) = 19.20, p = 0.022, ŋ2 = 0.865) and the positive 
β coefficient from the regression analysis showed that there was an increase in magnitude 
over time. However a significant cubic relationship for the electrode location within the IC 
was obtained (F(1,6) = 8.70, p = 0.026 with ŋ2 = 0.592), indicating that increases in 
magnitude differed between the different electrodes. Inspection of Figure 5-13 suggests 
that although all electrodes increased their activity the magnitude of increase was greater 
on the electrodes recording activity with CFs near 256 (E1), 512(E2) and 1024 Hz(E3). No 
condition x electrode interaction effect was observed.  
These data indicate that salicylate causes an increase in driven activity over time that 
appears to peak around five hours post salicylate. All electrodes irrespective of their 
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location show an increase in the relative magnitude of activity over time, although he 
change may differ for different frequency regions of the IC.  
 
Figure 5-12 The coloured triangles represent the ratio of the activity at each time point compared to baseline 
(indicated by the red line) for each animal averaged across all electrodes. The mean of all animals per time point is 
indicated by the grey lines. 
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Figure 5-13 The coloured triangles represent the ratio of the activity at each time point compared to baseline 
(indicated by the red line) averaged across animals, the red line indicates the baseline value.  
Salicylate-induced transient areas of decreased activity 
Following systemic administration of salicylate, areas of decreased activity were observed 
on several but not all electrodes. An example of this effect is shown in Figure 5-14 which 
shows the binary baseline subtracted FRA where the blue pixels represent values in which 
the firing rate was reduced relative to baseline. In this figure all time points throughout the 
experiment are shown for this one electrode from an individual animal. Figure 5-15 
illustrates the individual variation in latency and duration of the formation of these areas of 
decreased activity, it also highlights that these regions appear early in the experiment but 
shrink in the later hours of the experiment. 
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Figure 5-14 in the top left the original baseline FRA is shown, all subsequent FRAs are with baseline subtracted FRA 
and binarised to only show the regions of decreased activity for each hour after systemic salicylate administration. 
The white line traces the original FRA outline. The plots show the gradual growth and decline of these areas over 
the course of the experiment. 
 
Figure 5-15 with baseline subtracted binarised FRAs showing the areas of decreased activity from all experiments 
at hour 3, the time point at which the two experimental protocols split and hour 7 for the four full salicylate 
experiments. Animals receiving L-MeArg perfusion from hour 3 onwards are displayed in the top row and are 
highlighted by the yellow frame  
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Statistical analysis revealed that the formation of clusters of reduced activity exhibited a 
complex pattern over the first three hours. There was a significant linear relationship to time 
with F(1,6) = 8.96, p = 0.024, ŋ2 = 0.60) with a positive β indicating the cluster grew over 
time (Figure 5-16 and Figure 5-17). The effect also varied with electrode location. Thus, 
there was a significant cubic relationship between area of decreased activity and electrode 
(number/frequency/location) (F(1,6,) = 7.34, p = 0.035, ŋ2 = 0.55). Finally, the time x 
electrode interaction term also showed a significant cubic relationship (F(1,6) = 10.01, p = 
0.019, ŋ2 = 0.63). Figure 5-17 suggests that although areas of reduced activity were seen 
in the FRAs from all electrodes, FRAs from electrodes with a CF < 1024 Hz (E1, E2 and 
E3) developed larger clusters in which activity was decreased.  
The ANOVA over the full seven hour time points (N=4) gave no indication for any linear, 
quadratic or cubic relationships over this time period suggesting that no change was 
detected over this time period. Figure 5-16 and Figure 5-17 show that an initial decrease in 
activity rapidly goes back to the baseline to the extent that the areas showing decreased 
activity have mostly disappeared by hour six, although variation between the animals was 
observed.  
  
Figure 5-16 The coloured triangles represent the total pixels comprising the area of decreased activity for each 
individual animal at the different time points post salicylate injection, averaged across electrodes. The mean of all 
animals per time point is indicated by the grey lines 
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Figure 5-17 the number of pixels comprising the area of decreased activity in the subtracted FRA plotted over time. 
Data values are averaged across all animals and plotted for the different electrodes. 
Having established that regions of decreased activity are observed in the subtracted FRA 
in all animals for the first few hours, the magnitude of the decrease was then investigated.  
Magnitude of decreased activity reaches steady state 
The greatest reductions in activity compared to baseline were seen in the first hour after 
the salicylate administration, but then appeared to stabilise. The RM ANOVA showed that 
the reduction in firing had both significant linear (F(1,6) = 9.30, p = 0.023, ŋ2 = 0.60) and 
quadratic (F(1,6) = 9.24, p = 0.023, ŋ2 = .61) relationships to the time post salicylate 
administration. The regression analysis resulted in a negative β coefficient indicating that 
the rate of reduction declined over time.  
The RM ANOVA over all seven hours revealed a significant cubic relationship for time post 
salicylate (F(1,3)=23.493, p < 0.017, ŋ2 = 0.887). These results can be best interpreted by 
inspecting Figure 5-18 and Figure 5-19. In the figures we can see that the mean reduction 
in firing rate is greatest over the first hour post salicylate and then flattens out and remains 
stable in spite of the area shrinking, although the individual animals show great variability 
in actual numbers all show the same direction of the effect.  
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Figure 5-18 The coloured triangles represent the reduction in firing rate averaged across electrodes for each animal. 
The grey bars indicate the mean across the animals. The baseline was set to be 0. 
 
Figure 5-19 The coloured triangles represent the decrease in activity on each electrode averaged across animals at 
each time point. Baseline was set at 0. 
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Salicylate increases spontaneous activity 
Systemic salicylate-induced an increase in spontaneous activity over the later hours of the 
experiment. The spontaneous activity was calculated from the highest attenuation level 
present in the FRA (i.e. the lowest level) effectively silence. In the first three hours no 
significant relationships were detected indicating that the spontaneous activity remained 
unchanged in this time period, although there is individual variation between animals, 
illustrated in Figure 5-20.  
The seven hour time line showed an increase in spontaneous activity (F(1,3) = 12.63, p = 
0.038, ŋ2 = .81) with a positive β coefficient indicating a positive relationship. No significant 
main effect of electrode or electrode x time interaction was observed suggesting that the 
systemic administration of salicylate caused the spontaneous activity to increase over time 
irrespective of electrode location. There was no sign of an increase in the first three hours, 
but Figure 5-21 suggests that the onset starts around four hours after salicylate treatment. 
 
Figure 5-20 Spontaneous activity for the different animals averaged across all electrodes at each time point, 
expressed as a ratio to the baseline (red line). The grey bars represent the average across animals. 
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Figure 5-21 Spontaneous activity displayed for the different electrodes averaged across animals, expressed as a 
ratio to the baseline (red line).  
Having established that units show increased and decreased responses to a wide range of 
frequencies in response to salicylate an important question is what effect it has on the 
activity elicited by frequencies close to the CF of the multiunit activity.  
Total driven activity at low attenuation is not affected by salicylate 
Salicylate did not cause any change in the sound driven part of the PSTH in the low 
attenuation (30dB) condition. Thus the RM ANOVAs in both the three and the seven hour 
time series showed no significant polynomial trends for time, frequency or the interaction 
between the two. The figures, Figure 5-22 and Figure 5-23 show almost flat lines. 
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Figure 5-22 Sound evoked activity in the PSTH averaged over all electrodes for each animal, as a function of time 
post salicylate at each time point. The activity at each time point is expressed as a ratio to the baseline (red line). 
The grey bares represent the mean across all animals.  
 
Figure 5-23 the sound driven activity captured in the PSTH, plotted for the different electrodes averaged across the 
animals. Activity is expressed as a ratio to baseline (red line).  
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Onset activity at low attenuation is unaffected by salicylate 
Salicylate failed to affect the PSTH onset peak in either the three or seven hour time 
window. Figure 5-24 and Figure 5-25 both illustrate this point. No change in driven activity 
or onset peak activity was detected in the low attenuation condition.  
 
Figure 5-24 the onset peak expressed as a ratio to the baseline (red line) plotted for the individual animals averaged 
across the electrodes. The grey bars indicate the average across all animals.  
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Figure 5-25 the onset peak expressed as a ratio to the baseline (red line) plotted for the different electrodes averaged 
across the animals. 
Total driven activity at high attenuation is unaffected by salicylate 
Following salicylate injection, there was no change in the sound driven activity in the high 
attenuation condition over the three or the seven hour time courses. No linear, quadratic or 
cubic relationship for time, electrode or the interaction between the two was observed. Due 
to the variability between the animals, illustrated in Figure 5-26, the total driven activity was 
not shown to be significantly affected by salicylate. 
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Figure 5-26 the sound driven part of the PSTH per animal averaged over all electrodes at each time point. The activity 
at each time point is expressed as a ratio to the baseline. The grey bars represent the mean across all animals.  
Onset activity at high attenuation is unaffected by salicylate  
The onset peak of the driven activity showed no signs of significant systematic change for 
either the three or the seven hour time window. Figure 5-27 shows the variability between 
animals, interestingly the variability between animals increases over time. Systemic 
administration of salicylate does not appear to affect the sound driven response of the 
neurons at the attenuation levels presented here.  
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Figure 5-27 the onset peak expressed as a ratio to the baseline plotted for the individual animals averaged across 
the electrodes. The grey bars indicate the average across all animals.  
 The local administration of salicylate in the IC will give more insight into how salicylate acts 
on auditory processing in the IC. Because the local administration of salicylate had a much 
quicker onset than the systemic administration of salicylate, 4 blocks spaced 12 minutes 
apart extracted from the first hour post the onset of administration were added to the 
analysis. Note that the concentration of salicylate perfused through the dialysis probe was 
increased over time; this is indicated in all plots. Because only time was included in the 
analysis, and we don’t know the exact concentration of salicylate in the tissue, it is not 
possible in the current analysis to distinguish between duration of perfusion and the 
concentration of salicylate present. In Figure 5-28 an overview of an experiment with local 
administration of salicylate is shown. Immediately noticeable is that the FRA increases in 
area size 3 hours after administration begins, but in contrast to the response to systemic 
administration of salicylate, there is a reduction in area between 3 and 7 hours. Also 
apparent is the absence of areas of decreased activity and little increased spontaneous 
firing due to the absence of random scatter outside of the FRA. 
5.3.2 Local Administration of Salicylate
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Figure 5-28 Overview of experiment 9050. In the top row the original FRA's are shown for the baseline, 3 hours and 
7 hours after salicylate perfusion has started. The second row shows the FRA for that time point following 
subtraction of the baseline. In the third row the binary FRA's of which the baseline was subtracted are shown. Red 
pixels represents an increase in activity. 
Local salicylate did not affect the CF 
Perfusion of increasing concentrations of salicylate failed to alter the CF. Thus the RM 
ANOVA did not show any relationship for time, electrode location or the interaction between 
the two. Figure 5-29 and Figure 5-30 shows the CF stays close to the baseline value.  
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Figure 5-29 the coloured squares represent the CF for every animal averaged across all electrodes at each time point. 
The CF is expressed as a ratio to the baseline. The grey bars express the mean across animals. The red line indicates 
the baseline level. 
 
Figure 5-30 the coloured squares represent the CF for each electrode location averages across animals. The CF is 
expressed as a ratio to the baseline. The red line indicates the baseline level. 
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Local salicylate did not affect threshold attenuation at CF 
No change in threshold attenuation was detected for time post salicylate, electrode or the 
interaction between the two. In the figures Figure 5-31 and Figure 5-32 the attenuation 
levels are plotted against the baseline, just as the statistical test indicated no discernible 
effect is observed. These results suggest that the local administration of salicylate does not 
cause a shift in CF or threshold of the units.  
 
Figure 5-31 the coloured squares represent the attenuation level for each animal averaged across all electrodes on 
which the CF was obtained. The attenuation level is expressed as a ratio to baseline, indicated by the red line. The 
grey bars represent the mean across all animals.  
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Figure 5-32 the coloured squares represent the attenuation level for each electrode location averaged across all 
animals, on which the CF was obtained. The attenuation level is expressed as a ratio to baseline, indicated by the 
red line.  
Local salicylate induces areas of increased activity in FRA 
Local perfusion of salicylate induced marked changes in the FRA as shown in the example 
(Figure 5-28). Areas of increased activity were observed within the FRA in response to 
salicylate. The ANOVA revealed a significant linear relationship (F(1,2) = 18.53 = 0.049, ŋ2 
= 0.86) with the regression analysis showing a positive β coefficient indicating a positive 
linear relationship. Note that the x-axis is not linear, the first hour is broken down into 12 
minute blocks to highlight any early effects. No further polynomial relationship for the 
number of pixels in which activity increased was observed for either the electrode or the 
time x electrode interaction term. The increasing linear relationship is clearly visible in 
Figure 5-33 and Figure 5-34, these figures also illustrate the almost immediate onset of the 
effect. Effects are apparent twelve minutes after the onset of the salicylate perfusion. 
Having established that salicylate perfusion induced regions of increased activity in the 
FRA, the magnitude of this increase was then examined. 
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Figure 5-33 the coloured triangles represent the areas of increased activity in pixels averaged across all electrodes 
for the individual animals at the different time points. The grey bars indicate the mean across animals at each time 
point. Note the non-linear x-axis depicted the first hour in 12 minute blocks to allow for visualisation of rapid onset 
effects 
 
 
Figure 5-34 the coloured triangles represent the size of the area of increased activity averaged across the animals 
but plotted for the different electrode locations. Note the non-linear x-axis depicted the first hour in 12 minute blocks 
to allow for visualisation of rapid onset effects 
Results  Ι  183 
 
 
Magnitude of increased activity grew over time 
Salicylate caused the magnitude of the activity increase to grow rapidly within twelve 
minutes but kept increasing steadily afterwards indicated by a linear relationship (F(1,2) = 
22.50, p = 0.042, ŋ2 = 0.92) with a positive β coefficient indicating a constant increase. Note 
that the x-axis is not linear. No further significant polynomial effects for either electrode 
location or the interaction effect were observed. Figure 5-35 and Figure 5-36 show that 
most of this rise in magnitude takes place within the first twelve minutes of 0.1 mM salicylate 
administration. Note that increasing the dose a hundred fold did not result in any further 
increase in magnitude.  
 
Figure 5-35 the coloured triangles indicate the magnitude of the increased activity for the individual animals, 
averaged across all electrodes, compared to baseline, indicated by the red line. The grey bars show the mean across 
all animals for each time point. Note the non-linear x-axis depicted the first hour in 12 minute blocks to allow for 
visualisation of rapid onset effects 
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Figure 5-36 the coloured triangles indicate the magnitude of the increased activity for the different electrode 
locations, averaged across all animals, compared to baseline, indicated by the red line. Note the non-linear x-axis 
depicted the first hour in 12 minute blocks to allow for visualisation of rapid onset effects 
Local salicylate does not trigger the development of areas of decreased activity 
Local perfusion of salicylate did not trigger systematic areas of decreased activity in the 
FRA. In Figure 5-37 it is quite clear that areas of decreased activity only appear in one 
animal. Visual inspection of the other two animals do reveal a few unconnected pixels where 
there was a reduction in activity but these did not pass the connectivity protocol, which 
required 5 or more connected pixels to pass the threshold of being decreased substantially 
from baseline. Except for this one animal, no systematic areas of decreased activity were 
observed when salicylate was perfused via the dialysis probe, therefore no statistical testing 
was done on this data.  
Results  Ι  185 
 
 
 
Figure 5-37 the triangles represent the number of connected pixels that show reduced activity for each individual 
animal averaged across all electrodes. The grey bars represent the mean across all animals. Note the non-linear x-
axis depicted the first hour in 12 minute blocks to allow for visualisation of rapid onset effects 
Local salicylate decreases the spontaneous activity 
Spontaneous activity showed a complex change in response to local administered 
salicylate. Both a linear and a cubic trend were detected for time post salicylate perfusion. 
The linear relationship (F(1,2) = 28.88, P = 0.033, ŋ2 = 0.94) with a negative β coefficient 
indicating a decline and the cubic trend (F(1,2) = 45.55, p = 0.021, ŋ = 0.96) suggesting an 
inflexion in the data. No further polynomial trends for electrode location or interaction were 
found. In Figure 5-38 and Figure 5-39 the complex response is visible. An initial short lived 
increase in spontaneous activity was followed by a long lasting decrease in spontaneous 
activity that remained unchanged when the concentration of salicylate is increased a 
hundred fold. 
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Figure 5-38 the stars represent the spontaneous activity averaged across all electrodes per animal as a ratio to 
baseline, indicated by the red line. The grey bars represent the mean across all animals. Note the non-linear x-axis 
depicted the first hour in 12 minute blocks to allow for visualisation of rapid onset effects 
  
Figure 5-39 the stars represent the spontaneous activity for on the different electrode locations averaged across all 
animal as a ratio to baseline, indicated by the red line. Note the non-linear x-axis depicted the first hour in 12 minute 
blocks to allow for visualisation of rapid onset effects 
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PSTH measures 
Local salicylate reduces driven activity at high sound levels 
The total driven activity at 30 dB attenuation was reduced over time in response to the local 
perfusion of salicylate. A significant linear relationship (F(1,2) = 135.90, p = 0.007, ŋ2 = 
0.99) was detected, the regression analysis showed a negative β coefficient indicating a 
decrease in overall sound driven activity over time. No further polynomial relationships for 
electrode location or the interaction effect were observed. The activity elicited in response 
to the CF stimuli are plotted as a ratio to baseline in the Figure -5-40 and Figure 5-41.  
 
Figure -5-40 The individual squares represent the sound driven activity compared to baseline for the individual
animals averaged across electrodes. The baseline is indicated by the red line. The grey bars show the mean across
all animals. Note the non-linear x-axis depicted the first hour in 12 minute blocks to allow for visualisation of rapid
onset effects 
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Local salicylate has no effect on onset activity at high sound levels  
Although local salicylate decreased total driven activity, there was no effect on the onset 
activity No linear, quadratic or cubic relationship was detected in response to local 
salicylate. There was no main effect for time, electrode or interaction effect. Figure 5-42 
shows the onset response displayed as a ratio to baseline for each time point for each 
animal averaged  
Figure 5-41 the individual squares represent the sound driven activity for the different electrode locations averaged
across the animals. The baseline is indicated by the red line. Note the non-linear x-axis depicted the first hour in 12 
minute blocks to allow for visualisation of rapid onset effects 
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Figure 5-42 PSTH onset as a ratio to baseline, displayed for the individual animals averaged across electrode 
location. The red line indicated the baseline. The grey bar shows the mean value across animals. Note the non-linear 
x-axis depicted the first hour in 12 minute blocks to allow for visualisation of rapid onset effects 
 
 
Figure 5-43 PSTH onset as a ratio to baseline, displayed for the different electrodes averaged across animals. The 
red line indicated the baseline. Note the non-linear x-axis depicted the first hour in 12 minute blocks to allow for 
visualisation of rapid onset effects 
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Local salicylate decreased total driven activity in low sound levels  
In the high attenuation condition a decrease in the total driven activity was observed in 
response to local perfused salicylate. A statistical linear relationship for time was detected 
(F(1,2) = 98.82, p = 0.010, ŋ2 = 0.98) the regression shows a negative β coefficient, 
indicating a decrease in sound driven activity due to salicylate being perfused in the IC. No 
further polynomial relationships were observed for electrode location or interaction. In 
Figure 5-44 and Figure 5-45 the sound driven activity is plotted as a function of time after 
starting the perfusion of salicylate. No statistically significant differences were observed for 
the different doses of salicylate perfused.  
 
Figure 5-44 the sound driven activity is plotted for each animal averaged across all electrodes as ratio to baseline, 
the red line marks the original baseline activity. The grey bars indicated the mean change across animals. Note the 
non-linear x-axis depicted the first hour in 12 minute blocks to allow for visualisation of rapid onset effects 
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Figure 5-45 the sound driven response on each electrode averaged across the animals as a ratio to baseline, marked 
by the red line. Note the non-linear x-axis depicted the first hour in 12 minute blocks to allow for visualisation of 
rapid onset effects 
Local salicylate decreases the onset activity 
A decrease in the onset activity in response to local perfusion of salicylate was detected. A 
significant non-zero linear relationship (F(1,2) = 19.67, p = 0.047, ŋ = 0.91) with a negative 
β coefficient from the regression analysis was obtained for the onset activity. No further 
polynomial relationships were obtained suggesting only time of salicylate perfusion 
influenced the onset peak. In Figure 5-46 and Figure 5-47 activity during the onset peak is 
plotted as a function of time averaged across electrodes and animals. The decrease lasts 
for several hours and does not change when the salicylate dose is increased a hundredfold. 
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Figure 5-46 PSTH onset activity plotted as a ratio to baseline across electrodes, the baseline is indicated in red. The 
grey bars indicate the average across all animals. Note the non-linear x-axis depicted the first hour in 12 minute 
blocks to allow for visualisation of rapid onset effects 
 
Figure 5-47 PSTH onset activity plotted as a ratio to baseline across animals, the baseline is indicated in red. Note 
the non-linear x-axis depicted the first hour in 12 minute blocks to allow for visualisation of rapid onset effects 
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In three of the animals that received local salicylate perfusion, the NOS blocker L-MeArg 
was co-perfused direct into the IC, three hours after the L-MeArg perfusion was started. 
These data were analysed with two-way mixed design ANOVA where the presence of L-
MeArg was entered as a between subjects factor. No interaction effects between the 
presence of L-MeArg and time post salicylate were detected for the characteristic frequency 
change, the development of areas of increased or decreased activity, nor for the magnitude 
of change in either direction or for the increase in spontaneous activity. L-MeArg did not 
modulate any of the effects of local salicylate. 
5.4 Discussion 
In this Chapter, I present evidence from two different experiments to further our 
understanding of the changes that occur in the IC during the course of salicylate-induced 
tinnitus. Firstly, the data obtained from the systemic administered and locally perfused 
salicylate aimed to disentangle the direct and indirect effects salicylate has on neuronal 
processes in the inferior colliculus. Secondly, I tried to establish a possible link of salicylate 
acting on the NMDA receptor and possible NO signalling cascade.  
Systemically administered salicylate had three effects, an increase in spontaneous activity, 
an increase in acoustically evoked activity and an upward shift of the CF. Both, the increase 
in sound-driven activity and the upward shift of the CF were also seen when salicylate was 
locally perfused, suggesting that that these effects are at least partly mediated within the 
IC. In contrast, local perfusion of salicylate in the IC resulted in a decrease in spontaneous 
activity suggesting that the increase in spontaneous activity observed in the systemic 
experiments does not originate from the IC. The systemic salicylate experiments reported 
here extend the previous experiments about salicylate effects on auditory processing in the 
IC. In contrast to these earlier studies where single units were collected before and after 
salicylate treatment in the experiments reported here the same multi-unit activity was 
recorded before and up to seven hours after the systemic salicylate administration. This 
makes it possible to map the development of salicylate-induced effects over time, providing 
a unique window into the changes in neuronal activity observed in the IC.  
5.3.3 Local Salicylate and Nitric Oxide
5.4.1 Summary
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Some methodological limitations concerning the studies here need to be addressed. For 
the salicylate experiments the initial systemic dose chose was based on the literature 
reporting doses between 150 mg/kg up to 450 mg/kg (Jastreboff and Sasaki, 1986; 
Jastreboff et al., 1988; Yang et al., 2007; Sun et al., 2009; Stolzberg et al., 2012). In the 
pilot experiments leading up to the current study, I found that higher levels >350 mg/kg of 
Salicylate led to the premature death of the animal. For practical and ethical reasons the 
dose of salicylate used was kept below this, in our animals, and set at 200 mg/kg. This dose 
has been used by several other studies and reliably showed behavioural effects of tinnitus 
(Kenmochi and Eggermont, 1997; Eggermont and Roberts, 2004; Roberts et al., 2010; 
Eggermont and Roberts, 2015) as well as increases in spontaneous activity in auditory 
structures (Kenmochi and Eggermont, 1997; Eggermont and Kenmochi, 1998; Yang et al., 
2007; Roberts et al., 2010; Stolzberg et al., 2012; Eggermont and Roberts, 2015). To 
prevent respiratory arrest the animals were artificially respired with 100% medical oxygen.  
The concentration of salicylate that gets into the brain and the IC in these systemic 
salicylate experiments is not known. Salicylate uptake rates differ between tissues and the 
uptake into the brain is especially slow due to salicylate having a low lipid solubility at 
physiological pH levels, thereby hindering the crossing of the blood brain barrier (Bannwarth 
et al., 1986). The strong binding of salicylate to the protein albumin is another rate limiting 
factor for salicylate in reaching the brain (Reed and Palmisano, 1975; Jastreboff et al., 
1986). The half-life permeation from plasma levels to the cerebrospinal fluid is about two 
hours (Brodie et al., 1960). There is a marked difference between species where it concerns 
the binding of salicylate to serum proteins. Guinea pigs display high salicylate binding to 
the serum albumin, while rats, mice and dogs display a much lower plasma binding 
(Sturman and Smith, 1967). Meaning that permeation of salicylate into the brain will be 
slower for guinea pigs compared to rats. Manabe et al. (1997) observed salicylate levels in 
guinea pigs rising and declining over the course of 10 hours back to baseline levels. They 
established a direct link between the spontaneous firing rate and the serum concentrations 
of salicylate in that they rise and fall at similar rates. 
Because the concentration of salicylate in the IC is unknown for the systemic experiments 
it is impossible to directly compare whether the concentrations of salicylate directly perfused 
into the IC are comparable. However, the local perfusion experiments started out with low 
concentrations which were increased over time, thereby gathering responses to a range of 
5.4.2 Limitations
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concentrations. Regardless of whether the concentrations were comparable, the studies 
show similar effects in several measures, suggesting that these can be attributed to direct 
effects of salicylate on neuronal processing in the IC. Whereas the effects that differed 
between the local and systemic applied salicylate, most notably the spontaneous activity, 
suggest that these effects arise elsewhere in the auditory pathway.  
The question arises to what extent the local salicylate perfusion remains ‘local’ Extensive 
perfusion over the course of several hours with incremental concentrations could potentially 
lead to salicylate leaking out of the IC and affecting other brain regions or organs. No 
measurements of salicylate blood plasma levels were conducted in either the systemic or 
local salicylate experiments, so direct comparisons cannot be made, however, the total 
amount of salicylate administered in the local application is low. The four syringes 
containing 0.1 mM, 1 mM, 10 mM salicylate and 10 mM + 1 mM L-MeArg together contain 
in total 8.44 mg of salicylate. Even if we assume that all that salicylate dialysed into the IC 
and into the animal’s circulation, the dose would still be a 25 times lower than the systemic 
administration and well below the 50 mg/kg dose which has been shown to have no tinnitus 
inducing effects (Stolzberg et al., 2012).  
The sound driven activity which was found to increase in the FRA analysis failed to show 
consistent changes in the PSTH analysis which seems contradictory. However, this can be 
accounted for by the way the data was collected and analysed. The electrode was placed 
in the IC to record across the tonotopic laminae, thereby recording units with similar, but 
not exactly the same, range of CFs in every animal. To compare between animals the 
electrodes giving the highest number of spikes in the baseline condition to the set 
frequencies 256, 512, 1024, 2048 and 4096 were selected. This resulted in the selection of 
electrodes recording units with CFs close to these frequencies, but not necessarily the 
same CF. The fact that areas of decreased activity where usually observed on the lower 
frequency side of the CF whilst the areas of increased activity had the largest magnitude 
on the high frequency side of the CF leads to problems in this analysis. If the electrode 
selected for a set frequency had a CF higher than the set frequency the PSTH results were 
likely to be collected from an area of decreased activity whilst if the unit had a CF lower 
than the set frequency the reverse was true. This phenomenon is illustrated in Figure 5-48. 
Owing to this, the data showed great variability between animals and electrodes within 
animals because the different electrodes within one animal could belong to either group, 
therefor for the PSTH data in salicylate experiments more electrodes would need to be 
extracted and calculated and matched up based on a units CF and not the set frequencies.  
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Figure 5-48 cartoon illustrating how units with slightly different CFs could give variable results in the PSTH analysis. 
Yellow indicates the normal FRA area. Blue is the hypothesized area of decrease and red is the area of increased 
activity due to salicylate, both are often observed in these regions relative to the CF. Because PSTH were sampled 
at set frequencies and not the CF of the units they could be sampled from below or above the CF of a unit. X indicates 
a unit with a CF higher than the set frequency and results in a decrease of activity. O indicates a unit that has lower 
CF than the set frequency and results in an increase in activity. 
Finally the fact that the blocking of NO production by co-perfusing L-MeArg with salicylate 
did not result in a modulation of the obtained local salicylate effects could be due to 
methodological issues. The L-MeArg was not perfused into the IC until 5 hours of salicylate 
in increasing concentrations were perfused in the IC. Salicylate might be potent at triggering 
processes that cannot be halted once activated, or the L-MeArg concentration was not high 
enough to overcome the effects of salicylate. Although, the L-MeArg concentration used 
had been shown to be effective in the NMDA experiments.  
Not being able to find any results for the NO modulating drugs in attempting to manipulate 
the local salicylate-induced effects might reflect the problem that the statistical power of the 
current studies was low due to the number of animals used per experimental group, 
especially in the local salicylate experiments. Also, the number of channels extracted was 
limited because the tools for processing the complete dataset were not fully developed at 
the time.  
Even though the study had some limitations which will affect the scope of the findings none 
threaten the validity of the results. Some interesting observations were made in the 
systemic and the local administration of salicylate. Contrasting the two methods led to new 
insights on where, in the auditory pathway, salicylate can exert its effects. 
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Systemic administration of salicylate increased the CF of the recorded multi-unit activity 
over time but the threshold sensitivity at CF remained unchanged. Local perfusion of 
salicylate in the IC did not result in an upward shift of the CF, it also did not affect the 
threshold sensitivity at CF. The segregation of these findings suggests that the mechanism 
causing this upward shift in CF does not reside in the IC. It seems unlikely that the CF 
change is an artefact of the experimental method because in none of the previously 
described NMDA experiments or in the current local perfusion experiments were changes 
in CF observed, suggesting that this finding is directly linked to salicylate acting in the 
auditory pathway but not directly on the IC tissue. This upward shift in CF of neurons has 
not been described before by previous studies, and likely has not been observed before 
because these studies could not track the activity from the same units over time. The 
upward shift in CF makes the neurons more sensitive to higher frequencies a finding that 
could very well underlie tinnitus, which is often characterised as a high frequency 
phenomenon.  
The question as to what drives this shift in CF was addressed by analysing regions of 
decreased and increased activity in the FRAs. The regions of increased and the regions of 
decreased activity observed in the FRA represent changes over a wide range of 
frequencies and intensity levels. Interestingly, the increased and decreased regions do not 
occur uniformly across the entire FRA, but tend to have a relationship with the CF. Because 
they are different phenomena they will be discussed separately, although together they may 
underlie the shift of the CF. 
Direct and indirect salicylate induce areas of increased activity 
Both systemic and local administered salicylate result in regions of increased activity. In the 
systemic administration the regions of increased activity required three to four hours to form 
whereas the latency was much quicker in the local salicylate experiments. Thus strongly 
suggesting that this increase in activity is at least partially driven by the direct effects of 
salicylate on the IC. A finding that corresponds with previous research showing increased 
metabolic activity in the temporal cortex and the inferior colliculi as a result of salicylate 
5.4.3 Systemic Salicylate Shifts the CF upwards but does Not Alter
the Threshold Sensitivity  
5.4.4 Direct and Indirect Salicylate have Different Effects over a 
Range of Frequencies 
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induced tinnitus using PET and MRI in rats (Paul et al., 2009). In the systemic salicylate 
conditions the increase in activity is seen in both sound driven and spontaneous areas of 
the FRA, whereas in the local salicylate condition the increases were largely confined to 
the sound driven region of the FRA (contrast the examples from Figure 5-9 and Figure 
5-28). Another difference between the local and systemic salicylate conditions is the fact 
that the magnitude of the response continued to increase over several hours in the systemic 
salicylate condition, whereas in the local perfusion the magnitude of the increase reached 
a plateau with the lowest dose of salicylate. Further increases of the concentration of 
salicylate perfused did not alter the magnitude of the increase. The observed difference 
between the two conditions could be due to salicylate acting on one or more structures 
(including the cochlea) in the auditory pathway prior to the IC, in the systemic condition. 
Alternatively, the concentration of salicylate getting into the IC may have been higher in the 
systemic condition.  
Systemic salicylate induces areas of decreased activity 
Areas of decreased activity appear rapidly, within the first hour after the systemic 
administration of salicylate, but are virtually absent in the local perfusion of salicylate. The 
fact that the onset is so quick and that the maximum size of these regions of decreased 
activity is reached within the first hour of systemic salicylate administration suggests that 
this effect is mediated outside of the IC because, due to the relatively slow uptake of 
salicylate and time it takes for salicylate to cross the blood brain barrier (Brodie et al., 1960) 
it is likely that there is no salicylate present in the neuronal tissue of the IC during this first 
hour. Even more compelling evidence for the cause of decreased activity to lie outside of 
the IC is the segregation of findings between the local and systemic administration of 
salicylate. 
The areas of decreased activity are largest during the first hour after salicylate 
administration and start shrinking fast. Although the number of frequencies (expressed as 
an area in the FRA) declines within the second hour leaving only a few small regions in 
place, the magnitude of the decrease within the remaining regions remains constant.  
In agreement with previous studies, a systemic high dose of salicylate causes an increase 
the spontaneous discharge of neurons in the central nucleus of the IC (Jastreboff and 
Sasaki, 1986; Jastreboff et al., 1988; Ma et al., 2006; Berger et al., 2013). In those previous 
5.4.5 Spontaneous Activity 
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experiments it was not possible to record activity from the same neurons over the prolonged 
periods of time required. Activity was recorded from a set of neurons and there was then a 
delay for a couple of hours to let the salicylate take effect before the responses were 
measured from another group of cells. From behavioural experiments, we know that 
behavioural correlates of tinnitus can be perceived two hours after the salicylate treatment 
in guinea pig and rats (Kizawa et al., 2010; Berger et al., 2013). The current protocol allowed 
me to track the multi-unit activity at multiple sites as a function of time after salicylate was 
given. The current experiments replicated the previously reported findings of increased 
spontaneous activity in the central nucleus of the IC following systemic administration of 
salicylate. The figures show a gradual increase of spontaneous activity over time post 
salicylate treatment. Interestingly the other measures obtained in the current experiments 
showed different time scales, suggesting different points of origin in the auditory pathway.  
From the previous studies we know that this increase in spontaneous activity appears to be 
restricted to activity in the auditory pathway and not to be a general effect that salicylate 
has on all neurons in the brain. Recordings in the cerebellum showed no increase in the 
spontaneous activity under the same conditions (Jastreboff et al., 1988). The observation 
of increased spontaneous activity in the auditory brain stem structures and the IC has often 
been replicated but no real progress has been made in disentangling whether the observed 
increase is due to direct effects of salicylate on neurons in the IC or reflect the effects of 
salicylate at other levels of the auditory system including the cochlea. Previous slice 
electrophysiology studies have suggested a sensitivity of the IC to direct effects of 
salicylate. These studies show that 70% of the neurons in the CNIC increase their 
spontaneous firing rate, while 17% decreased their firing rate (Basta and Ernst, 2004) when 
the slice is superfused with salicylate. 
In contrast to the systemically administered salicylate, the local perfusion of salicylate in the 
IC in the current experiments reduced the spontaneous activity in the IC. This finding 
appears to contradict a previous iontophoresis study which reported that local iontophoresis 
in the dorsal cortex of the IC leads to increased spontaneous activity (Patel and Zhang, 
2014). Iontophoresis, is limited to only delivering to the tissue immediately surrounding the 
probe and can therefore not be used to study population effects. Also, the neurons in the 
dorsal cortex have different functions and networks from those in the central nucleus. 
However, close inspection of my graphs shows that immediately after switching on the 
salicylate perfusion a short lived increase in spontaneous activity can be observed, which 
declines within the first hour. This increase appears to be small and in order to substantiate 
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these findings more electrodes from the early time points will need to be extracted to obtain 
higher statistical power. The observed decrease of spontaneous activity in response to the 
direct perfusion of a low dose of salicylate starts to return to baseline when the 
concentration is increased a hundred fold to 10 mM. This suggests that salicylate in low 
doses may actually be beneficial because the decrease of spontaneous activity and the 
increase in sound driven activity effectively increases the signal to noise ratio in the brain 
Systemic administration of salicylate showed different effects on the sound driven response 
recorded in the PSTH data depending on the intensity level of the sound. PSTH analysis 
allows a temporal analysis of the response pre, during and after the stimuli. At high intensity 
levels the total number of spikes elicited by a stimulus near the CF was unchanged, but at 
low intensity levels, increases in activity were observed, which were comparable to the 
increases observed in spontaneous activity. The low intensity condition may have been 
close to threshold in some of the units recorded, and therefore been more susceptible to 
influences from spontaneous activity.  
In the local perfusion conditions, decreases were observed for both the high and low sound 
intensity levels. Which again argues for the findings of increased activity observed in the 
systemic condition to have arisen elsewhere in the auditory pathway.  
In the local perfusion of salicylate attempts were made to investigate to what extent blocking 
the NO pathway would have an effect on the salicylate effects. Unfortunately in the current 
set of experiments no evidence was observed for NO signalling meditating the direct actions 
of salicylate in the IC. However this absence of evidence may be due to a number of 
practical reasons that have been addressed above in the study limitations. Salicylate could 
have a wide range of direct effects on the NO signalling pathway. Salicylate has been 
shown to directly act on NMDA receptors in auditory centres (Guitton et al., 2003; Ruel et 
al., 2008; Hwang et al., 2011) as well as directly alter the GABA receptors in the IC (Bauer 
et al., 2000; Butt et al., 2016), therefore absence of an effect in this study may be due to 
methodological issues.  
5.4.6 Driven/Onset activity at 50 and 70 dB SPL
5.4.7 Blocking of NO Production does not alter Local Salicylate 
Effect 
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To make local and systemic experiments more comparable the measurements of serum 
concentrations of salicylate in the systemic salicylate protocols could be used. Knowing the 
serum concentration of salicylate in the hours post systemic administration will not directly 
tell us how much salicylate gets into the brain, but measurements obtained from the 
dialysate coming out of the probe can be used to estimate how much salicylate reaches the 
IC. Calculations between the plasma bound salicylate and salicylate in the IC at various 
time points could be correlated with changes in spontaneous activity, areas of increased or 
decreased activity or any of the other obtained measures.  
To estimate how much salicylate is reaching the brain in the local perfusion protocols the 
concentration of salicylate in the dialysate coming out of the probe could be compared to 
the concentration going in, although the extent of perfusion would still be unknown, an 
attempt to ensure comparable concentrations in the systemic and local perfusion 
experiments would extend the current findings. 
In the systemic salicylate experiments, the spontaneous activity observed appeared to 
decline near the end of the experiments, but no return of the CF to lower frequencies was 
observed. Extending the current experiments over longer time courses to confirm the 
decline of spontaneous activity and study whether the upward shift of the CF is maintained 
could help shed light on how these measures are related to tinnitus. Behavioural evidence 
of tinnitus in rats disappears between 24 - 72 hours (Ralli et al., 2010; Stolzberg et al., 2012) 
(Berger and Coomber, 2015), while the increase in spontaneous activity appears to decline 
much faster. Extending the duration of the experiments could disentangle these effects.  
A more extended dose response curve for the perfusion of local salicylate in the central 
nucleus of the IC would help moving observations forward. The suggestions in the current 
experiments that low levels of salicylate might actually be beneficial in hearing could be 
studied in more detail. Also increasing the number of animals in these groups would help 
increase the statistical power to detect the more subtle effects of salicylate that may have 
been missed in the current studies. Establishing the effects of direct perfusion of lower 
concentrations of salicylate could then be used to study to what extent the NO signalling 
pathway is involved. The suggestion that low concentrations of salicylate may be beneficial 
in hearing by increasing the signal to noise ratio in local perfusion is interesting but would 
carry more weight if it could be replicated in systemic administration experiments. 
5.4.8 Future Research
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Obviously, the doses administered would need to be reduced and possibly be administered 
chronically to take effect but if there is a true effect it has the potential to be beneficial.  
Specific studies investigating where in the auditory pathway the effects not mediated by 
direct salicylate perfusion in the IC originate could be performed by leaving the recording 
probe in the central nucleus but having microdialysis probes perfusing salicylate in other 
auditory structures. 
This chapter set out to obtain a better understanding of the effects of salicylate and 
determining which of these are direct effects on the IC and which arise from other sources.  
The reported results confirm previous findings of increased spontaneous rate and sound-
driven activity in response to systemic salicylate. Since salicylate applied locally in the IC 
decreased rather than increased spontaneous activity, I conclude that the elevation of 
spontaneous firing by salicylate is mediated outside the IC. Similarly, the initial effect of 
systemic salicylate in reducing sound-driven activity in a frequency-selective manner was 
not mirrored by locally applied salicylate and hence likely originates elsewhere. However, 
the finding that both locally applied and systemic salicylate raised the CF and increased 
sound driven activity, suggests that these effects are, at least in part, mediated directly 
within the IC. 
5.4.9 Conclusion
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Chapter  6. General Discussion 
6.1 Summary 
This thesis is concerned with the role NO signalling plays in auditory processing in the IC. 
Important structural and functional findings were presented that demonstrate new levels of 
complexity. The current findings will require us to reconsider the contribution of NO in 
auditory processing in the IC.  
In Chapter 3 evidence from immunohistochemistry demonstrated for the first time the 
presence of nNOS in the central nucleus, a subdivision of the IC previously believed to 
exhibit little or no nNOS expression. Data in Chapter 4 demonstrated that the nNOS 
observed in the central nucleus is associated with, and directly influenced by the activity of 
the glutamate NMDA receptor. The potential role of nNOS in the central nucleus of the IC 
in tinnitus was the main topic of investigation in Chapter 5. This chapter provided new 
information about the direct and indirect effects of the tinnitus inducing drug, salicylate, on 
the IC. Although I was not able to demonstrate a direct link between salicylate-induced 
activity, presumed to be linked to tinnitus, and nNOS in the central nucleus, limitations in 
the study may account for this.  
Previous studies have demonstrated the abundance of nNOS, the main NO producing 
enzyme in the brain, in the IC in several species (Herbert et al., 1991; Druga and Syka, 
1993; Coote and Rees, 2008). These prior studies reported extensive nNOS or NADPH 
positive labelling in the lateral and dorsal cortex with relatively little or no expression in the 
central nucleus of the IC. The new evidence brought forward in Chapter 3 of this thesis 
demonstrates that with the development of more advanced immunohistochemistry 
protocols, newer immunofluorescent imaging techniques, and more widely available 
computing power, the presence of nNOS can be demonstrated in the central nucleus albeit 
its expression is markedly different compared to the cortices. In the cortices, nNOS is 
distributed throughout the cell’s cytoplasm and labelling is seen in somata and dendrites. 
However careful inspection suggested that nNOS labelled puncta associated with the cell 
membrane were also present in these regions. In the central nucleus nNOS expression is 
virtually confined to puncta. These puncta in the central nucleus were shown to be 
associated with PSD95, a postsynaptic scaffolding protein that stabilises the NMDA 
receptor in the active zone of the postsynaptic membrane. Although the microscopy 
6.1.1 Anatomical Findings
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techniques used did not allow me to determine whether nNOS and PSD95 are physically 
linked, the association of the nNOS puncta in the central nucleus and PSD95 strongly 
suggest that this nNOS is located postsynaptically and is likely part of the nNOS-PSD95-
NMDA receptor complex.  
Further studies in this chapter investigated the neurotransmitter phenotype of the cells 
expressing nNOS. A minority of the cells expressing either distributed and/or punctate 
nNOS were shown to have a GABAergic phenotype. Given that few cells in this region are 
neither GABAergic nor glutamatergic, the data suggest that the majority of nNOS 
expressing cells in the IC must be glutamatergic. Given the calcium dependence of nNOS, 
the co-expression of some calcium binding proteins in cells expressing nNOS was explored. 
Calbindin showed near complete co-localization with nNOS whilst calretinin was rarely 
found in nNOS positive cells. For parvalbumin the picture was more complex, some 
parvalbumin positive cells did show distributed nNOS expression in the ventral IC or 
punctate nNOS expression throughout the central nucleus but many parvalbumin positive 
cells showed no nNOS labelling. Based on these findings, nNOS cells can express 
calbindin or parvalbumin but not calretinin. 
The finding that nNOS puncta are present in the central nucleus and are associated with 
PSD95 (and thus presumably the NMDA receptor) led to the functional studies in Chapter 
4. First I sought to determine whether NMDA receptor activity is involved in auditory 
processing in the IC. The selective activation of this receptor by direct perfusion of NMDA 
via a microdialysis probe caused an increase in both spontaneous and acoustically-evoked 
activity in the central nucleus of the IC. Both effects were abolished when NMDA was co-
perfused with the nNOS inhibitor, L-MeArg. Evidence substantiating the role of NO and 
giving further insight into the mechanism by which it operates came from the experiment in 
which NMDA was co-perfused with ODQ, a sGC blocker. Again the increase in neuronal 
activity caused by direct perfusion of NMDA was abolished by preventing the binding of NO 
to sGC. These two findings show that NMDA receptor stimulation can lead to an increase 
in both spontaneous and acoustically-evoked activity and that this is dependent on both the 
production of NO and its binding to sGC, thus implicating the involvement of the cGMP 
pathway. The virtually complete abolition of the NMDA effect suggests that NO acting on 
sGC is the sole mechanism underlying this effect. The local perfusion of L-MeArg and ODQ 
6.1.2 NMDA Receptor is Functionally Coupled to NO Acting on sGC
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in the absence of NMDA evoked no changes, suggesting that tonic NO transmission is low 
in the central nucleus of the IC at least in the anaesthetised guinea pig preparation. 
Previous studies have demonstrated that increases in spontaneous activity are observed 
in the VCN, in animal models of tinnitus. In these animal models, the nNOS expression is 
also upregulated in the same auditory brainstem nuclei (Zheng et al., 2006; Coomber et al., 
2015). In view of these findings and given the fact that the IC contains more nNOS 
expressing neurons than all auditory brainstem centres combined, even without considering 
the nNOS puncta observed in the central nucleus, it was hypothesised that tinnitus might 
be associated with upregulation of nNOS signalling in the IC. Mechanisms underlying the 
generation of the tinnitus percept are currently unknown and besides investigating a 
possible link between tinnitus and NO signalling, the studies described in Chapter 5 were 
aimed at furthering our understanding of the mechanisms underlying tinnitus. Here the high 
dose salicylate model of tinnitus was employed as a practical means to induce tinnitus 
acutely. High doses of salicylate have been shown to reliably induce transitory tinnitus in 
both humans and animals (Sée, 1877; Jastreboff et al., 1988; Eggermont and Roberts, 
2004; Yang et al., 2007; Roberts et al., 2010; Eggermont and Roberts, 2015). In order to 
determine which of the effects of salicylate occur directly in the IC, and which were likely to 
occur in lower (or higher) auditory centres, the effects of systemic administration and local 
perfusion of salicylate in the IC were compared. Systemically administered salicylate had 
three effects, an increase in spontaneous activity, and increase in acoustically evoked 
activity for higher frequencies and an upward shift of the CF. Both, the increase in sound-
driven activity and the upward shift of the CF were also seen when salicylate was locally 
perfused, indicating that these effects are mediated directly within the IC.  
 
 
 
 
 
6.1.3 Salicylate Exerts Direct and Indirect Effects on Processes in
the IC. 
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6.2 Methodological Considerations and Future Research 
For the questions addressed in this thesis, it was important that drugs were administered 
directly into the IC. In vivo delivery of drugs in a local fashion can be accomplished using 
iontophoresis, pressure injections as well as reverse microdialysis. The methodology 
employed in this thesis was reverse microdialysis because it has a number of advantages 
over the other two techniques.  
1. Microdialysis allows for the examination of drug effects over extended periods of 
time. Iontophoresis is limited to the concentration of drugs that is preloaded in the barrels 
and concentrations of drug in the tissue are unknown. In pressure injections, the initial 
concentration might be known, but a constant declining concentration gradient over time is 
present. In microdialysis, not unlike iontophoresis, the exact amount of drug perfused 
through the tissue may be unknown, studies have suggested that approximately 10% of the 
concentration in the probe is accessing the surrounding tissue. Initially, a gradient with high 
concentration closest to the probe and lower concentrations further from it is expected, over 
time it is likely that the entire central nucleus and possibly the entire IC is affected by 
extended perfusions. Because the microdialysis approach is based on diffusion, the method 
can be used for extensive periods of time without causing any volume effects. Using a 
microdialysis probe allowed me to see how effects build up over extended periods of 
perfusion and also allowed me to make multiple FRA and PSTH measures within each drug 
condition.  
2. Microdialysis allows for the examination of drug effects over a population of 
neurons. Iontophoresis delivers drugs too locally for this to be possible and likely only 
affects receptors on the soma or close to the recording probe. Drug delivery by 
iontophoresis is not able to target distal dendrites of one cell let alone a population of 
neurons as large as the central nucleus of the IC. Pressure injection, on the other hand, 
does allow for population studies but is likely to cause displacement of the tissue making 
recordings from the same units virtually impossible, also larger volumes are likely to disrupt 
the tissue. Microdialysis does not suffer from these issues because it is based on perfusion 
down a concentration gradient. A disadvantage, however, is that all cells in the population 
can be affected resulting in secondary and unpredictable effects. An unexpected shift in the 
normal excitatory/inhibitory balance could occur, although the fact that the NMDA effects 
did wash out over time suggests that the system was not permanently disturbed by it. 
6.2.1 Local Drug Delivery 
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3. Microdialysis is flexible and adaptable, it can be used to study the effects of several 
concentrations of a drug (e.g. concentration response curve for NMDA) and combinations 
of drugs (e.g. NMDA and L-MeArg/ODQ). Repeated pressure injections without disturbing 
the tissue are virtually impossible making long term recordings from the same units nearly 
impossible. Microdialysis does not suffer from these drawbacks but online monitoring of 
drug effects on neuronal activity would be advantageous and give more experimental 
control. 
Some further suggestions for further research to further power the microdialysis aspect of 
the studies would be to look into diffusion rates of the drugs used. An in vivo investigation 
to what extent they are metabolised or displaced would help in gaining more experimental 
control. Although the IC is a relatively isolated structure, diffusion of drugs out of the IC is 
a possibility and diffusion experiments can help determining to what extent this happens.  
Because the recording system used, did not allow for detailed online monitoring of the 
neuronal responses recorded it was sometimes difficult to gauge whether a drug effect had 
completely washed out. This resulted in having partial washouts in the experiments 
reported here, this issue can, however, be dealt with in future experiments by creating 
custom Matlab scripts that will allow for online comparisons between current responses and 
the baseline, allowing for more experimental control. 
Multi-unit recording has obvious advantages over single unit recordings in that it allows data 
to be gathered over the course of many hours and under different drug conditions. It also 
allows simultaneous recordings across the frequency laminae in the central nucleus. In the 
current experiments, electrodes with 32 recording contacts spaced 100 µm apart were 
used, this resulted in a large number of good quality recordings from each animal. Spike 
sorting allows these recordings to be separated into a several simultaneously single unit 
recordings with the advantages that they can inform us how different cells respond to the 
same set of stimuli or drug treatment. Many types of recording probes are available with 
different arrangements of recording electrodes can be bought or custom made to fit the 
specific requirements of the experiment. Multi-unit recording is more stable compared to 
single unit electrophysiology since with the latter it is as a rule impossible to hold single 
units for long periods as was necessary for the current experiments. Since a large number 
of recordings were made per animal this allowed post-hoc selection of the electrode that 
responded best to specific frequencies of interest, thus allowing for greater flexibility. 
6.2.2 Multi-Electrode Recordings
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Although multi-unit recording amasses enormous amounts of data that require new ways 
of analysis and dealing with, the further advances in computing power and storage being 
cheap, data can be stored and further analysed in the future. Multiple measures (e.g. single 
unit responses, PSTH, FRAs and LFPs) can be derived from the same dataset allowing 
further flexibility and in depth analysis.  
Because recordings appeared stable, no control experiments recording activity over many 
hours with only aCSF perfusion were performed, several of the drug manipulations had no 
direct effect (e.g. L-MeArg and ODQ) and drugs which did have a direct effect (e.g. NMDA), 
were shown to reverse (at least partially). Anecdotally (though not formally analysed), online 
observations of the PSTHs and FRAs were similar over the hours before drug 
administration started. I am therefore confident that the recordings were stable. The power 
of the methodology was particularly apparent in the salicylate experiments. The fact that 
multi-unit recordings were made from the same location, before and after systemic 
salicylate administration allowed me to track how salicylate-induced effects develop over 
time in a way not described before. Using this methodology an interesting and unexpected 
effect of salicylate on the CF was revealed which would not have been possible to observe 
with single electrode recordings.  
Similarly I can be confident that the observed shifts in CF were not the result of inserting a 
microdialysis probe and a multi-electrode recording probe in close proximity in the IC and 
recording over many hours because the CF shifts were only observed in response to 
salicylate (directly and systemically applied) but not in the NMDA, the L-MeArg or the ODQ 
experiments. Also the fact that the spontaneous activity increased but also decreased in 
the NMDA concentration response experiments indicates that the constant rise in 
spontaneous activity in the systemic salicylate experiment can also be attributed to the 
salicylate.  
By using a microdialysis probe the drug concentration surrounding the probe is unknown, 
previous studies have suggested that approximately 10% of the original drug concentration 
within the probe reaches the tissue (Chefer et al., 2009), however, the concentration in the 
tissue decreases as a cubic function of distance from the probe (Foeller et al., 2001) making 
statements about the actual drug concentrations difficult. Because the concentration in the 
tissue cannot be known, I always piloted new drugs by starting with low concentrations and 
switched to progressively higher concentrations, usually with aCSF washouts in between, 
6.2.3 Drug Doses/Concentrations
Methodological Considerations and Future Research  Ι  209 
 
 
not unlike the NMDA concentration response protocol. Using this methodology I found a 
concentration response relationship for NMDA in which the effects were qualitatively 
similar, but quantitatively greater at higher concentrations. Initial L-MeArg and ODQ 
concentrations were based loosely on those found in in-vitro studies using these drugs, but 
were piloted and further refined at the end of NMDA dose response experiments.  
For the salicylate experiments the initial systemic dose chosen was based on literature 
reporting doses between 150 mg/kg up to 450 mg/kg (Jastreboff and Sasaki, 1986; 
Jastreboff et al., 1988; Yang et al., 2007; Sun et al., 2009; Stolzberg et al., 2012). In initial 
experiments, I started out using 350 mg/kg which reliably induces tinnitus and I anticipated 
fewer adverse effects compared to higher concentrations. However, the first three guinea 
pigs all died within 3 hours after the salicylate administration. This was thought to be due 
to respiratory depression and to prevent this from happening the animals were artificially 
respired with 100% medical oxygen and the dose of salicylate was titrated down to 200 
mg/kg, still well within the tinnitus inducing range. No more deaths occurred after this 
intervention.  
For the local salicylate perfusion, a similar concentration response curve as for NMDA was 
made, part of which is reported here. The fact that the current salicylate studies failed to 
show any effects of blocking of nNOS does not necessarily mean that NO signalling is not 
related to tinnitus. In the current experiments, the salicylate concentration may have been 
too high or the L-MeArg concentration too low, although the L-MeArg concentration did, of 
course, prove to be effective in the NMDA experiments. The inability to monitor detailed 
changes online discussed earlier was partly the cause for the difficulty in finding the 
appropriate dose for salicylate. Unlike NMDA, salicylate effects took time to build up and 
they were more subtle. The NMDA related changes were clearly visible during the 
recordings which enabled me quickly to find the appropriate dose, however with the more 
subtle salicylate effects I tried perfusing higher concentrations with a result that the optimum 
was not easily found. Also, it is possible that by starting the perfusion of salicylate into the 
IC before blocking the production of NO, mechanisms were triggered that could not be 
stopped. Further dose response studies for L-MeArg, ODQ and salicylate will need to 
address these issues. Also, the null finding for L-MeArg and ODQ could be due to the 
duration of the perfusion, the concentration used, the stimuli presented or the low number 
of animals in the sample. 
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All animals were anaesthetised with an IP injection of urethane and were further 
supplemented with either Hypnorm or, in later experiments due to the unavailability of 
Hypnorm, with Fentanyl and Midazolam. The depth of anaesthesia was checked at regular 
intervals during the experiment by testing the paw reflex. It was noted that animals receiving 
Fentanyl and Midazolam needed less supplementary anaesthesia throughout the 
experiment. It is possible that the Fentanyl and Midazolam have interacted with the 
salicylate resulting in premature deaths of the animals.  
All experiments were performed under anaesthesia and although the brainstem is believed 
to be less affected by anaesthesia compared to the cortex, the IC does receive a significant 
degree of cortical input that under anaesthesia, could be influenced. The effects observed 
on the FRA or the spontaneous activity may all relate to the fact there is no top-down 
inhibition. Even though the current studies may be influenced by changes in cortical input, 
they do however reveal that NMDA receptor activity, nNOS activity, and sGC activity can 
be functionally linked in the central nucleus of the IC. The current experiments also 
demonstrate that salicylate exerts direct effects on neural responses in the IC, even though 
these effects might be different in awake and freely behaving animals. 
6.3 Implications of Experimental Results 
The anatomical studies presented here demonstrated that the presence of nNOS in the IC 
is more extensive than previously described. In the cortices, the nNOS expression is seen 
distributed throughout the cell whereas in the central nucleus the nNOS expression is solely 
observed in punctate labelling. It is likely, that the cells showing distributed nNOS labelling 
also have punctate labelling, but that these are being obscured from view by the bright 
distributed labelling. Evidence was presented demonstrating that the nNOS puncta are 
associated with PSD95. Although the wide field microscopy employed here does not allow 
me to rule out the possibility that some of the nNOS puncta may be located in presynaptic 
terminals, it seems more likely that the nNOS puncta represent postsynaptic nNOS which 
is coupled to PSD95 in the postsynaptic density.  
6.2.4 Influence of Anaesthesia
6.3.1 Different Expression Patterns of nNOS Suggest Different
Functionality 
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The nature of the distributed labelling is more difficult to discern and there is the possibility 
that, while the punctate labelling represents nNOSα bound to PSD95, the distributed 
labelling represents unbound nNOSα and not nNOSβ. However, while nNOSα has a PDZ 
domain allowing it to bind to PSD95, the alternate splice variant nNOS lacks the PDZ 
domain and hence cannot associate with PSD95. Thus the two expression patterns 
observed (punctate and distributed labelling) may represent the two nNOS splice variants 
nNOSα and nNOSβ, respectively.  
Previous work on nNOS, in general, have tended to treat nNOS as a single protein and the 
studies in the IC are no exception. There is usually no mention of the different splice variants 
present, however, in studying the expression of nNOS splice variants we are hampered by 
the fact that NADPH-diaphorase histochemistry and most commercial antibodies do not 
distinguish between different splice variants. Although we do know from in situ hybridization 
studies that the mRNAs coding both splice variants are present in most auditory brainstem 
structures including the IC (Eliasson et al., 1997). It is of note that the mRNAs coding for 
nNOSα and nNOSβ are often expressed in the same cells, at least in the hippocampus and 
cortical areas (Eliasson et al., 1997). While they can demonstrate the presence of mRNA, 
such in situ hybridization studies cannot, however, make any statement about the resulting 
protein levels in these cells and regions. Given the previous evidence and the current 
immunohistochemical observations showing two distinct nNOS expression patterns, it is 
clear we need to entertain the possibility that NO in the IC might perform different functions 
in different cells. The different distributions suggest different splice variants, and even if 
they turn out to be the same, the different distributions suggest different functions.  
In the literature, the idea has been proposed that NO could operate by volume transmission, 
as well as being a trans-synaptic signalling molecule. Garthwaite and colleagues 
demonstrated in hippocampal slices that nNOS is linked to NMDA receptor activity 
(Garthwaite et al., 1989; Hopper et al., 2004). The amount of NO that can be produced is 
limited by the number of NMDA receptors present on a dendritic spine. Calculations and 
mathematical modelling place the amount of NO produced in the synapse in the picomolar 
range, suggesting that NO produced in this way is at too low a concentration to act as a 
volume transmitter (Hall and Garthwaite, 2009; Wood et al., 2011; Garthwaite, 2016). 
However, this assumes that every nNOS protein is directly coupled to an NMDA receptor, 
and hence ignores any contribution from cytoplasmic nNOSβ (or cytoplasmic nNOSα) 
which is possibly too far from an NMDA receptor to be directly influenced by its activity. 
Given that nNOS is dependent on calcium signalling and calcium is tightly regulated by 
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cells, these signals usually fade within 1-2 µm (Augustine et al., 2003), making it unlikely 
that NMDA receptors can directly alter the intracellular calcium levels to the level required 
to activate nNOS proteins not directly associated with the NMDA receptor itself. Thus it 
seems highly unlikely that nNOSβ is regulated by NMDA receptor activity. 
The immunohistochemical evidence presented in Chapter 3 showed that a substantial 
number of nNOS expressing cells also express the calcium binding proteins calbindin and 
parvalbumin. These proteins are well known to regulate intracellular calcium levels and 
trigger secondary messenger systems (Schwaller et al., 2002; Schwaller, 2009), and these 
may very well have a role to play in regulating nNOS activity. The current experiments also 
showed a number of nNOS positive cells not labelling for any of the three calcium binding 
proteins examined, but since the EF-hand calcium binding family comprises over 240 
members this cannot be taken as evidence that they do not contain calcium binding 
proteins. Identifying which calcium binding proteins are co-expressed in nNOS cells may 
have implications for function. The calcium binding proteins have been heavily investigated 
and have proven to be far more complex than previously believed (Schwaller et al., 2002; 
Schwaller, 2009). Given the finding that calbindin positive cells in the IC always contain 
nNOS, whereas, in contrast, calretinin expression hardly ever does, suggests that there 
must be a fundamental difference between the cellular functions these two proteins 
perform.  
From non-neuronal cells (e.g. skeletal muscle cells) that express nNOSβ, we know that this 
protein is attached to and regulated directly by the Golgi-complex (Percival et al., 2010). If 
this were the case in the IC, you would expect the nNOS labelling to form rings around the 
nucleus, which was not observed in the current studies. Even though this regulatory 
mechanism may not necessarily translate directly to neurons, it shows that nNOS can be 
regulated by other proteins besides PSD95. From the knock out studies, we know that 
nNOSβ can rescue the phenotype to a great extent when nNOSα is lost (Langnaese et al., 
2007). In these models, there is evidence for some remaining NO production and NADPH 
diaphorase labelling in the brain and no gross neurological symptoms were observed. 
However, these studies have not investigated auditory processing or the IC and it is likely 
that neuroplasticity, learning and possible other auditory phenomena are being affected in 
these animals.  
As stated earlier, the in situ hybridization studies showed the presence of both splice 
variants but a larger amount of nNOSα mRNA is generally detected. However, due to post 
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translational processing mRNA levels do not directly indicate protein content. Further 
studies investigating the IC by subdivision could certainly help bring in answers to some of 
these questions regarding expression levels of the different splice variants. Even in the 
absence of commercially available antibodies labelling nNOSα and nNOSβ, an in situ study 
targeting the different subdivisions of the IC would be helpful. For example, if NOSβ mRNA 
were shown to be present in the cortices but not in the central nucleus, that would 
substantiate the hypothesis that the distributed nNOS labelling is nNOSβ. Determining the 
role of nNOSβ is currently difficult because there are no selective synthesis blockers or 
selective agonist available. Permanent knock out models of nNOSα can be difficult to 
interpret because they result in changes in nNOSβ expression. An alternative possibility 
might, therefore, be to use conditional knockouts or disrupt the binding of nNOSα to PSD95 
with specific drugs designed for this purpose. 
No studies have directly addressed the functional role of NO in the IC, although some have 
addressed this in other brain regions. However, this is usually done in a limited way. All 
studies thus far have employed iontophoretic methods and as discussed above they do 
suffer from a major limitation, they apply the drugs locally which prevents them from 
studying population wide effects. The data presented in this thesis employing a 
microdialysis probe builds on those previous studies and forms a natural extension of them. 
From previous studies, we know that the vast majority of neurons in the IC are of a 
glutamatergic neurotransmitter phenotype ((Oliver, 2005b; Wu et al., 2008)) and that 
glutamatergic connections are abundant (see Chapter 3). The two main receptors in the IC 
transducing these glutamate signals are the AMPA and the NMDA receptors ((Parks, 
2000)).  
In this thesis, evidence was presented that demonstrated, in accordance with previous 
research that the direct perfusion of NMDA increases the auditory evoked response as well 
as the spontaneous activity observed in the IC. However quite remarkably it does not affect 
the CF or the threshold measured at CF indicating that it does not alter the sensitivity of the 
neurons. The subsequent experiments blocking NO production completely abolished the 
observed increases in activity in response to NMDA. This argues for a direct coupling of the 
NMDA receptor and the nNOS protein in the IC. Because only nNOSα has the ability to 
associate itself with the NMDA receptor via their mutual interaction with PSD95, this finding 
6.3.2 nNOS, the NMDA Receptor and sGC have a Functional 
Relationship 
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further substantiates the idea that nNOSα is being expressed in the puncta seen in the 
central nucleus.  
Blocking the binding of NO to sGC thereby interfering with the cGMP pathway showed the 
same blockade of the otherwise robust NMDA driven increase in activity. This finding 
demonstrates that the NMDA mediated increase in activity is not only NO dependent but 
that it is dependent on NO acting on sGC. Previously, NO has been shown to (negatively) 
regulate presynaptic glutamate release (Ahern et al., 1999) and also to decrease the 
number of NMDA and AMPA receptors in the post synaptic domain during times of high 
activity (Steinert et al., 2010). This is hypothesised to be a protective mechanism to limit 
the amount of calcium entering the cell. Blocking NMDA receptor activity after noise trauma 
has been shown to prevent the development of tinnitus (Guitton and Dudai, 2007; Steinert 
et al., 2010) The studies presented in this thesis show that NMDA receptor activation 
mediates effects in the IC through nNOS and sGC, demonstrating that NO is playing a 
crucial role in mediating NMDA receptor effects. 
The findings in the current research indicate a functional coupling between the NMDA 
receptor, nNOS activity and sGC activity. This functional coupling between the three 
proteins, and the fact that some of their splice variants and subunits contain PDZ domains 
known to associate with PSD95, strongly suggest that this coupling is governed by all three 
proteins associating with PSD95 into a multiprotein signalling complex. This proposed 
multiprotein signalling complex is depicted in Figure 6-1 and comprised of the NMDA 
receptor, nNOSα and sGC all interacting via their PDZ domains with PSD95. 
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Figure 6-1 proposed multi-protein signalling complex comprised of the NMDA receptor, nNOSα and sGC interacting 
with the PDZ binding domains of PSD95. The red blocks in PSD95 represent the respective PDZ binding motifs 1, 2 
and 3. Calcium is depicted entering the cell via the NMDA receptor and binding to nNOSα. The produced NO travels 
to the sGC protein which in turn amplifies the cGMP production a hundredfold. nNOSβ is depicted in the cytoplasm 
but too far from the NMDA receptor to utilise the calcium influx associated with this receptor.  
Tinnitus is a widespread auditory phenomenon reported in virtually all populations and 
across cultures. Due to its subjective nature, it has been difficult to develop an animal model 
for the disorder. Although these have their flaws, the recently developed behavioural tests 
measuring whether animals experience tinnitus, have helped to make strides in tinnitus 
research. Systemic administration of high concentrations of salicylate, chemically similar to 
the main component of aspirin (acetyl salicylate), results in tinnitus albeit of a transitory 
nature. Although the underlying cause and duration are different between noise- and 
salicylate-induced tinnitus, both are believed to share some common mechanism since they 
both result in the same tinnitus percept.  
Virtually all in vivo studies using a systemic administration of salicylate showed an increase 
in spontaneous activity throughout the auditory pathway, and although good progress in 
describing the effects of salicylate have been made, we remain uncertain about how the 
tinnitus percept is being generated. The initial onset of tinnitus has been related to 
(temporary) deficits of the cochlea, but long term tinnitus has been shown to be independent 
from the cochlea (House and Brackmann, 1981; Bauer et al., 2008) and is hypothesized to 
6.3.3  Salicylate Exerts Direct and Indirect Effects on Auditory
Processing in the IC 
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arise from neuroplastic changes higher in the auditory pathway (Eggermont and Roberts, 
2004; Roberts et al., 2010; Guitton, 2012). The IC is uniquely placed in the auditory pathway 
because virtually all ascending and most descending information is processed here making 
this a likely structure to be involved in the generation of the tinnitus percept.  
To tease apart the mechanisms by which salicylate induces tinnitus, comparisons were 
made between the systemic administration and direct perfusion of salicylate in the IC. 
Salicylate has been demonstrated to lead to an increase in the stiffness of outer hair cells, 
by binding to prestin, which leads to a reduction of input in the auditory brainstem pathway 
in a similar fashion to noise-induced trauma. Multiple strands of in vivo and in vitro evidence 
have shown that salicylate influences neuronal activity (Reed and Palmisano, 1975; 
Stypulkowski, 1990). PET scanning showed widespread effects of salicylate in the auditory 
brainstem (Wallhäusser-Franke et al., 1996) while recent MRI scanning in mice showed 
effects of salicylate both on auditory and non-auditory brain structures (Gröschel et al., 
2016). These direct effects of salicylate on the brain cannot be discarded as underlying the 
generation of the tinnitus percept. In fact, if they were to form a part of it, they could 
potentially help us investigate how noise-induced tinnitus is brought about. The current 
hypothesis adopted in this thesis is that the tinnitus percept does not originate from the 
peripheral auditory structures, but is generated in the brain. Pharmacological methods like 
salicylate and quinine are best suited to study such effects because they allow for selective 
targeting of regions and cells expressing specific receptors within these regions.  
Perfusing NMDA locally in the IC presumably shifts the excitatory/inhibitory balance in 
favour of excitatory activity because NMDA stimulates the glutamate NMDA receptor (an 
excitatory receptor), thus resulting in an increase in spontaneous activity. This increase in 
spontaneous (i.e. non-sound-driven activity) could be considered to be ‘noise’ in the system 
and is likely to be underlying the tinnitus percept as this increase in ‘noise’ is interpreted in 
the auditory cortex as an actual sound. A shift in the excitatory/inhibitory balance could also 
be brought about by changing the inhibitory activity, salicylate has been shown to directly 
reduce the GABAergic activity in the central nucleus of the IC (Bauer et al., 2000). Because 
most inhibitory activity that the IC receives is generated in the IC itself, this direct effect of 
salicylate on GABAergic activity could underlie the increased activity observed here.  
Previous in vivo systemic salicylate experiments were not able to track the same units over 
the course of the entire experiment. They collected a number of single cell recordings before 
salicylate administration and another set after. By recording the activity from the same 
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location in the IC, I was able to show that initially salicylate causes a frequency specific 
decrease in activity in the early hours after administration. Only in the later hours of the 
experiment is the increase in spontaneous activity as reported in previous studies observed. 
However, the finding that direct application of salicylate decreases the spontaneous activity 
rather than increasing it suggests that the observed increase in spontaneous activity in the 
IC observed in previous studies and here, arises elsewhere in the auditory system. Over 
the course of the salicylate treatment, the recorded units were seen to shift their CF to 
higher frequencies without altering their threshold sensitivity. Previous studies obviously 
were not able to detect this because they sampled different cells at the different time points. 
The fact that direct perfusion of salicylate in the IC shows the same shift in CF suggests 
that this effect is at least partially originating from the IC. Salicylate may affect the lower 
auditory structures in a similar way and these shifting effects along the pathway may prove 
to be additive. The frequency dependent changes observed in the shape of the FRAs 
suggest there might be some modulation of inhibition 
The current studies failed to demonstrate a link between salicylate-induced effects and the 
NO signalling pathway. However, the NOS blocking agent L-MeArg was infused after 
several hours of increasing salicylate concentration perfusion. It is entirely possible that the 
concentration of L-MeArg was too low, the levels of salicylate were too high or that 
salicylate-induced effects via NO occur down-stream and hence were not reversible. 
Clearly, this area of research would deserve further attention especially now that we know 
that there is nNOS expression present in the central nucleus.  
6.4 Future Studies 
The structural studies reported here brought about new findings about the presence and 
activity of nNOS in the IC. Findings that may require us to reconsider the role NO plays in 
the processing of auditory stimuli, but most certainly requires us to further investigate in 
what types of cells nNOS is expressed. Different protein expressions in cells have been 
well described in other brain regions and can help to shed light on the processes occurring 
in the IC.  
The close functional link between NMDA receptors and nNOS puncta in the central nucleus 
will require us to investigate the NMDA receptors in this structure more closely. We know 
little about NMDA subunit composition in the IC, but from in situ hybridization studies, we 
6.4.1 Future Anatomical Studies
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know that mRNAs for all NMDA subunits are expressed in almost equal levels. There is no 
full description of the NMDA subunit distribution in the different subdivisions of the IC at 
protein level available yet, but it is possible that certain subunits are more likely to be 
associated with nNOS expression. In fact nNOSα knockout studies show that the loss of 
nNOSα is accompanied by the loss of expression of specific NMDA subunits and an 
upregulation for others throughout the brain (Putzke et al., 2000). Understanding what 
NMDA receptor subunits are expressed and how they are linked to different nNOS 
expression patterns can give us clues about their relationship. 
The different subcellular distribution patterns of nNOS are suggestive that these may 
represent nNOSα and nNOSβ however in the absence of commercially available -splice 
variant specific- antibodies this is a difficult hypothesis to test. Antibodies against both splice 
variant have successfully been developed in the past (Langnaese et al., 2007) and access 
to them would mark a major step forward in our ability to visualise the different splice 
variants, not only to confirm the current hypothesis about the distribution patterns, but will 
also allow us to study their distributions and co-expression of other proteins (e.g. calcium 
binding proteins) potentially leading to hypotheses about the roles each splice variant has 
in the IC. Alternatively, current pan-nNOS antibodies could be used in Western blots using 
tissue micro dissected from the subregions of the IC. Because nNOSβ is a smaller protein 
(140 kDa) compared to nNOSα (165 kDa) the expression of the protein would be visible in 
a distinct band on the Western blot.  
The current immunohistochemistry experiments focused on glutamate signalling on nNOS 
expressing cells, but as suggested above the results observed in the functional studies 
cannot eliminate the possibility that the changes in spontaneous and sound evoked activity 
are caused by changes in inhibitory activity. Focussing on, to what extent nNOS expression 
is associated with GABAergic neurons will need further investigation, as well as relating this 
to the distribution of both types of nNOS. Because the cells showing distributed nNOS 
expression are possibly capable of using NO as a volume transmitter, studies should further 
investigate to what extent targets of NO (e.g. sGC) are present in GABAergic cells. 
The findings of the association between nNOS and PSD95 in the central nucleus (Chapter 
3) and the functional evidence indicating a close link between nNOS activity acting on the 
NMDA receptor via sGC (Chapter 4) together with the evidence from literature that sGC 
can interact with PSD95 suggests the presence of a multiunit protein signalling complex. 
Future work should investigate whether this proposed signalling complex exists in the 
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central nucleus and possibly elsewhere in the IC using immunoprecipitation and 
immunohistochemistry employing confocal methods. 
Regardless of whether or not the NMDA receptor, nNOS and sGC are physically linked in 
a single multi-protein signalling complex, this thesis presented evidence for a functional link 
between the NMDA receptor, nNOS and sGC. Further functional studies investigating the 
existence of this complex could be designed aimed at specifically targeting the PDZ domain 
interactions between the nNOSα protein and PSD95. Drugs doing precisely that, including 
homotaurine as well as IC87201 and ZL-006 exist and have been used successfully both 
in vitro and in vivo in disrupting the binding of nNOSα to PSD95 thereby significantly 
decreasing the amount of NO produced (Dev, 2004; Doucet et al., 2012). Further in vivo 
studies using this class of drugs should lead to similar results obtained here and would 
further substantiate the current findings. Although the uncoupled nNOSα could still be 
active, and not necessarily be completely stopped from functioning.  
In both the NMDA and the salicylate studies the range of acoustic stimuli that has been 
used was limited to only brief pure tones. To study more aspects of auditory processing 
(e.g. interaural time and level differences) is will be important in future studies to look at a 
wider a range of sound stimuli.  
Some of the studies of this thesis focussed on direct effects of salicylate in the IC. The 
techniques proved to be a powerful tool and can easily be adapted to examine how activity 
in ascending and descending system affect the IC. Specific studies on the auditory pathway 
to investigating the origin of effects not mediated by direct salicylate perfusion in the IC 
could be performed recording in the central nucleus but perfusing salicylate into other 
auditory structures and observing these effects in the IC.  
Future studies will need to further investigate the salicylate effects observed here, the direct 
effects of salicylate on the IC provide fascinating windows in the way salicylate effects 
neuronal tissue. Findings presented here show that shortly after systemic salicylate 
treatment short lived decreases in activity in spontaneous activity regions of the FRA could 
suggest that low doses of salicylate help shape the frequency tuning and possibly even 
improve hearing. Further studies could be aimed at teasing apart to what extent this 
happens and whether it is a concentration or time dependent effect.  
6.4.2 Future Functional Studies
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It is unclear what the observed upward shift in the CF evident in the FRA in response to 
local or systemic salicylate would represent in terms of what the animal perceives: would 
this shift be noticeable and do these changes represent tinnitus or do they represent 
something else entirely? Future experiments need to be designed, preferably in awake and 
possibly trained animals to examine both the electrophysiological and behavioural 
consequences of these phenomena.  
6.5 Final Thoughts 
Over the last twenty-five years since it became first apparent that NO can function as a 
neurotransmitter in the brain, much progress has been made in our understanding of this 
elusive neurotransmitter. However large gaps in our knowledge still persist, we now know, 
due to the advances in immunohistochemistry techniques that nNOS is expressed 
throughout the brain but expression is especially pronounced in the brainstem regions. The 
original project plan for this thesis had a strong focus on the potential role of NO in tinnitus. 
However, it quickly became quite apparent that we had a limited understanding of NO 
signalling in general and knew even less about its role in the processes that take place in 
the IC. The focus of the project and hence this thesis shifted more towards studying basic 
properties of nNOS and NO signalling in the IC.  
The presence of nNOS in the IC, a predominantly auditory structure indicates that NO plays 
some role in auditory processing. NO signalling in the IC may be involved in pathological 
states including tinnitus. It is believed that there is a fundamental difference between onset 
and the persistence of tinnitus. The onset and transient tinnitus are due to a decrease in 
input from the auditory sense organs accompanied by increased ‘gain’, however, chronic 
tinnitus even after the sense organs have healed is probably due to neural plasticity gone 
awry. The fact that the NO-sGC pathway has been shown to be directly involved in LTP 
and LTD tells us that NO can alter the synaptic strength and this might be what is underlying 
persistent tinnitus.  
The IC is a hub for the integration of many different strands of information. The IC can be 
thought of not just in terms of subregions but within these regions specialised organisation 
exists like for example the tonotopic laminar organisation of the central nucleus and the 
existence of GABA modules in the lateral cortex.  
In order to further our understanding of how NO signalling affects processing in the IC, we 
will need to ask more specific questions, because the different nNOS distributions in 
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different subregions suggests the possibility of having different roles within these cells. 
Evidence presented here strongly suggests that there is not just one NO signalling pathway. 
Even if most of the produced NO is binding to sGC there would still be multiple possible 
pathways to be considered, with differences between pre and post synaptic occurring nNOS 
and sGC. NO has been used by living organisms since the origins of life and can be found 
in the most ancient and simple of organisms. The NO signalling pathway acting through 
sGC is observed in simple species without a real nervous system like jellyfish (Moroz and 
Kohn, 2007). Given its extremely long history in life, it should not come as a surprise that it 
may perform different functions. 
The different subcellular expressions of nNOS may have different regulatory mechanisms 
and need to be further understood. Treating nNOS as one type of protein occurring in the 
IC is an oversimplification which holds us back from asking the appropriate questions. The 
presence of nNOS in the IC is extensive and its abilities affecting other signalling pathways 
and receptor availability make it all the more important for us to understand how the different 
expression patterns operate and are regulated.  
Throughout the brain, signals are not carried by the signalling molecules themselves but by 
the receptors detecting these molecules. Just as glutamate binds to both AMPA and NMDA 
receptors, it is these receptors and their properties that determine the signal transduction 
and subsequent interpretation of the signal. In calcium signalling it is of no use to ask the 
question what the role of calcium is in a brain region because calcium is involved in so 
many different cellular processes even within one cell it performs a multitude of functions. 
We know that nNOS has a range of potential targets and even when we limit our discussion 
to its main target sGC we need to consider a variety of subunit compositions with their own 
unique properties. We need to accept that NO is likely to perform different functions in 
different cells and quite possibly in different subcellular areas of the same cell. 
My thesis has raised important issues about the splice variants, subcellular location, 
regulation and sub regional distinctions within the IC regarding nNOS. It is evident, that 
asking the question ‘how is NO related to auditory processing in the IC?’ was too naïve a 
question to ask because the reality of nNOS expression in the IC was more complex than 
previously thought. However, having uncovered some of these layers of complexity and 
having proposed some new hypothesis regarding nNOS expression in the IC, I do believe 
that we are now in a position to take into account these factors and that will help us move 
toward, and eventually gain a full understanding of NO signalling in the IC.  
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